Publications

Publications published since 2010 from OUS - Department of Oncology

2623 publications found (only first 1000 shown)

Publications 2025

Amat-Fernandez C, Garin O, Luer-Aguila R, Pardo Y, Briseño R, Lizano-Barrantes C, Rojas-Concha L, S Y Thong M, Apolone G, Brunelli C, Caraceni A, Couespel N, Bos N, Groenvold M, Kaasa S, Ciliberto G, Lombardo C, Pietrobon R, Pravettoni G, Sirven A, Vachon H, Gilbert A, Velikova G, Ferrer M, EUonQoL Working Group (2025)
Systematic review of the needs and health-related quality of life domains relevant to people surviving cancer in Europe
Qual Life Res, 34 (4), 913-936
DOI 10.1007/s11136-024-03884-w, PubMed 39847267
Ascierto PA, Tang H, Dolfi S, Nyakas M, Marie Svane I, Muñoz-Couselo E, Grob JJ, Gomez-Roca CA, Chiarion-Sileni V, Peltola K, Larkin J, Melero I, Callahan M, Dummer R, Djidel P, Warad D, Reusser-Wolf D, Lipson EJ, Garnett-Benson C (2025)
Effect of prior and first-line immunotherapy on baseline immune biomarkers and modulation of the tumor microenvironment in response to nivolumab and relatlimab combination therapy in patients with melanoma from RELATIVITY-020
J Immunother Cancer, 13 (2)
DOI 10.1136/jitc-2024-009773, PubMed 40010775
Banys-Paluchowski M, Hartmann S, Basali T, Gasparri ML, de Boniface J, Gentilini OD, Cakmak GK, Ditsch N, Stickeler E, Schlichting E, Rubio I, Peintinger F, Untch M, Mau C, Federspiel FK, Bucher S, Ramaker K, Paluchowski P, Bauer L, Riemer S, Langanke D, Leuf TD, Schnabel J, von Abel E, Solbach C et al. (2025)
Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial
Breast Cancer Res Treat, 211 (1), 203-211
DOI 10.1007/s10549-025-07635-4, PubMed 39976867
Berner K, Hernes E, Kvassheim M, Revheim ME, Bastiansen J, Selboe S, Bakken CL, Grønningsæter SR, Bruland ØS, Larsen RH, Bouzelmat L, Jardine VL, Stokke C (2025)
First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted ²¹²Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer
J Nucl Med, 66 (5), 732-738
DOI 10.2967/jnumed.124.269299, PubMed 40081958
Bjelic-Radisic V, Cardoso F, Weis J, Pogoda K, Arraras JI, Greimel E, Bottomley A, Cameron D, Brain E, Hartup S, da Costa Vieira RA, Hoefnagels N, Huang CC, Shamieh O, Pinto M, Belay YB, Serpentini S, Bleiker E, Nookala Krishnamurthy M, Shimomura A, Sturm-Inwald EC, Getu MA, Bliem B, Astrup G, Morag O et al. (2025)
An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42
Breast, 80, 103890
DOI 10.1016/j.breast.2025.103890, PubMed 39947087
Bregni G, Adams R, Bale R, Bali MA, Bargellini I, Blomqvist L, Brown G, Cremolini C, Demetter P, Denecke T, Dohan A, Dopazo C, Elez E, Evrard S, Feakins R, Guckenberger M, Guren MG, Hawkins M, Hoorens A, Huguet E, Intven M, Koessler T, Kunz WG, Lordick F, Lucidi V et al. (2025)
EORTC consensus recommendations on the optimal management of colorectal cancer liver metastases
Cancer Treat Rev, 136, 102926
DOI 10.1016/j.ctrv.2025.102926, PubMed 40179590
Casali PG, Antoine-Poirel H, Berrocoso S, Blay JY, Dubois T, Ferrari A, Fullaondo A, Hovig E, Jagodzińska-Mucha P, Ługowska I, Kaasa S, Nicoară D, Pletsa V, Provenzano S, Santoro M, Šekerija M, Van Hoof W, Vyas M, Trama A, JANE Consortium (2025)
Health networking on cancer in the European Union: a 'green paper' by the EU Joint Action on Networks of Expertise (JANE)
ESMO Open, 10 (2), 104126
DOI 10.1016/j.esmoop.2024.104126, PubMed 39874899
Cilla S, Rossi R, Donati CM, Habberstad R, Klepstad P, Dall'Agata M, Valenti V, Kaasa S, Medici F, Morganti AG, Maltoni M (2025)
Pain Management Adequacy in Patients With Bone Metastases: A Secondary Analysis From the Palliative Radiotherapy and Inflammation Study Trial
Clin Med Insights Oncol, 19, 11795549241297054
DOI 10.1177/11795549241297054, PubMed 40144780
Connolly EA, Boye K, Bonvalot S, Kratz CP, Leithner A, Malkin D, Messiou C, Miah AB, Pantziarka P, Timmermann B, van der Graaf WTA, Thomas DM, Stacchiotti S (2025)
Genetic predisposition in sarcomas: clinical implications and management
EClinicalMedicine, 83, 103203
DOI 10.1016/j.eclinm.2025.103203, PubMed 40291347
Dajani O, Philips I, Størkson EK, Balstad TR, Brown LR, Bye A, Dolan R, Greil C, Hjermstad M, Jakobsen G, Kaasa S, McDonald J, Ottestad I, Sayers J, Simpson M, Sousa MS, Vagnildhaug OM, Yule MS, Laird BJA, Skipworth RJE, Solheim TS, Stares M, Arends J, Cancer Cachexia Endpoints Working Group (2025)
Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoints Series
J Cachexia Sarcopenia Muscle, 16 (2), e13756
DOI 10.1002/jcsm.13756, PubMed 40065459
Daw S, Claviez A, Kurch L, Stoevesandt D, Attarbaschi A, Balwierz W, Beishuizen A, Cepelova M, Ceppi F, Fernandez-Teijeiro A, Fosså A, Georgi TW, Hjalgrim LL, Hraskova A, Leblanc T, Mascarin M, Pears J, Landman-Parker J, Prelog T, Klapper W, Ramsay A, Kluge R, Dieckmann K, Pelz T, Vordermark D et al. (2025)
Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical Trial
JAMA Oncol, 11 (3), 258-267
DOI 10.1001/jamaoncol.2024.5636, PubMed 39745682
Donia M, Jespersen H, Jalving M, Lee R, Eriksson H, Hoeller C, Hernberg M, Gavrilova I, Kandolf L, Liszkay G, Helgadottir H, Zhukavets A, Pianova D, Marquez-Rodas I, Neyns B, Westgeest H, Pourmir I, Sobczuk P, Ellebaek E, Amaral T (2025)
Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028
ESMO Open, 10 (3), 104295
DOI 10.1016/j.esmoop.2025.104295, PubMed 39954389
Engelaar M, van Schelven F, Bos N, L'Hote M, Rialland C, Couespel N, Dantas C, Higgins C, Kalmi T, Minnée-van Braak I, Pinnavaia L, Apolone G, Brunelli C, Caraceni A, Ferrer M, Groenvold M, Kaasa S, Ciliberto G, Lombardo C, Pietrobon R, Pravettoni G, Sirven A, Vachon H, Velikova G, Rademakers J (2025)
Evaluating the Involvement of People With Cancer and Informal Caregivers in the Development Process of a New Set of Quality of Life Questionnaires
Health Expect, 28 (3), e70267
DOI 10.1111/hex.70267, PubMed 40297991
Engh A, Rueegg CS, Bjerre Trent PK, Opheim LØ, Engeskaug I, Nordskar NJ, Bakken A, Steene-Johannessen J, Eriksson AGZ, Thorsen L (2025)
Physical activity and lower extremity lymphedema among endometrial cancer survivors: A population-based cross-sectional study
Gynecol Oncol, 195, 82-88
DOI 10.1016/j.ygyno.2025.03.009, PubMed 40086214
Eriksen JG, Maare C, Johansen J, Primdahl H, Bratland Å, Kristensen CA, Andersen M, Alsner J, Overgaard J, DAHANCA (2025)
DAHANCA19: A randomized phase III study of primary curative (chemo)-radiotherapy and the EGFR-inhibitor zalutumumab for squamous cell carcinoma of the head and neck
Radiother Oncol, 208, 110899 (in press)
DOI 10.1016/j.radonc.2025.110899, PubMed 40258418
Fager A, Samuelsson M, Olofsson Bagge R, Pivodic A, Bjursten S, Levin M, Jespersen H, Ny L (2025)
Immune checkpoint inhibitor therapy is associated with a decreased risk of developing melanoma brain metastases
BJC Rep, 3 (1), 22
DOI 10.1038/s44276-025-00137-2, PubMed 40217072
Festvåg LE, Sverre BL, Paulsen Ø, Eilertsen G (2025)
The value of home-based advance care planning in addressing existential concerns among older Norwegian patients with cancer and their relatives: A narrative ethnographic study
Palliat Care Soc Pract, 19, 26323524251330658
DOI 10.1177/26323524251330658, PubMed 40291547
Flølo TN, Tørris C, Riiser K, Almendingen K, Chew HSJ, Fosså A, Albertini Früh E, Hennessy E, Leung MM, Misvær N, Pavel N, Sundar TKB, Sæterstrand TM, Torbjørnsen A, Løyland B, Holmen H (2025)
Digital health interventions to treat overweight and obesity in children and adolescents: An umbrella review
Obes Rev, e13905 (in press)
DOI 10.1111/obr.13905, PubMed 39972996
Forsgren E, Jørgensen RRK, Bentzen H, Riise J, Haaber J, Pasanen A, Kuitunen H, Wader KF, El-Galaly TC, Hutchings M, Glimelius I, Jerkeman M (2025)
Ibrutinib, lenalidomide, and rituximab in relapsed mantle cell lymphoma: Long-term follow-up of the Nordic Lymphoma Group MCL6 Philemon trial
Hemasphere, 9 (3), e70101
DOI 10.1002/hem3.70101, PubMed 40104044
Fosså A, Molin D, Bröckelmann PJ, Schneider G, Schnetzke U, Linderoth J, Kamper PMH, Leppä SM, Meissner J, Schaub V, Lia K, Fuchs M, Borchmann P, Böll B (2025)
Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG-NLG phase II BVB trial
Hemasphere, 9 (3), e70099
DOI 10.1002/hem3.70099, PubMed 40124718
Fosså SD, Bjerner LJ, Tandstad T, Brydøy M, Dahl AA, Nome RV, Negaard H, Myklebust TÅ, Haugnes HS (2025)
Biochemical Hypogonadism in Aging Testicular Cancer Survivors: A Clinical Challenge
Eur Urol Open Sci, 72, 10-16
DOI 10.1016/j.euros.2024.12.010, PubMed 39897186
Frøen HM, Brodtkorb M, Holte H, Kolstad A, Myhre AE, Remberger M, Tjønnfjord GE, Gedde-Dahl T (2025)
Allogeneic stem cell transplantation for patients with lymphoma 2011-21
Tidsskr Nor Laegeforen, 145 (3)
DOI 10.4045/tidsskr.24.0443, PubMed 40042014
Garcia-Foncillas J, Bayle A, Arnold D, Avouac B, Awada A, de la Cruz-Merino L, Helland Å, Lassen U, Laurent-Puig P, Normanno N, Rohrberg K, Taieb J, Stenzinger A (2025)
Overcoming barriers to advanced biomolecular technologies that inform treatment of solid tumors: a roadmap to access
Future Oncol, 1-8 (in press)
DOI 10.1080/14796694.2025.2501523, PubMed 40340714
Ghadimi M, Pelzer U, Besselink MG, Siveke J, Telgmann R, Braren R, Wilmink H, Crede M, Koenig A, Koenig U, Liffers ST, Antweiler K, Uijterwijk B, Seppanen H, Nordin A, Puolakkainen P, Dajani OF, Labori KJ, Johansson M, Bratlie SO, Friede T, Jo P (2025)
Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial
BMC Cancer, 25 (1), 208
DOI 10.1186/s12885-025-13573-7, PubMed 39915735
Grønberg BH, Killingberg KT, Fløtten Ø, Bjaanæs MM, Brustugun OT, Madebo T, Langer SW, Risumlund SL, Schytte T, Helbekkmo N, Neumann K, Yksnøy Ø, Engleson J, Fluge S, Naustdal T, Giske LE, Nyman J, Tsakonas G, Halvorsen TO (2025)
High-dose versus standard dose twice-daily thoracic radiotherapy in limited stage small-cell lung cancer: final survival data, long-term toxicity and relapse patterns in a randomised, open-label, phase II trial
J Thorac Oncol (in press)
DOI 10.1016/j.jtho.2025.04.007, PubMed 40258573
Heggebø LC, Borgen IMH, Blakstad H, Saxhaug C, Rønning PA, Niehusmann PF, Werlenius K, Blomstrand M, Brandal P (2025)
Case report: Pseudoprogression mimicking neoplastic recurrence three months after completion of proton beam therapy for an IDH-mutant astrocytoma CNS WHO grade 3
Front Oncol, 15, 1397912
DOI 10.3389/fonc.2025.1397912, PubMed 39949738
Hoppe R, Winter S, Lo WY, Michailidou K, Bolla MK, Keeman R, Wang Q, Dennis J, Lush M, Kalari KR, Goetz MP, Wang L, Cairns J, Weinshilboum R, Shepherd L, Chen BE, Häberle L, Ruebner M, Beckmann MW, He W, Larson NL, Armasu SM, Schroth W, Chowbay B, Khor CC et al. (2025)
Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer
NPJ Breast Cancer, 11 (1), 18
DOI 10.1038/s41523-025-00733-y, PubMed 39971965
Hustad KS, Koteng LH, Urrizola A, Arends J, Bye A, Dajani O, Deliens L, Fallon M, Hjermstad MJ, Kohlen M, Kurita GP, Lundeby T, Mitrea N, Payne C, Roselló-Keränen S, Warmbrodt N, de Wilde A, Kaasa S, de Vos-Geelen J, Laird BJA, MyPath consortium (2025)
Practical cancer nutrition, from guidelines to clinical practice: a digital solution to patient-centred care
ESMO Open, 10 (4), 104529
DOI 10.1016/j.esmoop.2025.104529, PubMed 40179818
Inderberg EM, Singh N, Miller R, Arbe-Barnes S, Eriksen HK, Lversen B, Juul HV, Eriksen JA, Handeland KR (2025)
Generation of frameshift-mutated TGFβR2-specific T cells in healthy subjects following administration with cancer vaccine candidate FMPV-1/GM-CSF in a phase 1 study
Cancer Immunol Immunother, 74 (4), 115
DOI 10.1007/s00262-025-03969-6, PubMed 39998682
Kimby E, Schär S, Pirosa MC, Vanazzi A, Mey UM, Rauch D, Wahlin BE, Hitz F, Hernberg M, Johansson AS, de Nully Brown P, Hagberg H, Ferreri AJM, Krasniqi F, Voegeli M, Novak U, Zander T, Bersvendsen H, Mamot C, Mingrone W, Stathis A, Dirnhofer S, Hayoz S, Østenstad B, Zucca E (2025)
Six-month rituximab-lenalidomide regimen in advanced untreated follicular lymphoma: SAKK 35/10 trial 10-year update
Blood Adv, 9 (7), 1712-1719
DOI 10.1182/bloodadvances.2024014840, PubMed 39883948
Kolstad A, Emanuel G, Hjortland GO, Nilssen Y, Ulvestad M, Areffard A, Aahlin EK (2025)
Long-term trends in the clinical management and outcomes of patients with gastroesophageal cancer in Norway
Acta Oncol, 64, 540-549
DOI 10.2340/1651-226X.2025.43167, PubMed 40235057
Kvæl LAH, Bye A, Bergland A, Fromholt Olsen C (2025)
Healthcare professionals' experiences of the Four Habits Model communication course: a qualitative and survey approach to evaluate impact in an intermediate care setting
BMJ Open, 15 (3), e091143
DOI 10.1136/bmjopen-2024-091143, PubMed 40132831
Laird BJA, Skipworth R, Bonomi PD, Fallon M, Kaasa S, Giorgino R, McMillan DC, Currow DC (2025)
Anamorelin Efficacy in Non-Small-Cell Lung Cancer Patients With Cachexia: Insights From ROMANA 1 and ROMANA 2
J Cachexia Sarcopenia Muscle, 16 (1), e13732
DOI 10.1002/jcsm.13732, PubMed 39992021
Larsen BH, Gerwing J, Lundeby T, Gulbrandsen P, Førde R (2025)
More than an extra set of ears: A video-based analysis exploring the role of companions in routine oncology visits
J Psychosoc Oncol, 1-22 (in press)
DOI 10.1080/07347332.2025.2457964, PubMed 39910871
Leysen L, Marticic Giljevic K, Piccinin C, Shkodra M, Pe M, Petersen M, Apolone G, Brunelli C, Lombardo C, Velikova G, Gilbert A, Pravettoni G, Ciliberto G, Groenvold M, Ferrer M, Bos N, Pietrobon R, Couespel N, Caraceni A, Guren M, Sirven A, Vachon H, EUonQOL consortium (2025)
Evaluation of the psychometric properties of patient-reported outcome measures of health-related quality of life across the European cancer continuum: a systematic review protocol using COSMIN methodology
BMJ Open, 15 (3), e088716
DOI 10.1136/bmjopen-2024-088716, PubMed 40157731
Lia K, Jørgensen RRK, Wikman P, Wold BL, Övergaard N, Fluge Ø, Fagerli UM, Bersvendsen H, Bø IB, Bhargava S, Molin D, Fosså A (2025)
A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma
Haematologica (in press)
DOI 10.3324/haematol.2025.287509, PubMed 40270216
Lindberg S, Grozman V, Karlsson K, Onjukka E, Lindbäck E, Palme JÖ, Jirf KA, Lax I, Wersäll P, Persson GF, Josipovic M, Khalil AA, Møller DS, Hoffmann L, Knap MM, Nyman J, Drugge N, Bergström P, Olofsson J, Rogg LV, Traa T, Hagen RK, Frøland AS, Ramberg C, Kristiansen C et al. (2025)
Stereotactic body radiation therapy (SBRT) of centrally located medically inoperable early-stage non-small cell lung cancer (T1-T3N0M0) - A subgroup analysis of the expanded HILUS study
Lung Cancer, 203, 108527 (in press)
DOI 10.1016/j.lungcan.2025.108527, PubMed 40184836
Liu Q, Fuster-Garcia E, Hovden IT, MacIntosh BJ, Grodem EOS, Brandal P, Lopez-Mateu C, Sederevicius D, Skogen K, Schellhorn T, Bjornerud A, Emblem KE (2025)
Treatment-aware Diffusion Probabilistic Model for Longitudinal MRI Generation and Diffuse Glioma Growth Prediction
IEEE Trans Med Imaging, PP (in press)
DOI 10.1109/TMI.2025.3533038, PubMed 40031286
Ludvigsen LUP, Åsberg A, Spetalen S, Sørensen MD, Hamilton-Dutoit S, Gramkow AM, Christiansen CF, Kro GB, Thomsen MK, Ulrichsen SP, Pedersen RM, Holte H, Thiesson HC, Bjerre A, D'Amore F, Dahle DO, Jespersen B, Jensen-Fangel S, Reisæter AV (2025)
Risk and prognosis of posttransplant lymphoproliferative disease in Epstein-Barr virus-seronegative kidney transplant recipients - an observational cohort study from Norway and western Denmark
Am J Transplant (in press)
DOI 10.1016/j.ajt.2025.01.035, PubMed 39884653
Lunde P, Bye A, Grimsmo J, Pripp AH, Ritschel V, Jarstad E, Nilsson BB (2025)
Effects of Individualized Follow-Up With an App Postcardiac Rehabilitation: Five-Year Follow-Up of a Randomized Controlled Trial
J Med Internet Res, 27, e60256
DOI 10.2196/60256, PubMed 39946716
Maravelia P, Yao H, Cai C, Nascimento Silva D, Fransson J, Nilsson OB, Lu YW, Micke P, Botling J, Gatto F, Rovesti G, Carlsten M, Sallberg M, Stål P, Jorns C, Buggert M, Pasetto A (2025)
Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation
Gut (in press)
DOI 10.1136/gutjnl-2024-334148, PubMed 39832892
Marhelava K, Fidyt K, Pepek M, Krawczyk M, Forcados C, Malinowska A, Swiderska B, Fernandez-Fuentes N, Czerwik N, Baranowska I, Krzywdzinska A, Sedek L, Slota L, Perkowski B, Villatoro A, Leray T, Lech-Maranda E, Menendez P, Inderberg EM, Wälchli S, Winiarska M, Firczuk M (2025)
LILRB1-directed CAR-T cells for the treatment of hematological malignancies
Leukemia (in press)
DOI 10.1038/s41375-025-02580-z, PubMed 40186066
Marzorati C, Voskanyan V, Sala D, Grasso R, Borgogni F, Pietrobon R, van der Heide I, Engelaar M, Bos N, Caraceni A, Couspel N, Ferrer M, Groenvold M, Kaasa S, Lombardo C, Sirven A, Vachon H, Gilbert A, Brunelli C, Apolone G, Pravettoni G, EUonQoL Consortium (2025)
Psychosocial factors associated with quality of life in cancer patients undergoing treatment: an umbrella review
Health Qual Life Outcomes, 23 (1), 31
DOI 10.1186/s12955-025-02357-z, PubMed 40188134
Mazzotti L, Borges de Souza P, Azzali I, Angeli D, Nanni O, Sambri V, Semprini S, Bravaccini S, Cerchione C, Gaimari A, Nicolini F, Ancarani V, Martinelli G, Pasetto A, Calderon H, Juan M, Mazza M (2025)
Exploring the Relationship Between Humoral and Cellular T Cell Responses Against SARS-CoV-2 in Exposed Individuals From Emilia Romagna Region and COVID-19 Severity
HLA, 105 (1), e70011
DOI 10.1111/tan.70011, PubMed 39807702
Medhus A, Schink KO, Longva AS, Engebraaten O, Berg K, Weyergang A (2025)
The mechanisms of HER2 targeted ADCs are dependent on Rab GTPases
Ther Adv Med Oncol, 17, 17588359251332473
DOI 10.1177/17588359251332473, PubMed 40297622
Minnai F, Shkodra M, Noci S, Esposito M, Brunelli C, Pigni A, Zecca E, Skorpen F, Klepstad P, Kaasa S, Corli O, Pallotti MC, Maltoni MC, Caraceni AT, Colombo F (2025)
A genome-wide association study of European advanced cancer patients treated with opioids identifies regulatory variants on chromosome 20 associated with pain intensity
Eur J Pain, 29 (1), e4764
DOI 10.1002/ejp.4764, PubMed 39629963
Njølstad TH, Jensen K, Andersen HK, Berstad AE, Hagen G, Johansen CK, Øye K, Glittum J, Dybwad A, Thingstad E, Guren MG, Dormagen JB, Schulz A (2025)
Deep learning reconstruction for detection of liver lesions at standard-dose and reduced-dose abdominal CT
Eur Radiol (in press)
DOI 10.1007/s00330-025-11596-z, PubMed 40251443
Nyen JE, Booth AØ, Husby Ø, Bugge C, Engebretsen I, Oteiza F, Helland Å, Fjellbirkeland L, Brustugun OT, Grønberg BH (2025)
Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients - a nationwide and longitudinal study
Front Oncol, 15, 1506041
DOI 10.3389/fonc.2025.1506041, PubMed 40052133
Nyen JE, Booth AØ, Husby Ø, Bugge C, Engebretsen I, Oteiza F, Helland Å, Fjellbirkeland L, Brustugun OT, Grønberg BH (2025)
Corrigendum: Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients - a nationwide and longitudinal study
Front Oncol, 15, 1595028
DOI 10.3389/fonc.2025.1595028, PubMed 40206591
Ost P, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Everaerts W, Shelan M, Conde-Moreno A, López Campos F, Papachristofilou A, Guckenberger M, Scorsetti M, Zapatero A, Villafranca Iturre AE, Eito C, Couñago F, Muto P, Duthoy W, Mach N, Fonteyne V, Moon D, Thon K, Mercier C et al. (2025)
Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial
Lancet Oncol (in press)
DOI 10.1016/S1470-2045(25)00197-4, PubMed 40339593
Pati NB, Jin Y, Kumar S, Kyte JA, Ciosk R (2025)
Thermal potentiation improves IFN-γ production but not cytotoxicity in human CAR-T cells
BMC Res Notes, 18 (1), 192
DOI 10.1186/s13104-025-07249-5, PubMed 40270044
Pierson SK, Brandstadter JD, Torigian DA, Bagg A, Lechowicz MJ, Alapat D, Casper C, Chadburn A, Chandrakasan S, Dispenzieri A, Fosså A, Hoffmann C, Ide M, Kurzrock R, Mukherjee S, Nasta S, Navarro JT, Noy A, Oksenhendler E, Bustamante MS, Shyamsundar S, Streetly M, Wong RSM, Zhang L, Lim MS et al. (2025)
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry
Blood Adv, 9 (8), 1952-1965
DOI 10.1182/bloodadvances.2024014391, PubMed 39951615
Schytte T, Knap MM, Kristiansen C, Appelt AL, Khalil A, Peucelle C, Lutz CM, Møller DS, Sande EPS, Sundby F, Persson G, Schmidt H, Land LH, Rogg L, Pøhl M, Lund MD, Nielsen M, Levin N, Hansen O, Thing RS, Borissova S, Halvorsen T, Nielsen TB, Hansen TS, Haakensen VD et al. (2025)
Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial
J Clin Oncol, JCO2401386 (in press)
DOI 10.1200/JCO-24-01386, PubMed 40249893
Skipar K, Hompland T, Lund KV, Fjeldbo CS, Lindemann K, Hellebust TP, Lyng H, Bruheim K (2025)
Tolerability, safety and feasibility of metformin combined with chemoradiotherapy in patients with locally advanced cervical cancer: A phase II, randomized study
Acta Oncol, 64, 439-447
DOI 10.2340/1651-226X.2025.43045, PubMed 40105683
Skåre TS, Lundeby T, Lund JÅ, Hjermstad MJ, Midtbust MH (2025)
First-time use of electronic patient-reported outcome measures in a cluster randomized trial: a qualitative study
J Patient Rep Outcomes, 9 (1), 9
DOI 10.1186/s41687-025-00840-1, PubMed 39832107
Skaarud KJ, Gudmundstuen AM, Pesonen M, Hjermstad MJ, Iversen PO, Tjønnfjord GE (2025)
The role of fat-soluble vitamins for graft-versus host disease after myeloablative conditioning in allogeneic stem cell transplanted patients
Sci Rep, 15 (1), 1675
DOI 10.1038/s41598-024-84805-2, PubMed 39799129
Smedman TM, Line PD, Dueland S (2025)
Assessing the attitudes of next of kin toward living donor liver transplantation for patients with colorectal liver metastases
Scand J Surg, 14574969251335467 (in press)
DOI 10.1177/14574969251335467, PubMed 40271620
Storaas E, Switlyk MD, Dahl S, Amdal CD, Bratland Å, Huynh TM, Eide HA, Vischioni B, Orlandi E, Dale E (2025)
Distinct patterns of osteoradionecrosis after photon-based radiotherapy and carbon ion radiotherapy for unresectable adenoid cystic carcinoma of the head and neck: case series from two institutions
Acta Oncol, 64, 63-68
DOI 10.2340/1651-226X.2025.42209, PubMed 39813173
Svalastoga M, Larsen TL, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2025)
Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism
Front Oncol, 15, 1520725
DOI 10.3389/fonc.2025.1520725, PubMed 39931081
Sæter M, Johansen SH, Reinertsen KV, Thorsen L, Haugaa KH, Nilsen TS, Sarvari SI (2025)
Cardiorespiratory fitness, cardiac morphology and function, and cardiovascular risk factors in long-term breast cancer survivors compared with non-cancer controls
Cardiooncology, 11 (1), 1
DOI 10.1186/s40959-024-00296-0, PubMed 39755716
Tahara M, Greil R, Rischin D, Harrington KJ, Burtness B, de Castro G, Psyrri A, Braña I, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Ishak WZW, Lin J, Gumuscu B, Lerman N, Soulières D (2025)
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study
Eur J Cancer, 221, 115395
DOI 10.1016/j.ejca.2025.115395, PubMed 40262400
Thomassen D, Roychoudhury S, Amdal CD, Reynders D, Musoro JZ, Sauerbrei W, Goetghebeur E, le Cessie S, SISAQOL-IMI Work Package 3 (2025)
Handling missing values in patient-reported outcome data in the presence of intercurrent events
BMC Med Res Methodol, 25 (1), 56
DOI 10.1186/s12874-025-02510-8, PubMed 40025441
Ullmann Miller J, Fauske L, Sigurdardottir S, Arfa S, von der Lippe C (2025)
'In the dark': parents' lifelong commitment to supporting children with Bardet-Biedl syndrome
Health Psychol Behav Med, 13 (1), 2467432
DOI 10.1080/21642850.2025.2467432, PubMed 39968158
Wei Q, Foyn H, Landskron J, Wang S, Rye IH, Skånland SS, Russnes HEG, Klaveness J, Ahmad R, Taskén K (2025)
Identification of a group of 9-amino-acridines that selectively downregulate regulatory T cell functions through FoxP3
iScience, 28 (3), 111931
DOI 10.1016/j.isci.2025.111931, PubMed 40034859
Yaqub S, Busund S, Smedman TM, Syversveen T, Khan A, Solheim JM, Folseraas T, Wiencke K, Lassen K, Dueland S, Line PD (2025)
Liver transplantation for locally advanced non-resectable intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: early results from the TESLA trial
Br J Surg, 112 (3)
DOI 10.1093/bjs/znaf054, PubMed 40099404
Yaqub S, Longva A, Angelsen JH, Brudvik KW, Carling U, Edwin B, Fretland ÅA, Grünhagen DJ, Line PD, Røsok BI, Smedman TM, Sparrelid E, Syversveen T, Villanger O, Lassen K (2025)
Multimodal treatment for colorectal liver metastases: A toolbox for clinicians
Scand J Surg, 14574969251333524 (in press)
DOI 10.1177/14574969251333524, PubMed 40247715
Yip D, Zalcberg J, Blay JY, Eriksson M, Espinoza D, Price T, Marreaud S, Italiano A, Steeghs N, Boye K, Underhill C, Gebski V, Simes J, Gelderblom H, Joensuu H (2025)
Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial
Br J Cancer (in press)
DOI 10.1038/s41416-025-02983-w, PubMed 40133509
Yri OE, Kaasa S (2025)
A balancing ACT: maximizing the benefits of appropriate brain radiation therapy-authors' reply
Lancet Reg Health Eur, 52, 101291
DOI 10.1016/j.lanepe.2025.101291, PubMed 40247950
Åsberg E, Giskeødegård GF, Karlsen J, Kiserud CE, Aune G, Nilsen M, Reidunsdatter RJ (2025)
Sexual health in female and male cancer survivors - compared with age-matched cancer-free controls in Norway
Acta Oncol, 64, 380-390
DOI 10.2340/1651-226X.2025.42451, PubMed 40052251

Publications 2024

Alm-Kruse K, Gjerset GM, Tjelmeland IBM, Isern CB, Kramer-Johansen J, Garratt AM (2024)
How do survivors after out-of-hospital cardiac arrest perceive their health compared to the norm population? A nationwide registry study from Norway
Resusc Plus, 17, 100549
DOI 10.1016/j.resplu.2023.100549, PubMed 38292469
Andresen NK, Røssevold AH, Borgen E, Schirmer CB, Gilje B, Garred Ø, Lømo J, Stensland M, Nordgård O, Falk RS, Mathiesen RR, Russnes HG, Kyte JA, Naume B (2024)
Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors - a biomarker analysis of the ALICE and ICON trials
Mol Oncol (in press)
DOI 10.1002/1878-0261.13675, PubMed 38978352
Andresen NK, Røssevold AH, Quaghebeur C, Gilje B, Boge B, Gombos A, Falk RS, Mathiesen RR, Julsrud L, Garred Ø, Russnes HG, Lereim RR, Chauhan SK, Lingjærde OC, Dunn C, Naume B, Kyte JA (2024)
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial
J Immunother Cancer, 12 (1)
DOI 10.1136/jitc-2023-007990, PubMed 38242720
Apolone G, Costantini M, Caselli L, Bos N, Caraceni A, Ciliberto G, Couespel N, Ferrer M, Groenvold M, Kaasa S, Lombardo C, Pietrobon R, Pravettoni G, Sirven A, Vachon H, Velikova G, Garin O, Gilbert A, Machiavelli A, Marzorati C, Miceli R, Pe M, Petersen MA, Tanzilli A, van Schelven F et al. (2024)
Validation of the European Oncology toolkit for the self-assessment of Quality of Life (EUonQoL-Kit) in cancer patients and survivors: study protocol of a pan European survey
BMC Public Health, 24 (1), 3517
DOI 10.1186/s12889-024-21008-4, PubMed 39696103
Areklett EW, Hagen BI, Stubberud J, Fagereng E, Andersson S, Lindemann K (2024)
Digital goal management training for cognitive impairment in cervical cancer survivors-a randomized comparison study
J Cancer Surviv (in press)
DOI 10.1007/s11764-024-01701-4, PubMed 39576570
Arffman M, Meriranta L, Autio M, Holte H, Jørgensen J, Brown P, Jyrkkiö S, Jerkeman M, Drott K, Fluge Ø, Björkholm M, Karjalainen-Lindsberg ML, Beiske K, Pedersen MØ, Leivonen SK, Leppä S (2024)
Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas
Med, 5 (6), 583-602.e5
DOI 10.1016/j.medj.2024.03.007, PubMed 38579729
Ask EH, Tschan-Plessl A, Hoel HJ, Kolstad A, Holte H, Malmberg KJ (2024)
MetaGate: Interactive analysis of high-dimensional cytometry data with metadata integration
Patterns (N Y), 5 (7), 100989
DOI 10.1016/j.patter.2024.100989, PubMed 39081571
Autio M, Brück O, Pollari M, Karjalainen-Lindsberg ML, Beiske K, Jørgensen JM, Holte H, Pellinen T, Leivonen SK, Leppä S (2024)
Characterization of tumor microenvironment and cell interaction patterns in testicular and diffuse large B-cell lymphomas
Haematologica (in press)
DOI 10.3324/haematol.2024.286267, PubMed 39665214
Azim HA, Niman SM, Partridge AH, Demeestere I, Ruggeri M, Colleoni M, Saura C, Shimizu C, Saetersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Ruíz-Borrego M, Moore HCF, Saunders C, Bjelic-Radisic V et al. (2024)
Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy
J Clin Oncol, 42 (23), 2822-2832
DOI 10.1200/JCO.23.02292, PubMed 38810178
Bai B, Wise JF, Vodák D, Nakken S, Sharma A, Blaker YN, Brodtkorb M, Hilden V, Trøen G, Ren W, Lorenz S, Lawrence MS, Myklebost O, Kimby E, Pan-Hammarström Q, Steen CB, Meza-Zepeda LA, Beiske K, Smeland EB, Hovig E, Lingjærde OC, Holte H, Myklebust JH (2024)
Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma
Blood Cancer J, 14 (1), 147
DOI 10.1038/s41408-024-01124-5, PubMed 39191762
Bjerre Trent PK, Nordskar NJ, Wangen KR, Engeskaug MI, Opheim MLØ, Aune G, Staff AC, Thorsen L, Falk RS, Eriksson AGZ (2024)
Corrigendum to "Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional study" [Gynecologic Oncology 175 (2023) 72-80]
Gynecol Oncol, 183, 7-8
DOI 10.1016/j.ygyno.2024.02.026, PubMed 38484693
Bjerring AW, Smeland KH, Stokke T, Haugaa KH, Holte E, Rösner A, Kiserud CE, Edvardsen T, Sarvari SI (2024)
Long-term cardiac effects of modern treatment for Hodgkin's lymphoma
Cardiooncology, 10 (1), 19
DOI 10.1186/s40959-024-00222-4, PubMed 38576044
Bjørgo E, Fagereng GL, Russnes HG, Smeland S, Taskén K, Helland Å (2024)
Acta Oncologica Nordic Precision Cancer Medicine Symposium 2023 - merging clinical research and standard healthcare
Acta Oncol, 63, 487-490
DOI 10.2340/1651-226X.2024.24954, PubMed 38910311
Blakstad H, Mendoza Mireles EE, Kierulf-Vieira KS, Singireddy D, Mdala I, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Vik-Mo EO, Brandal P (2024)
The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients
J Neurooncol, 169 (1), 137-145
DOI 10.1007/s11060-024-04709-z, PubMed 38762830
Bobrowicz M, Kusowska A, Krawczyk M, Zhylko A, Forcados C, Slusarczyk A, Barankiewicz J, Domagala J, Kubacz M, Šmída M, Dostalova L, Marhelava K, Fidyt K, Pepek M, Baranowska I, Szumera-Cieckiewicz A, Inderberg EM, Wälchli S, Granica M, Graczyk-Jarzynka A, Majchrzak M, Poreba M, Gehlert CL, Peipp M, Firczuk M et al. (2024)
CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies
Oncoimmunology, 13 (1), 2362454
DOI 10.1080/2162402X.2024.2362454, PubMed 38846084
Borchmann P, Ferdinandus J, Schneider G, Moccia A, Greil R, Hertzberg M, Schaub V, Hüttmann A, Keil F, Dierlamm J, Hänel M, Novak U, Meissner J, Zimmermann A, Mathas S, Zijlstra JM, Fosså A, Viardot A, Hertenstein B, Martin S, Giri P, Scholl S, Topp MS, Jung W, Vucinic V et al. (2024)
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial
Lancet, 404 (10450), 341-352
DOI 10.1016/S0140-6736(24)01315-1, PubMed 38971175
Brativnyk A, Ankill J, Helland Å, Fleischer T (2024)
Multi-omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma
Int J Cancer, 155 (2), 282-297
DOI 10.1002/ijc.34915, PubMed 38489486
Bratteteig M, Rueegg CS, Lie HC, Thorsen L, Larsen EH, Larsen MH, Torsvik IK, Götte M, Järvelä LS, Kriemler S, Larsen HB, Anderssen SA, Ruud E, Grydeland M (2024)
Physical activity behaviors and screen time in young childhood cancer survivors: the Physical Activity in Childhood Cancer Survivors Study
J Cancer Surviv (in press)
DOI 10.1007/s11764-024-01671-7, PubMed 39287916
Brenne AT, Løhre ET, Knudsen AK, Lund JÅ, Thronæs M, Driller B, Brunelli C, Kaasa S (2024)
Standardizing Integrated Oncology and Palliative Care Across Service Levels: Challenges in Demonstrating Effects in a Prospective Controlled Intervention Trial
Oncol Ther, 12 (2), 345-362
DOI 10.1007/s40487-024-00278-3, PubMed 38744750
Brown LR, Sousa MS, Yule MS, Baracos VE, McMillan DC, Arends J, Balstad TR, Bye A, Dajani O, Dolan RD, Fallon MT, Greil C, Hjermstad MJ, Jakobsen G, Maddocks M, McDonald J, Ottestad IO, Phillips I, Sayers J, Simpson MR, Vagnildhaug OM, Solheim TS, Laird BJA, Skipworth RJE, Cancer Cachexia Endpoints Working Group (2024)
Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series
J Cachexia Sarcopenia Muscle, 15 (3), 816-852
DOI 10.1002/jcsm.13478, PubMed 38738581
Bührer E, D'Haese D, Daugaard G, de Wit R, Albany C, Tryakin A, Fizazi K, Stahl O, Gietema JA, De Giorgi U, Cafferty FH, Hansen AR, Tandstad T, Huddart RA, Necchi A, Sweeney CJ, Garcia-Del-Muro X, Heng DYC, Lorch A, Chovanec M, Winquist E, Grimison P, Feldman DR, Terbuch A, Hentrich M et al. (2024)
Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium
Eur J Cancer, 202, 114042
DOI 10.1016/j.ejca.2024.114042, PubMed 38564927
Bøhn SKH, Svendsen K, Balto A, Gjelsvik YM, Myklebust TÅ, Børøsund E, Eriksen HR, Meland A, Østby K, Nes LS, Kiserud CE, Reinertsen KV, Ursin G (2024)
Health-related quality of life among women diagnosed with in situ or invasive breast cancer and age-matched controls: a population-based study
J Patient Rep Outcomes, 8 (1), 105
DOI 10.1186/s41687-024-00781-1, PubMed 39298004
Cameron AL, Mandeville H, Coppadoro B, Periasamy M, Davila Fajardo R, Ferrari A, Gaze MN, Helfre S, Magelssen H, Minard-Colin V, Ramos M, Schoot R, Zanetti I, Bisogno G, Chisholm JC, Merks JHM (2024)
The Impact of Radiation Therapy on Metastatic Rhabdomyosarcoma: Results From the EpSSG MTS 2008 Study
Int J Radiat Oncol Biol Phys, 121 (2), 388-402
DOI 10.1016/j.ijrobp.2024.08.039, PubMed 39222824
Casey NP, Kleinmanns K, Forcados C, Gelebart PF, Joaquina S, Lode M, Benard E, Kaveh F, Caulier B, Helgestad Gjerde C, García de Jalón E, Warren DJ, Lindemann K, Rokkones E, Davidson B, Myhre MR, Kvalheim G, Bjørge L, McCormack E, Inderberg EM, Wälchli S (2024)
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16
J Immunother Cancer, 12 (4)
DOI 10.1136/jitc-2023-008179, PubMed 38604812
Caulier B, Joaquina S, Gelebart P, Dowling TH, Kaveh F, Thomas M, Tandaric L, Wernhoff P, Katyayini NU, Wogsland C, Gjerstad ME, Fløisand Y, Kvalheim G, Marr C, Kobold S, Enserink JM, Gjertsen BT, McCormack E, Inderberg EM, Wälchli S (2024)
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia
Cell Rep Med, 5 (6), 101572
DOI 10.1016/j.xcrm.2024.101572, PubMed 38754420
Chauhan SK, Dunn C, Andresen NK, Røssevold AH, Skorstad G, Sike A, Gilje B, Raj SX, Huse K, Naume B, Kyte JA (2024)
Peripheral immune cells in metastatic breast cancer patients display a systemic immunosuppressed signature consistent with chronic inflammation
NPJ Breast Cancer, 10 (1), 30
DOI 10.1038/s41523-024-00638-2, PubMed 38653982
Chávez-Villa M, Ruffolo LI, Byrne M, Line PD, Dueland S, Tomiyama K, Hernandez-Alejandro R (2024)
Reply to A. Jain et al
J Clin Oncol, 42 (26), 3165-3166
DOI 10.1200/JCO.24.00922, PubMed 38976818
Chen N, McGrath CB, Ericsson CI, Vaselkiv JB, Rencsok EM, Stopsack KH, Guard HE, Autio KA, Rathkopf DE, Enting D, Bitting RL, Mateo J, Githiaka CW, Chi KN, Cheng HH, Davis ID, Anderson SG, Badal SAM, Bjartell A, Russnes KM, Heath EI, Pomerantz MM, Henegan JC, Hyslop T, Esteban E et al. (2024)
Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer
Cancer Epidemiol Biomarkers Prev, 33 (3), 419-425
DOI 10.1158/1055-9965.EPI-23-1207, PubMed 38189661
Chen ZJ, Li XA, Brenner DJ, Hellebust TP, Hoskin P, Joiner MC, Kirisits C, Nath R, Rivard MJ, Thomadsen BR, Zaider M (2024)
AAPM Task Group Report 267: A joint AAPM GEC-ESTRO report on biophysical models and tools for the planning and evaluation of brachytherapy
Med Phys, 51 (6), 3850-3923
DOI 10.1002/mp.17062, PubMed 38721942
Chiavelli C, Prapa M, Rovesti G, Silingardi M, Neri G, Pugliese G, Trudu L, Dall'Ora M, Golinelli G, Grisendi G, Vinet J, Bestagno M, Spano C, Papapietro RV, Depenni R, Di Emidio K, Pasetto A, Nascimento Silva D, Feletti A, Berlucchi S, Iaccarino C, Pavesi G, Dominici M (2024)
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma
NPJ Precis Oncol, 8 (1), 26
DOI 10.1038/s41698-024-00506-z, PubMed 38302615
Chopra S, Bosse T, Horeweg N, Deodhar K, Menon S, Rafael T, Pai V, Rijstenberg L, van Kemenade F, Kannan S, Mahantshetty U, Segedin B, Huang F, Bruheim K, Perez M, Rai B, Tan LT, Giannakopoulos N, Schmid M, Tanderup K, Pötter R, Nout RA (2024)
Biomarker Expression and Clinical Outcomes in International Study of Chemoradiation and Magnetic Resonance Imaging-Based Image-Guided Brachytherapy for Locally Advanced Cervical Cancer: BIOEMBRACE
Int J Radiat Oncol Biol Phys, 121 (1), 97-106
DOI 10.1016/j.ijrobp.2024.07.2316, PubMed 39067486
Cilla S, Rossi R, Habberstad R, Klepstad P, Dall'Agata M, Kaasa S, Valenti V, Donati CM, Maltoni M, Morganti AG (2024)
Explainable Machine Learning Model to Predict Overall Survival in Patients Treated With Palliative Radiotherapy for Bone Metastases
JCO Clin Cancer Inform, 8, e2400027
DOI 10.1200/CCI.24.00027, PubMed 38917384
Dahl AA (2024)
[Not Available]
Tidsskr Nor Laegeforen, 144 (11)
DOI 10.4045/tidsskr.24.0420, PubMed 39319761
Dahl AA, Johannesen TB, Gjelsvik Y, Myklebust TÅ, Fosså SD (2024)
A controlled study of use and effectiveness of phosphodiesterase-5 inhibitors in long-term survivors after curative radiotherapy for prostate cancer (PCa)
Radiother Oncol, 204, 110704
DOI 10.1016/j.radonc.2024.110704, PubMed 39732292
Dahl AA, Smeland KB, Eikeland S, Fagerli UM, Bersvendsen HS, Fosså A, Kiserud CE (2024)
Distressed personality is associated with late adverse effects in long-term survivors of Hodgkin lymphoma
Acta Oncol, 63, 600-606
DOI 10.2340/1651-226X.2024.40312, PubMed 39099321
Damek A, Kurch L, Franke FC, Attarbaschi A, Beishuizen A, Cepelova M, Ceppi F, Daw S, Dieckmann K, Fernández-Teijeiro A, Feuchtinger T, Flerlage JE, Fosså A, Georgi TW, Hasenclever D, Hraskova A, Karlen J, Klekawka T, Kluge R, Körholz D, Landman-Parker J, Leblanc T, Mauz-Körholz C, Metzler M, Pears J et al. (2024)
Hodgkin lymphoma: hypodense lesions in mediastinal masses
Sci Rep, 14 (1), 14591
DOI 10.1038/s41598-024-64253-8, PubMed 38918503
Dávila Fajardo R, Scarzello G, Gaze MN, Boterberg T, Cameron A, Fuchs J, Guérin F, Hoskin P, Krasin MJ, Kroon P, Magelssen H, Mercke C, Merks JHM, Paulsen F, Pommier P, Ramos M, Rees H, Rogers T, Schmid M, Seitz G, Slater O, Smeulders N, Stenman J, Terwisscha S, Chargari C et al. (2024)
Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelines
Radiother Oncol, 195, 110273
DOI 10.1016/j.radonc.2024.110273, PubMed 38588921
Deng WH, Lie HC, Ruud E, Loge JH, Kiserud CE, Rueegg CS (2024)
Profiles of Fatigue and Psychological Symptoms in Long-Term Childhood, Adolescent, and Young Adult Cancer Survivors-The NOR-CAYACS Study
Cancer Med, 13 (22), e70425
DOI 10.1002/cam4.70425, PubMed 39584526
Dinh PC, Monahan PO, Fosså SD, Sesso HD, Feldman DR, Dolan ME, Nevel K, Kincaid J, Vaughn DJ, Martin NE, Sanchez VA, Einhorn LH, Frisina R, Fung C, Kroenke K, Travis LB (2024)
Impact of pain and adverse health outcomes on long-term US testicular cancer survivors
J Natl Cancer Inst, 116 (3), 455-467
DOI 10.1093/jnci/djad236, PubMed 37966940
Dreyling M, Doorduijn J, Giné E, Jerkeman M, Walewski J, Hutchings M, Mey U, Riise J, Trneny M, Vergote V, Shpilberg O, Gomes da Silva M, Leppä S, Jiang L, Stilgenbauer S, Kerkhoff A, Jachimowicz RD, Celli M, Hess G, Arcaini L, Visco C, van Meerten T, Wirths S, Zinzani PL, Novak U et al. (2024)
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
Lancet, 403 (10441), 2293-2306
DOI 10.1016/S0140-6736(24)00184-3, PubMed 38705160
Dreyling M, Fowler NH, Dickinson M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell L, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Pérez-Simón JA, Chen AI, Nastoupil LJ, von Tresckow B, María Ferreri AJ, Teshima T, Patten PEM, McGuirk JP, Petzer AL et al. (2024)
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update
Blood, 143 (17), 1713-1725
DOI 10.1182/blood.2023021567, PubMed 38194692
Egeland EV, Seip K, Skourti E, Øy GF, Pettersen SJ, Pandya AD, Dahle MA, Haugen MH, Kristian A, Nakken S, Engebraaten O, Mælandsmo GM, Prasmickaite L (2024)
The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy
Br J Cancer, 131 (10), 1656-1667
DOI 10.1038/s41416-024-02875-5, PubMed 39390250
Eide NA, Noer A, Jespersen H, Jebsen P, Geisler J (2024)
Delayed Distant Recurrence of a Uveal Melanoma 4 Decades after Enucleation
Case Rep Oncol, 17 (1), 1131-1139
DOI 10.1159/000541341, PubMed 39474560
Elvebakken H, Venizelos A, Perren A, Couvelard A, Lothe IMB, Hjortland GO, Myklebust TÅ, Svensson J, Garresori H, Kersten C, Hofsli E, Detlefsen S, Vestermark LW, Knappskog S, Sorbye H (2024)
Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasms
Br J Cancer, 131 (4), 676-684
DOI 10.1038/s41416-024-02773-w, PubMed 38909137
Engelaar M, Bos N, van Schelven F, Lorenzo I Sunyer N, Couespel N, Apolone G, Brunelli C, Caraceni A, Ferrer M, Groenvold M, Kaasa S, Ciliberto G, Lombardo C, Pietrobon R, Pravettoni G, Sirven A, Vachon H, Gilbert A, Rademakers J (2024)
Collaborating with cancer patients and informal caregivers in a European study on quality of life: protocol to embed patient and public involvement within the EUonQoL project
Res Involv Engagem, 10 (1), 59
DOI 10.1186/s40900-024-00597-9, PubMed 38863075
Fange Gjelstad IM, Lyckander C, Høidalen A, Bratland Å, Blomhoff R, Paur I, Henriksen C (2024)
Impact of radiotherapy on body weight in head and neck cancer patients: A prospective study
Clin Nutr ESPEN, 65, 390-399
DOI 10.1016/j.clnesp.2024.12.019, PubMed 39710169
Farooqi SJ, Zhao Z, Öjlert ÅK, Thunold S, Juul HV, Bjaanæs MM, Horndalsveen H, Nymoen HMG, Helland Å, Haakensen VD (2024)
Serum cytokines as a biomarker for immune checkpoint inhibitor toxicity in patients with pleural mesothelioma
Front Immunol, 15, 1480183
DOI 10.3389/fimmu.2024.1480183, PubMed 39687621
Felip E, Metro G, Soo RA, Wolf J, Solomon BJ, Tan DS, Ardizzoni A, Lee DH, Sequist LV, Barlesi F, Ponce-Aix S, Abreu DR, Campelo MRG, Sprauten M, Djentuh LO, Smith N, Jary A, Belli R, Glaser S, Zou M, Cui X, Giovannini M, Yang JC (2024)
Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer
Eur J Cancer, 208, 114182
DOI 10.1016/j.ejca.2024.114182, PubMed 38986421
Festvåg LE, Sverre BL, Paulsen Ø, Eilertsen G (2024)
Advance care planning with older Norwegian adults in their homes: a narrative ethnographic study
BMC Palliat Care, 23 (1), 44
DOI 10.1186/s12904-024-01378-7, PubMed 38369465
Filippi AR, Bar J, Chouaid C, Christoph DC, Field JK, Fietkau R, Garassino MC, Garrido P, Haakensen VD, Kao S, Markman B, McDonald F, Mornex F, Moskovitz M, Peters S, Sibille A, Siva S, van den Heuvel M, Vercauter P, Anand S, Chander P, Licour M, de Lima AR, Qiao Y, Girard N (2024)
Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R
ESMO Open, 9 (6), 103464
DOI 10.1016/j.esmoop.2024.103464, PubMed 38833971
Fischer A, Albert TK, Moreno N, Interlandi M, Mormann J, Glaser S, Patil P, de Faria FW, Richter M, Verma A, Balbach ST, Wagener R, Bens S, Dahlum S, Göbel C, Münter D, Inserte C, Graf M, Kremer E, Melcher V, Di Stefano G, Santi R, Chan A, Dogan A, Bush J et al. (2024)
Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas
Nat Commun, 15 (1), 8571
DOI 10.1038/s41467-024-52826-0, PubMed 39362842
Fleischer T, Haugen MH, Ankill J, Silwal-Pandit L, Børresen-Dale AL, Hedenfalk I, Hatschek T, Tost J, Engebraaten O, Kristensen VN (2024)
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer
Mol Oncol, 18 (8), 2042-2059
DOI 10.1002/1878-0261.13656, PubMed 38671580
Fosså SD, Holck Storås A, Aas K, Børge Johannesen T, Maria Gjelsvik Y, Myklebust TÅ (2024)
Pretreatment Patient-reported Overall Health: A Prognostic Factor for Early Overall Mortality After Primary Curative Treatment of Prostate Cancer
Eur Urol Open Sci, 63, 62-70
DOI 10.1016/j.euros.2024.03.005, PubMed 38558766
Frich L, Hermann R, Ryder T (2024)
Breast implant-associated anaplastic large cell lymphoma
Tidsskr Nor Laegeforen, 144 (12)
DOI 10.4045/tidsskr.24.0315, PubMed 39404238
Gaimari A, De Lucia A, Nicolini F, Mazzotti L, Maltoni R, Rughi G, Zurlo M, Marchesini M, Juan M, Parras D, Cerchione C, Martinelli G, Bravaccini S, Tettamanti S, Pasetto A, Pasini L, Magnoni C, Gazzola L, Borges de Souza P, Mazza M (2024)
Significant Advancements and Evolutions in Chimeric Antigen Receptor Design
Int J Mol Sci, 25 (22)
DOI 10.3390/ijms252212201, PubMed 39596267
Gelderblom H, Bhadri V, Stacchiotti S, Bauer S, Wagner AJ, van de Sande M, Bernthal NM, López Pousa A, Razak AA, Italiano A, Ahmed M, Le Cesne A, Tinoco G, Boye K, Martín-Broto J, Palmerini E, Tafuto S, Pratap S, Powers BC, Reichardt P, Casado Herráez A, Rutkowski P, Tait C, Zarins F, Harrow B et al. (2024)
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Lancet, 403 (10445), 2709-2719
DOI 10.1016/S0140-6736(24)00885-7, PubMed 38843860
Gerdtsson A, Negaard HFS, Almås B, Bergdahl AG, Cohn-Cedermark G, Glimelius I, Halvorsen D, Haugnes HS, Hedlund A, Hellström M, Holmberg G, Karlsdóttir Á, Kjellman A, Larsen SM, Thor A, Wahlqvist R, Ståhl O, Tandstad T (2024)
Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
BJU Int, 133 (6), 717-724
DOI 10.1111/bju.16289, PubMed 38293778
Green D, van Ewijk R, Tirtei E, Andreou D, Baecklund F, Baumhoer D, Bielack SS, Botchu R, Boye K, Brennan B, Capra M, Cottone L, Dirksen U, Fagioli F, Fernandez N, Flanagan AM, Gambarotti M, Gaspar N, Gelderblom H, Gerrand C, Gomez-Mascard A, Hardes J, Hecker-Nolting S, Kabickova E, Kager L et al. (2024)
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement
Clin Cancer Res, 30 (16), 3395-3406
DOI 10.1158/1078-0432.CCR-24-0101, PubMed 38869831
Grivas P, Garralda E, Meric-Bernstam F, Mellinghoff IK, Goyal L, Harding JJ, Dees EC, Bahleda R, Azad NS, Karippot A, Kurzrock R, Tabernero J, Kononen J, Ng MCH, Mehta R, Uboha NV, Bigot F, Boni V, Bowyer SE, Breder V, Cervantes A, Chan N, Cleary JM, Dhawan M, Eefsen RL et al. (2024)
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial
Clin Cancer Res, 30 (20), 4572-4583
DOI 10.1158/1078-0432.CCR-24-0012, PubMed 38771739
Guldhav KV, Andersen JR, Eldal K, Lundeby T, Hegland PA (2024)
Practices for Reporting Scale Structure and Summarizing Scores in Studies Using FAMCARE Scale to Assess Caregiver Satisfaction with Cancer Care: A Scoping Review
Patient Relat Outcome Meas, 15, 271-286
DOI 10.2147/PROM.S479195, PubMed 39534014
Guldvik IJ, Ramberg H, Kristensen G, Røder A, Mills IG, Lilleby W, Taskén KA (2024)
Systemic interrogation of immune-oncology-related proteins in patients with locally advanced prostate cancer undergoing androgen deprivation and intensity-modulated radiotherapy
World J Urol, 42 (1), 95
DOI 10.1007/s00345-024-04787-8, PubMed 38386171
Gullhaug A, Haakensen VD, De Ruysscher D, Simone CB, Hotca-Cho AE, Chhabra AM, Hellebust TP, Paulsen EE, Dimopoulos MP, Johansen S (2024)
Lung cancer reirradiation: Exploring modifications to utilization, treatment modalities and factors associated with outcomes
J Med Imaging Radiat Sci, 55 (2), 221-231
DOI 10.1016/j.jmir.2024.02.004, PubMed 38429174
Halldorsson S, Nagymihaly RM, Patel A, Brandal P, Panagopoulos I, Leske H, Lund-Iversen M, Sahm F, Vik-Mo EO (2024)
Accurate and comprehensive evaluation of O6-methylguanine-DNA methyltransferase promoter methylation by nanopore sequencing
Neuropathol Appl Neurobiol, 50 (3), e12984
DOI 10.1111/nan.12984, PubMed 38783575
Hamfjord J, Guren TK, Glimelius B, Sorbye H, Pfeiffer P, Dajani O, Lingjærde OC, Tveit KM, Spindler KG, Pallisgaard N, Kure EH (2024)
Exploring Early Kinetic Profiles of CEA, ctDNA and cfDNA in Patients With RAS-/BRAF-Mutated Metastatic Colorectal Cancer
Clin Colorectal Cancer (in press)
DOI 10.1016/j.clcc.2024.11.004, PubMed 39743478
Hanekamp BA, Virdee PS, Goh V, Jones M, Hvass Hansen R, Hjorth Johannesen H, Schulz A, Serup-Hansen E, Guren MG, Muirhead R (2024)
Diffusion-weighted magnetic resonance imaging as an early prognostic marker of chemoradiotherapy response in squamous cell carcinoma of the anus: An individual patient data meta-analysis
Phys Imaging Radiat Oncol, 31, 100618
DOI 10.1016/j.phro.2024.100618, PubMed 39188809
Heggebø LC, Blakstad H, Eriksson MC, Brandal P (2024)
Lomustine overdose in a patient with diffuse glioma: symptoms, management and outcome
BMJ Case Rep, 17 (7)
DOI 10.1136/bcr-2024-260450, PubMed 39043464
Helland Å (2024)
[Not Available]
Tidsskr Nor Laegeforen, 144 (15)
DOI 10.4045/tidsskr.24.0603, PubMed 39692664
Helland Å, Steinskog ESS, Blix ES, Flobak Å, Brabrand S, Puco K, Niehusmann P, Meltzer S, Oppedal IA, Haug Å, Torkildsen CF, Randen U, Gilje B, Lønning PE, Gjertsen BT, Hovland R, Russnes HG, Fagereng GL, Smeland S, Tasken K (2024)
[Raising the quality of cancer treatment]
Tidsskr Nor Laegeforen, 144 (1)
DOI 10.4045/tidsskr.23.0740, PubMed 38258713
Heramb-Aamot J, Mala T, Fauske L (2024)
Everyday Life Six to Eight Months After Esophagectomy for Cancer: A Qualitative Study
Anticancer Res, 44 (2), 743-750
DOI 10.21873/anticanres.16865, PubMed 38307550
Hershenfeld SA, Tobin JWD, Shelton V, Calvente L, Lajkosz K, Liu T, Brodtkorb M, d'Amore FA, Ludvigsen M, Baetz T, LeBrun D, Johnson N, Crump M, Hong M, Kuruvilla J, Tremblay-LeMay R, MacManus M, Tsang R, Hodgson DC, Gandhi MK, Kridel R (2024)
Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy
Br J Haematol, 205 (5), 1810-1814
DOI 10.1111/bjh.19698, PubMed 39112220
Hjermstad MJ, Jakobsen G, Arends J, Balstad TR, Brown LR, Bye A, Coats AJS, Dajani OF, Dolan RD, Fallon MT, Greil C, Grzyb A, Kaasa S, Koteng LH, May AM, McDonald J, Ottestad I, Philips I, Roeland EJ, Sayers J, Simpson MR, Skipworth RJE, Solheim TS, Sousa MS, Vagnildhaug OM et al. (2024)
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
J Cachexia Sarcopenia Muscle, 15 (3), 794-815
DOI 10.1002/jcsm.13453, PubMed 38553255
Hjermstad MJ, Pirnat A, Aass N, Andersen S, Astrup GL, Dajani O, Garresori H, Guldhav KV, Hamre H, Haukland EC, Jordal F, Lundeby T, Løhre ET, Mjåland S, Paulsen Ø, Semb KA, Staff ES, Wester T, Kaasa S (2024)
PALLiative care in ONcology (PALLiON): A cluster-randomised trial investigating the effect of palliative care on the use of anticancer treatment at the end of life
Palliat Med, 38 (2), 229-239
DOI 10.1177/02692163231222391, PubMed 38193250
Hompland I, Boye K, Wiedswang AM, Papakonstantinou A, Røsok B, Joensuu H, Bruland Ø (2024)
Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study
Acta Oncol, 63, 288-293
DOI 10.2340/1651-226X.2024.39851, PubMed 38712513
Huynh BN, Groendahl AR, Tomic O, Liland KH, Knudtsen IS, Hoebers F, van Elmpt W, Dale E, Malinen E, Futsaether CM (2024)
Deep learning with uncertainty estimation for automatic tumor segmentation in PET/CT of head and neck cancers: impact of model complexity, image processing and augmentation
Biomed Phys Eng Express, 10 (5)
DOI 10.1088/2057-1976/ad6dcd, PubMed 39127060
Huynh BN, Groendahl AR, Tomic O, Liland KH, Knudtsen IS, Hoebers F, van Elmpt W, Malinen E, Dale E, Futsaether CM (2024)
Corrigendum: Head and neck cancer treatment outcome prediction: a comparison between machine learning with conventional radiomics features and deep learning radiomics
Front Med (Lausanne), 11, 1421603
DOI 10.3389/fmed.2024.1421603, PubMed 38813378
Huynh TM, Falk RS, Hellebust TP, Dale E, Astrup GL, Hjermstad MJ, Malinen E, Bjordal K, Kiserud CE, Herlofson BB, Nome R, Amdal CD (2024)
Chronic fatigue in long-term survivors of head and neck cancer treated with radiotherapy
Radiother Oncol, 195, 110231
DOI 10.1016/j.radonc.2024.110231, PubMed 38518958
Hyldebrandt HK, Stormorken AT, Vitelli V, Mæhle L, Schlichting E, Grindedal EM (2024)
Risk reducing mastectomy in Norwegian BRCA1/2 carriers
Eur J Surg Oncol, 51 (3), 109571
DOI 10.1016/j.ejso.2024.109571, PubMed 39765192
Haakensen VD, Öjlert ÅK, Thunold S, Farooqi S, Nowak AK, Chin WL, Grundberg O, Szejniuk WM, Cedres S, Sørensen JB, Dalen TS, Lund-Iversen M, Bjaanæs M, Helland Å (2024)
UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial
Eur J Cancer, 202, 113973
DOI 10.1016/j.ejca.2024.113973, PubMed 38447379
Ilmarinen T, Bratland Å, Tøndel H, Guðjónsson A, Gebre-Medhin M, Palmgren B, Mäenpää H, Bjørndal K, Grau Eriksen J (2024)
Current aspects of the quality of head and neck cancer care - survey of the Scandinavian Society for Head and Neck Oncology
Acta Otolaryngol, 144 (5-6), 404-408
DOI 10.1080/00016489.2024.2386097, PubMed 39109489
Jerkeman M, Kolstad A, Hutchings M, Pasanen A, Meriranta L, Niemann CU, Kragh Jørgensen RR, El-Galaly TC, Riise J, Leppä S, Christensen JH, Sonnevi K, Pedersen LB, Wader KF, Glimelius I (2024)
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial
Blood Adv, 8 (2), 407-415
DOI 10.1182/bloodadvances.2023011920, PubMed 38113470
Jin Y, Dunn C, Persiconi I, Sike A, Skorstad G, Beck C, Kyte JA (2024)
Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers
Int J Mol Sci, 25 (1)
DOI 10.3390/ijms25010586, PubMed 38203757
Jin Y, Dunn C, Persiconi I, Sike A, Skorstad G, Beck C, Kyte JA (2024)
Correction: Jin et al. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. Int. J. Mol. Sci. 2024, 25, 586
Int J Mol Sci, 25 (18)
DOI 10.3390/ijms251810024, PubMed 39337718
Joensuu H, Reichardt A, Eriksson M, Hohenberger P, Boye K, Cameron S, Lindner LH, Jost PJ, Bauer S, Schütte J, Lindskog S, Kallio R, Jaakkola PM, Goplen D, Wardelmann E, Reichardt P (2024)
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial
Br J Cancer, 131 (2), 299-304
DOI 10.1038/s41416-024-02738-z, PubMed 38862742
Karlsson AT, Hjermstad MJ, Aass N, Skovlund E, Kaasa S, Yri OE (2024)
Overall Survival after Radiotherapy for Brain Metastases According to ECOG Status-A Prospective Study of 294 NSCLC Patients
Cancers (Basel), 16 (8)
DOI 10.3390/cancers16081486, PubMed 38672568
Kirchheiner K, Zaharie A, Smet S, Spampinato S, Chargari C, Haie-Meder C, Mahantshetty U, Šegedin B, Bruheim K, Rai B, Cooper R, Van der Steen-Banasik E, Wiebe E, Pötter R, Sturdza A, Schmid MP, Tanderup K, De Leeuw A, Jürgenliemk-Schulz IM, Nout RA, EMBRACE Collaborative Group (2024)
Association Between the Regular Use of Vaginal Dilators and/or Sexual Activity and Vaginal Morbidity in Locally Advanced Cervical Cancer Survivors: An EMBRACE-I Study Report
Int J Radiat Oncol Biol Phys, 121 (2), 452-464
DOI 10.1016/j.ijrobp.2024.09.011, PubMed 39278418
Kristensen MH, Holm AIS, Hansen CR, Zukauskaite R, Samsøe E, Maare C, Johansen J, Primdahl H, Bratland Å, Kristensen CA, Andersen M, Overgaard J, Eriksen JG (2024)
High-dose loco-regional pattern of failure after primary radiotherapy in p16 positive and negative head and neck squamous cell carcinoma - A DAHANCA 19 study
Clin Transl Radiat Oncol, 46, 100772
DOI 10.1016/j.ctro.2024.100772, PubMed 38596816
Kristensen MH, Sørensen MK, Tramm T, Alsner J, Sørensen BS, Maare C, Johansen J, Primdahl H, Bratland Å, Kristensen CA, Andersen M, Lilja-Fischer JK, Holm AIS, Samsøe E, Hansen CR, Zukauskaite R, Overgaard J, Eriksen JG (2024)
Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma - A DAHANCA 19 study
Radiother Oncol, 193, 110149
DOI 10.1016/j.radonc.2024.110149, PubMed 38341096
Labori KJ, Bratlie SO, Andersson B, Angelsen JH, Biörserud C, Björnsson B, Bringeland EA, Elander N, Garresori H, Grønbech JE, Haux J, Hemmingsson O, Liljefors MG, Myklebust TÅ, Nymo LS, Peltola K, Pfeiffer P, Sallinen V, Sandström P, Sparrelid E, Stenvold H, Søreide K, Tingstedt B, Verbeke C, Öhlund D et al. (2024)
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial
Lancet Gastroenterol Hepatol, 9 (3), 205-217
DOI 10.1016/S2468-1253(23)00405-3, PubMed 38237621
Labori KJ, Bratlie SO, Dueland S, Lassen K (2024)
NORPACT-1: implications for future trials - Authors' reply
Lancet Gastroenterol Hepatol, 9 (5), 408-409
DOI 10.1016/S2468-1253(24)00079-7, PubMed 38604194
Larsen SG, Graf W, Larsen RH, Revheim ME, Mariathasan AM, Sørensen O, Spasojevic M, Rashid G, Lundstrøm N, Gjertsen TJ, Aksnes AK, Bruland ØS (2024)
Eighteen-Months Safety and Efficacy Following Intraperitoneal Treatment With ²²⁴Radium-Labeled Microparticles After CRS-HIPEC in Patients With Peritoneal Metastasis From Colorectal Cancer
J Surg Oncol, 130 (6), 1395-1402
DOI 10.1002/jso.27897, PubMed 39428687
Lereim RR, Dunn C, Aamdal E, Chauhan SK, Straume O, Guren TK, Kyte JA (2024)
Plasma protein dynamics during ipilimumab treatment in metastatic melanoma: associations with tumor response, adverse events and survival
Oncoimmunology, 14 (1), 2440967
DOI 10.1080/2162402X.2024.2440967, PubMed 39703053
Lia K, Jørgensen RRK, L Wold B, Fluge Ø, Fagerli UM, Bersvendsen H, Bø IB, Bhargava S, Fosså A (2024)
Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study
Haematologica, 109 (5), 1403-1412
DOI 10.3324/haematol.2023.283721, PubMed 37881879
Lilleby W, Kishan A, Geinitz H (2024)
Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer
World J Urol, 42 (1), 41
DOI 10.1007/s00345-023-04714-3, PubMed 38244053
Lillekroken D, Bye A, Halvorsrud L, Terragni L, Debesay J (2024)
Food for Soul-Older Immigrants' Food Habits and Meal Preferences After Immigration: A Systematic Literature Review
J Immigr Minor Health, 26 (4), 775-805
DOI 10.1007/s10903-023-01571-5, PubMed 38165601
Long GV, Carlino MS, McNeil C, Ribas A, Gaudy-Marqueste C, Schachter J, Nyakas M, Kee D, Petrella TM, Blaustein A, Lotem M, Arance AM, Daud AI, Hamid O, Larkin J, Yao L, Singh R, Lal R, Robert C (2024)
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study
Ann Oncol, 35 (12), 1191-1199
DOI 10.1016/j.annonc.2024.08.2330, PubMed 39306585
Long GV, Hauschild A, Santinami M, Kirkwood JM, Atkinson V, Mandala M, Merelli B, Sileni VC, Nyakas M, Haydon A, Dutriaux C, Robert C, Mortier L, Schachter J, Schadendorf D, Lesimple T, Plummer R, Larkin J, Tan M, Adnaik SB, Burgess P, Jandoo T, Dummer R (2024)
Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
N Engl J Med, 391 (18), 1709-1720
DOI 10.1056/NEJMoa2404139, PubMed 38899716
Lordick F, Mauer ME, Stocker G, Cella CA, Ben-Aharon I, Piessen G, Wyrwicz L, Al-Haidari G, Fleitas-Kanonnikoff T, Boige V, Lordick Obermannová R, Martens UM, Gomez-Martin C, Thuss-Patience P, Arrazubi V, Avallone A, Shiu KK, Artru P, Brenner B, Buges Sanchez C, Chau I, Lorenzen S, Daum S, Sinn M, Merelli B et al. (2024)
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study
Ann Oncol, 36 (2), 197-207
DOI 10.1016/j.annonc.2024.10.829, PubMed 39542422
Lund JÅ, Lydersen S, Aksnessæther B, Solberg A, Wanderås A, Lervåg C, Kaasa S, Tøndel H (2024)
Image guided radiotherapy in curative treatment for prostate cancer. 5-year results from a randomized controlled trial (RIC-trial)
Radiother Oncol, 196, 110309
DOI 10.1016/j.radonc.2024.110309, PubMed 38670265
Lunde P, Grimsmo J, Nilsson BB, Bye A, Finbråten HS (2024)
Health literacy in patients participating in cardiac rehabilitation: A prospective cohort study with pre-post-test design
Int J Cardiol Cardiovasc Risk Prev, 22, 200314
DOI 10.1016/j.ijcrp.2024.200314, PubMed 39161973
Löffeler S, Bertilsson H, Müller C, Aas K, Haugnes HS, Aksnessæther B, Pesonen M, Thon K, Tandstad T, Murtola T, Poulsen MH, Nordstrøm T, Vigmostad MN, Ottosson F, Holmsten K, Christiansen O, Slaaen M, Haug ES, Storås AH, Asphaug L, Rannikko A, Brasso K, Scandinavian Prostate Cancer Group (SPCG) and the Norwegian Get‐Randomized (GRand) Initiative (2024)
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P)
BJU Int, 133 (6), 680-689
DOI 10.1111/bju.16314, PubMed 38469686
Machak GN, Bruland ØS, Romanova TN, Kovalev AV (2024)
Denosumab induction and Zoledronic acid maintenance therapy for recurrent unresectable giant cell tumour of the distal tibia: A case report with sustained tumour control after drug withdrawal
J Bone Oncol, 45, 100596
DOI 10.1016/j.jbo.2024.100596, PubMed 38545297
MacManus MP, Seymour JF, Tsang H, Fisher R, Keane C, Sabdia MB, Law SC, Gunawardana J, Nath K, Kazakoff SH, Marques-Piubelli ML, Duenas DE, Green MR, Roos D, O'Brien P, McCann A, Tsang R, Davis S, Christie D, Cheah C, Amanuel B, Cochrane T, Butler J, Johnston A, Shanavas M et al. (2024)
Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma
EBioMedicine, 110, 105468
DOI 10.1016/j.ebiom.2024.105468, PubMed 39631145
Maggadottir SM, Dueland S, Mensali N, Hamre H, Andresen PA, Myhre MR, Juul HV, Bigalke I, Lundby M, Hønnåshagen TK, Sæbøe-Larssen S, Josefsen D, Hagtvedt T, Wälchli S, Kvalheim G, Inderberg EM (2024)
Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer
Mol Ther, 32 (6), 2021-2029
DOI 10.1016/j.ymthe.2024.04.009, PubMed 38582964
Mahon P, Chatzitheofilou I, Dekker A, Fernández X, Hall G, Helland A, Traverso A, Van Marcke C, Vehreschild J, Ciliberto G, Tonon G (2024)
A federated learning system for precision oncology in Europe: DigiONE
Nat Med, 30 (2), 334-337
DOI 10.1038/s41591-023-02715-8, PubMed 38195748
Mala T, Abelseth BK, Al-Haidari G, Dørum LMR, Hatlevoll I, Rekstad LC, Stenvold H, Øvrebø KK, Aahlin EK (2024)
[Not Available]
Tidsskr Nor Laegeforen, 144 (15)
DOI 10.4045/tidsskr.24.0547, PubMed 39692659
Marsilla J, Weiss J, Ye XY, Welch M, Milosevic M, Lyng H, Hompland T, Bruheim K, Tadic T, Haibe-Kains B, Han K (2024)
A T2-weighted MRI-based radiomic signature for disease-free survival in locally advanced cervical cancer following chemoradiation: An international, multicentre study
Radiother Oncol, 199, 110463
DOI 10.1016/j.radonc.2024.110463, PubMed 39067707
Martelli M, Ceriani L, Ciccone G, Ricardi U, Kriachok I, Botto B, Balzarotti M, Tucci A, Usai SV, Zilioli VR, Pennese E, Arcaini L, Dabrowska-Iwanicka A, Ferreri AJM, Merli F, Zhao W, Rigacci L, Cellini C, Hodgson D, Ionescu C, Minoia C, Lucchini E, Spina M, Fosså A, Janikova A et al. (2024)
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results
J Clin Oncol, 42 (34), 4071-4083
DOI 10.1200/JCO-24-01373, PubMed 39159403
Mediå LM, Fauske L, Sigurdardottir S, Billaud Feragen KJ, Waehre A (2024)
Differences of sex development and surgical decisions: focus group interviews with health care professionals in Norway
Health Psychol Behav Med, 12 (1), 2371134
DOI 10.1080/21642850.2024.2371134, PubMed 38979393
Miceli R, Eriksson H, Lo Russo G, Alfieri S, Moksnes Bjaanæs M, Pietrantonio F, De Cecco L, Prelaj A, Proto C, Franzén J, McDonnell D, Berenguer Pina JJ, Beninato T, Mazzeo L, Giannatempo P, Verzoni E, Crown J, Helland Å, Eustace A (2024)
Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter study
Acta Oncol, 63, 213-219
DOI 10.2340/1651-226X.2024.24179, PubMed 38647024
Minnai F, Shkodra M, Noci S, Brunelli C, Pigni A, Zecca E, Skorpen F, Klepstad P, Kaasa S, Corli O, Pallotti MC, Maltoni MC, Caraceni AT, Colombo F (2024)
Genomic Study in Opioid-Treated Cancer Patients Identifies Variants Associated With Nausea-Vomiting
J Pain Symptom Manage, 69 (2), 175-182.e5
DOI 10.1016/j.jpainsymman.2024.10.033, PubMed 39515597
Nilssen Y, Brustugun OT, Fjellbirkeland L, Grønberg BH, Haram PM, Helbekkmo N, Helland Å, Wahl SGF, Aanerud M, Solberg S (2024)
Small Cell Lung Cancer in Norway: Patterns of Care by Health Region and Survival Trends
Clin Lung Cancer, 25 (5), e221-e228.e3
DOI 10.1016/j.cllc.2024.04.002, PubMed 38692990
Nilssen Y, Brustugun OT, Fjellbirkeland L, Helland Å, Møller B, Wahl SGF, Solberg S (2024)
Distribution and characteristics of malignant tumours by lung lobe
BMC Pulm Med, 24 (1), 106
DOI 10.1186/s12890-024-02918-w, PubMed 38439038
Nilsson M, Aas K, Myklebust TÅ, Gjelsvik YM, Johannesen TB, Fosså SD (2024)
Adverse Health Outcomes 3 Years after Radical Prostatectomy Compared with Men in the General Population: A Study from the Cancer Registry of Norway
Clin Genitourin Cancer, 22 (6), 102219
DOI 10.1016/j.clgc.2024.102219, PubMed 39340952
Nome RV, Flatebø Ø, Bøe SL, Klaasen RA, Aamdal E, Normann M, Bolstad N, Warren DJ (2024)
A simple automated assay format for measuring multiple immune checkpoint inhibitors
J Pharm Biomed Anal, 255, 116657
DOI 10.1016/j.jpba.2024.116657, PubMed 39756153
Nymoen HM, Alver TN, Horndalsveen H, Eide HA, Bjaanæs MM, Brustugun OT, Grønberg BH, Haakensen VD, Helland Å (2024)
Thoracic radiation in combination with erlotinib-results from a phase 2 randomized trial
Front Oncol, 14, 1412716
DOI 10.3389/fonc.2024.1412716, PubMed 39148905
Ohnstad HO, Blix ES, Akslen LA, Gilje B, Raj SX, Skjerven H, Borgen E, Janssen EAM, Mortensen E, Brekke MB, Falk RS, Schlichting E, Boge B, Songe-Møller S, Olsson P, Heie A, Mannsåker B, Vestlid MA, Kursetgjerde T, Gravdehaug B, Suhrke P, Sanchez E, Bublevic J, Røe OD, Geitvik GA et al. (2024)
Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1)
ESMO Open, 9 (6), 103475
DOI 10.1016/j.esmoop.2024.103475, PubMed 38838499
Olsen SU, Tazmini K, Aas AM, Ranhoff AH, Pripp AH, Hesseberg K, Sunde S, Bye A (2024)
The incidence and mortality of refeeding syndrome in older hospitalized patients, based on three different diagnostic criteria: A longitudinal study
Clin Nutr ESPEN, 61, 101-107
DOI 10.1016/j.clnesp.2024.03.006, PubMed 38777421
Oort Q, Reijneveld JC, Sikkes SAM, Koekkoek JAF, Boele F, Young T, Brannan C, Chalk T, Talacchi A, Mazzotta A, Narita Y, Sato H, Miyakita Y, Shamieh O, Alrjoob W, Pace A, Petranovic D, Ploh M, Capela A, Silva J, Hjermstad MJ, Purkart TU, Seidel C, Talhi N, Pichler J et al. (2024)
Instrumental activities of daily living in neuro-oncology: International validation of the EORTC IADL-BN32 questionnaire
Eur J Cancer, 212, 114335
DOI 10.1016/j.ejca.2024.114335, PubMed 39332215
Os SS, Skipar K, Skovlund E, Hompland I, Hellebust TP, Guren MG, Lindemann K, Nakken ES (2024)
Survival prediction in patients with gynecological cancer irradiated for brain metastases
Acta Oncol, 63, 206-212
DOI 10.2340/1651-226X.2023.34899, PubMed 38647023
Papadakis V, Astigarraga I, van den Bos C, Donadieu J, Henter JI, Jacobs S, Lehrnbecher T, Munthe-Kaas MC, Naeije L, Nanduri V, Nguyen T, Nysom K, Pears J, Raciborska A, Sieni E, Svojgr K, Tzotzola V, Minkov M, European Consortium for Histiocytosis (ECHO) (2024)
The ECHO recommendations for dealing with vinblastine shortage affecting standard treatment of systemic Langerhans cell histiocytosis
Pediatr Blood Cancer, 71 (3), e30850
DOI 10.1002/pbc.30850, PubMed 38185727
Prysiazhniuk Y, Server A, Leske H, Bech-Aase Ø, Helseth E, Eijgelaar RS, Fuster-García E, Brandal P, Bjørnerud A, Otáhal J, Petr J, Nordhøy W (2024)
Diffuse glioma molecular profiling with arterial spin labeling and dynamic susceptibility contrast perfusion MRI: A comparative study
Neurooncol Adv, 6 (1), vdae113
DOI 10.1093/noajnl/vdae113, PubMed 39036439
Puco K, Fagereng GL, Brabrand S, Niehusmann P, Støre Blix E, Samdal Steinskog ES, Haug Å, Fredvik Torkildsen C, Oppedal IA, Meltzer S, Flobak Å, Johansson KAM, Bjørge L, Hjortland GO, Dalhaug A, Lund JÅ, Gilje B, Grønlie Cameron M, Hovland R, Falk RS, Smeland S, Giercksky Russnes HE, Taskén K, Helland Å, InPreD Consortium et al. (2024)
IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results
Acta Oncol, 63, 379-384
DOI 10.2340/1651-226X.2024.28322, PubMed 38779911
Pulczynski EJ, Simonsen MR, Kuittinen O, Fagerli UM, Erlanson M, Fluge Ø, Leppä S, Østenstad B, Fosså A, Eriksson M, El-Galaly T, Kuitunen H, Papworth K, Ljungqvist M, Pedersen MB, Pollari M (2024)
Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up
Haematologica, 109 (7), 2359-2363
DOI 10.3324/haematol.2024.285207, PubMed 38546689
Qvigstad LF, Eri LM, Lien MD, Fosså SD, Aas K, Berge V (2024)
Reduction of lower urinary tract symptoms in prostate cancer patients treated with robot assisted laparoscopic prostatectomy
Scand J Urol, 59, 121-125
DOI 10.2340/sju.v59.40070, PubMed 38888041
Rask Kragh Jørgensen R, Bergström F, Eloranta S, Tang Severinsen M, Bjøro Smeland K, Fosså A, Haaber Christensen J, Hutchings M, Bo Dahl-Sørensen R, Kamper P, Glimelius I, E Smedby K, K Parsons S, Mae Rodday A, J Maurer M, M Evens A, C El-Galaly T, Hjort Jakobsen L (2024)
Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma
JCO Clin Cancer Inform, 8, e2300255
DOI 10.1200/CCI.23.00255, PubMed 38608215
Ree AH, Høye E, Esbensen Y, Beitnes AR, Negård A, Bernklev L, Tetlie LK, Fretland ÅA, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Nilsen HL, Flatmark K, Meltzer S (2024)
Complete response of metastatic microsatellite-stable BRAF V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockade
Oncoimmunology, 13 (1), 2372886
DOI 10.1080/2162402X.2024.2372886, PubMed 38952672
Ree AH, Šaltytė Benth J, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Johansen C, Negård A, Bjørnetrø T, Nilsen HL, Berg JP, Flatmark K, Meltzer S (2024)
First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trial
Br J Cancer, 130 (12), 1921-1928
DOI 10.1038/s41416-024-02696-6, PubMed 38664577
Reis Costa D, Winge-Main AK, Skog A, Tsuruda KM, Robsahm TE, Kulle Andreassen B (2024)
From trials to practice: Immune checkpoint inhibitor therapy for melanoma patients in Norway
Acta Oncol, 63, 965-973
DOI 10.2340/1651-226X.2024.41266, PubMed 39690735
Rekeland IG, Sørland K, Neteland LL, Fosså A, Alme K, Risa K, Dahl O, Tronstad KJ, Mella O, Fluge Ø (2024)
Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
PLoS One, 19 (7), e0307484
DOI 10.1371/journal.pone.0307484, PubMed 39042627
Riba M, Sala C, Culhane AC, Flobak Å, Patocs A, Boye K, Plevova K, Pospíšilová Š, Gandolfi G, Morelli MJ, Bucci G, Edsjö A, Lassen U, Al-Shahrour F, Lopez-Bigas N, Hovland R, Cuppen E, Valencia A, Poirel HA, Rosenquist R, Scollen S, Arenas Marquez J, Belien J, De Nicolo A, De Maria R et al. (2024)
The 1+Million Genomes Minimal Dataset for Cancer
Nat Genet, 56 (5), 733-736
DOI 10.1038/s41588-024-01721-x, PubMed 38702538
Riis MLH (2024)
The Challenges of Lobular Carcinomas from a Surgeon's Point of View
Clin Breast Cancer, 24 (8), e645-e654
DOI 10.1016/j.clbc.2024.06.007, PubMed 39033066
Ringborg U, von Braun J, Celis J, Baumann M, Berns A, Eggermont A, Heard E, Heitor M, Chandy M, Chen CJ, Costa A, De Lorenzo F, De Robertis EM, Dubee FC, Ernberg I, Gabriel M, Helland Å, Henrique R, Jönsson B, Kallioniemi O, Korbel J, Krause M, Lowy DR, Michielin O, Nagy P et al. (2024)
Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023
Mol Oncol, 18 (2), 245-279
DOI 10.1002/1878-0261.13575, PubMed 38135904
Rosselle L, Leray T, Joaquina S, Caulier B, McCormack E, Gelebart P, Wälchli S, Inderberg EM (2024)
Protocol for production of tonic CAR T cells with dasatinib
STAR Protoc, 6 (1), 103529
DOI 10.1016/j.xpro.2024.103529, PubMed 39739533
Rossi R, Medici F, Habberstad R, Klepstad P, Cilla S, Dall'Agata M, Kaasa S, Caraceni AT, Morganti AG, Maltoni M (2024)
Development of a predictive model for patients with bone metastases referred to palliative radiotherapy: Secondary analysis of a multicenter study (the PRAIS trial)
Cancer Med, 13 (19), e70050
DOI 10.1002/cam4.70050, PubMed 39390750
Safont MM, Leitch C, Popa M, Gjerstad ME, Caulier B, Inderberg EM, Wälchli S, Gelebart P, McCormack E (2024)
Protocol for the development of a bioluminescent AML-PDX mouse model for the evaluation of CAR T cell therapy
STAR Protoc, 5 (4), 103522
DOI 10.1016/j.xpro.2024.103522, PubMed 39673705
Samuel R, Knight SR, Adams R, Das P, Dorth J, Finch D, Guren MG, Hawkins MA, Moug S, Rajdev L, Sebag-Montefiore D, Renehan AG, Fish R, plus the CORMAC-2 collaborators (2024)
International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome set
EClinicalMedicine, 78, 102939
DOI 10.1016/j.eclinm.2024.102939, PubMed 39720423
Scherrens AL, Jacobs A, Beernaert K, Pardon K, Raemdonck E, Fallon M, Cresswell K, Faric N, Williams R, Lundeby T, Hjermstad MJ, Deliens L, Kaasa S (2024)
Integrating patient-centred and tumour-centred cancer care: the EU-MyPath implementation project offers an innovative digital solution with care pathways
Palliat Care Soc Pract, 18, 26323524241296143
DOI 10.1177/26323524241296143, PubMed 39568798
Schlichting E (2024)
[Men can have breast cancer too]
Tidsskr Nor Laegeforen, 144 (5)
DOI 10.4045/tidsskr.24.0144, PubMed 38651719
Schou-Bredal I, Moberg IO, Schou SM, Sætnan EV, Fuglesteg IK, Tønseth KA, Schlichting E (2024)
Preoperative Expectations of Women Undergoing Breast Reconstruction Surgery
Plast Reconstr Surg Glob Open, 12 (6), e5928
DOI 10.1097/GOX.0000000000005928, PubMed 38903141
Sharma A, Debik J, Naume B, Ohnstad HO, Oslo Breast Cancer Consortium (OSBREAC), Bathen TF, Giskeødegård GF (2024)
Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes
Oncogenesis, 13 (1), 22
DOI 10.1038/s41389-024-00521-6, PubMed 38871719
Shelton V, Detroja R, Liu T, Isaev K, Silva A, Passerini V, Bakhtiari M, Calvente L, Hong M, He MY, Modi S, Hershenfeld SA, Ludvigsen M, Madsen C, Hamilton-Dutoit S, d'Amore FA, Brodtkorb M, Johnson NA, Baetz T, LeBrun D, Tobin JWD, Gandhi MK, Mungall AJ, Xu W, Ben-Neriah S et al. (2024)
Identification of genetic subtypes in follicular lymphoma
Blood Cancer J, 14 (1), 128
DOI 10.1038/s41408-024-01111-w, PubMed 39112453
Shkodra M, Mulvey M, Fallon M, Brunelli C, Zecca E, Bracchi P, Caputo M, Massa G, Lo Dico S, Rolke R, Kaasa S, Caraceni A (2024)
Application and accuracy of the EAPC/IASP diagnostic algorithm for neuropathic cancer pain and quantitative sensory testing profile in patients with pain due to cancer
Pain Rep, 9 (2), e1140
DOI 10.1097/PR9.0000000000001140, PubMed 38375093
Singer S, Hammerlid E, Tomaszewska IM, Amdal CD, Herlofson BB, Santos M, Castro Silva J, Mehanna H, Fullerton A, Young T, Fernandez Gonzalez L, Inhestern J, Pinto M, Arraras JI, Yarom N, Bonomo P, Baumann I, Galalae R, Nicolatou-Galitis O, Kiyota N, Raber-Durlacher J, Salem D, Fabian A, Boehm A, Krejovic-Trivic S et al. (2024)
The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important change
Eur J Cancer, 212, 115062
DOI 10.1016/j.ejca.2024.115062, PubMed 39405647
Sioud M, Juzeniene A, Sæbøe-Larssen S (2024)
Exploring the Impact of mRNA Modifications on Translation Efficiency and Immune Tolerance to Self-Antigens
Vaccines (Basel), 12 (6)
DOI 10.3390/vaccines12060624, PubMed 38932353
Skaga E, Trewin-Nybråten CB, Niehusmann P, Johannesen TB, Marienhagen K, Oltedal L, Schipman S, Skjulsvik AJ, Solheim O, Solheim TS, Sundstrøm T, Vik-Mo EO, Petter Brandal, Ingebrigtsen T (2024)
Stable glioma incidence and increased patient survival over the past two decades in Norway: a nationwide registry-based cohort study
Acta Oncol, 63, 83-94
DOI 10.2340/1651-226X.2024.24970, PubMed 38501768
Skipar K, Hompland T, Lund KV, Lindemann K, Hellebust TP, Bruheim K, Lyng H (2024)
MRI-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy
Radiother Oncol, 195, 110263
DOI 10.1016/j.radonc.2024.110263, PubMed 38556173
Slørdahl KS, Balto A, Guren MG, Wibe A, Kørner H, Norderval S, Gjelsvik YM, Myklebust TÅ, Larsen IK (2024)
Patient-reported outcomes after treatment for rectal cancer-A prospective nationwide study
Colorectal Dis, 27 (1) (in press)
DOI 10.1111/codi.17231, PubMed 39515999
Slaaen M, Røyset IM, Saltvedt I, Grønberg BH, Halsteinli V, Døhl Ø, Vossius C, Kirkevold Ø, Bergh S, Rostoft S, Oldervoll L, Bye A, Melby L, Røsstad T, Eriksen GF, Sollid MIV, Rolfson D, Šaltytė Benth J (2024)
Geriatric assessment with management for older patients with cancer receiving radiotherapy: a cluster-randomised controlled pilot study
BMC Med, 22 (1), 232
DOI 10.1186/s12916-024-03446-4, PubMed 38853251
Sodergren SC, Hurley-Wallace A, Vassiliou V, Alkhaffaf B, Batsaikhan B, Darlington AS, Fleitas-Kanonnikof T, Guren MG, Honda M, Kim YW, Kim S, Krishnamurthy MN, Loh SY, Turhal NS, Zhou J, Dennis K, Krishnatry R, Terashima M, Tsironis G, Yoshikawa T, Terada M, EORTC Quality of Life Group (2024)
Revisiting the use of the EORTC QLQ-STO22 to assess health-related quality of life of patients with gastric cancer: incorporating updated treatment options and cross-cultural perspectives
Gastric Cancer, 27 (4), 722-734
DOI 10.1007/s10120-024-01492-8, PubMed 38668819
Sorbye H, Hjortland GO, Vestermark LW, Sundlov A, Assmus J, Couvelard A, Perren A, Langer SW (2024)
NETest in advanced high-grade gastroenteropancreatic neuroendocrine neoplasms
J Neuroendocrinol, 36 (11), e13428
DOI 10.1111/jne.13428, PubMed 38937137
Stoevesandt D, Ludwig C, Mauz-Körholz C, Körholz D, Hasenclever D, McCarten K, Flerlage JE, Kurch L, Wohlgemuth WA, Landman-Parker J, Wallace WH, Fosså A, Vordermark D, Karlén J, Cepelová M, Klekawka T, Attarbaschi A, Hraskova A, Uyttebroeck A, Beishuizen A, Dieckmann K, Leblanc T, Daw S, Steglich J (2024)
Pulmonary lesions in early response assessment in pediatric Hodgkin lymphoma: prevalence and possible implications for initial staging
Pediatr Radiol, 54 (5), 725-736
DOI 10.1007/s00247-024-05859-y, PubMed 38296856
Stray K, Wibe T, Debesay J, Bye A (2024)
Older adults' perceptions and experiences of interprofessional communication as part of the delivery of integrated care in the primary healthcare sector: a meta-ethnography of qualitative studies
BMC Geriatr, 24 (1), 146
DOI 10.1186/s12877-024-04745-4, PubMed 38347442
Stub T, Mathisen M, Thorsen L, Kiserud CE, Lie HC (2024)
Experiences Using Nonpharmacological Interventions for Chronic Fatigue: A Focus Group Study of Long-Term Survivors of Young Adult Cancers With Fatigue
Cancer Rep (Hoboken), 7 (9), e2139
DOI 10.1002/cnr2.2139, PubMed 39233646
Støyten M, Knutsen T, Stikbakke E, Agledahl I, Wilsgaard T, Eggen AE, Richardsen E, Giovannucci E, Thune I, Haugnes HS (2024)
Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life study
Acta Oncol, 63, 154-163
DOI 10.2340/1651-226X.2024.32953, PubMed 38591351
Svendsen K, Leithe S, Trewin-Nybråten CB, Balto A, Nes LS, Meland A, Børøsund E, Kiserud CE, Reinertsen KV, Eriksen HR, Gjelsvik YM, Ursin G (2024)
How Did Breast Cancer Patients Fare during Different Phases of the COVID-19 Pandemic in Norway Compared to Age-Matched Controls?
Cancers (Basel), 16 (3)
DOI 10.3390/cancers16030602, PubMed 38339359
Tabouret E, Furtner J, Graillon T, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepúlveda-Sánchez JM, Brandal P, Bendszus M, Golfinopoulos V, Gorlia T, Weller M, Sahm F, Wick W, Preusser M (2024)
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas
Neuro Oncol, 26 (7), 1302-1309
DOI 10.1093/neuonc/noae037, PubMed 38452246
Taskén K, F Haj Mohammad S, Fagereng GL, Sørum Falk R, Helland Å, Barjesteh van Waalwijk van Doorn-Khosrovani S, Steen Carlsson K, Ryll B, Jalkanen K, Edsjö A, Russnes HG, Lassen U, Hallersjö Hult E, Lugowska I, Blay JY, Verlingue L, Abel E, Lowery MA, Krebs MG, Staal Rohrberg K, Ojamaa K, Oliveira J, Verheul HMW, Voest EE, Gelderblom H et al. (2024)
PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe
Acta Oncol, 63, 385-391
DOI 10.2340/1651-226X.2024.34791, PubMed 38779910
Tauziède-Espariat A, Nicaise Y, Sievers P, Sahm F, von Deimling A, Guillemot D, Pierron G, Duchesne M, Edjlali M, Dangouloff-Ros V, Boddaert N, Roux A, Dezamis E, Hasty L, Lhermitte B, Hirsch E, Hirsch MPV, Ardellier FD, Karnoub MA, Csanyi M, Maurage CA, Mokhtari K, Bielle F, Rigau V, Roujeau T et al. (2024)
CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas
Acta Neuropathol Commun, 12 (1), 55
DOI 10.1186/s40478-023-01695-7, PubMed 38581034
Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, Gama RR, Jacinto A, Hammerlid E, Scricciolo M, Jansen F, Verdonck-de Leeuw IM, Fanetti G, Guntinas-Lichius O, Inhestern J, Dragan T, Fabian A, Boehm A, Wöhner U, Kiyota N, Krüger M, Bonomo P, Pinto M, Nuyts S, Silva JC et al. (2024)
Long-term health-related quality of life in head and neck cancer survivors: A large multinational study
Int J Cancer, 154 (10), 1772-1785
DOI 10.1002/ijc.34861, PubMed 38312044
Thomassen D, Roychoudhury S, Amdal CD, Reynders D, Musoro JZ, Sauerbrei W, Goetghebeur E, le Cessie S, SISAQOL-IMI Work Package 3 (2024)
The role of the estimand framework in the analysis of patient-reported outcomes in single-arm trials: a case study in oncology
BMC Med Res Methodol, 24 (1), 290
DOI 10.1186/s12874-024-02408-x, PubMed 39580440
Thor A, Negaard HFS, Grenabo Bergdahl A, Almås B, Melsen Larsen S, Lundgren PO, Gerdtsson A, Halvorsen D, Johannsdottir B, Jansson AK, Hellström M, Wahlqvist R, Langberg CW, Hedlund A, Akre O, Glimelius I, Ståhl O, Haugnes HS, Cohn-Cedermark G, Kjellman A, Tandstad T (2024)
Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience
Eur Urol Open Sci, 65, 13-19
DOI 10.1016/j.euros.2024.05.006, PubMed 38966804
Thunold S, Hernes E, Farooqi S, Öjlert ÅK, Francis RJ, Nowak AK, Szejniuk WM, Nielsen SS, Cedres S, Perdigo MS, Sørensen JB, Meltzer C, Mikalsen LTG, Helland Å, Malinen E, Haakensen VD (2024)
Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine
Eur J Nucl Med Mol Imaging, 52 (2), 693-707
DOI 10.1007/s00259-024-06853-0, PubMed 39133306
Torland LA, Lai X, Kumar S, Riis MH, Geisler J, Lüders T, Tekpli X, Kristensen V, Sahlberg K, Tahiri A (2024)
Benign breast tumors may arise on different immunological backgrounds
Mol Oncol, 18 (10), 2495-2509
DOI 10.1002/1878-0261.13655, PubMed 38757377
Tulipan A, Kratochwil C, Lilleby J, Lilleby W (2024)
A case of severe side effects to androgen receptor inhibitor and consequently switch to radioligand therapy in early castration resistant prostate cancer
Urol Case Rep, 54, 102752
DOI 10.1016/j.eucr.2024.102752, PubMed 38779691
Ullern A, Holm K, Røssevold AH, Andresen NK, Bang C, Lingjærde OC, Naume B, Hov JR, Kyte JA (2024)
Gut microbiota diversity is prognostic and associated with benefit from chemo-immunotherapy in metastatic triple-negative breast cancer
Mol Oncol, 19 (4), 1229-1243
DOI 10.1002/1878-0261.13760, PubMed 39545921
Urrizola A, Dajani O, Aass N, Bjerkeset E, Hjermstad MJ, Kaasa S, Klepstad P, Pirnat A, Raaness I, Steinsheim H, Bye A (2024)
Nutrition impact symptom monitoring and weight loss outcomes: a longitudinal radiotherapy study
BMJ Support Palliat Care (in press)
DOI 10.1136/spcare-2024-004939, PubMed 38862183
Vagnildhaug OM, Balstad TR, Ottestad I, Bye A, Greil C, Arends J, Baracos V, Brown LR, Dajani OF, Dolan RD, Fallon M, Fraser E, Grzyb A, Hjermstad MJ, Jakobsen G, Kaasa S, McDonald J, Philips I, Sayers J, Simpson MR, Sousa MS, Skipworth RJE, Laird BJA, Solheim TS, Cancer Cachexia Endpoints Working Group (2024)
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series
J Cachexia Sarcopenia Muscle, 15 (2), 513-535
DOI 10.1002/jcsm.13434, PubMed 38343065
van der Perk MEM, Broer L, Yasui Y, Laven JSE, Robison LL, Tissing WJE, Versluys B, Bresters D, Kaspers GJL, Lambalk CB, Overbeek A, Loonen JJ, Beerendonk CCM, Byrne J, Berger C, Clemens E, van Dulmen-den Broeder E, Dirksen U, van der Pal HJ, de Vries ACH, Winther JF, Ranft A, Fosså SD, Grabow D, Muraca M et al. (2024)
Interindividual variation in ovarian reserve after gonadotoxic treatment in female childhood cancer survivors - a genome-wide association study: results from PanCareLIFE
Fertil Steril, 122 (3), 514-524
DOI 10.1016/j.fertnstert.2024.05.002, PubMed 38729340
Vandraas K, Reinertsen KV, Gudim HB, Bowen CA, Gjerdalen G, Schlichting E, Naume B, Sætersdal A (2024)
[Not Available]
Tidsskr Nor Laegeforen, 144 (12)
DOI 10.4045/tidsskr.24.0182, PubMed 39404245
Voskanyan V, Marzorati C, Sala D, Grasso R, Pietrobon R, van der Heide I, Engelaar M, Bos N, Caraceni A, Couspel N, Ferrer M, Groenvold M, Kaasa S, Lombardo C, Sirven A, Vachon H, Velikova G, Brunelli C, Apolone G, Pravettoni G (2024)
Psychosocial factors associated with quality of life in cancer survivors: umbrella review
J Cancer Res Clin Oncol, 150 (5), 249
DOI 10.1007/s00432-024-05749-8, PubMed 38727730
Voskanyan V, Marzorati C, Sala D, Grasso R, Pietrobon R, van der Heide I, Engelaar M, Bos N, Caraceni A, Couspel N, Ferrer M, Groenvold M, Kaasa S, Lombardo C, Sirven A, Vachon H, Velikova G, Brunelli C, Apolone G, Pravettoni G (2024)
Correction to: Psychosocial factors associated with quality of life in cancer survivors: umbrella review
J Cancer Res Clin Oncol, 150 (9), 408
DOI 10.1007/s00432-024-05929-6, PubMed 39222144
Western B, Ivarsson A, Vistad I, Demmelmaier I, Aaronson NK, Radcliffe G, van Beurden M, Bohus M, Courneya KS, Daley AJ, Galvão DA, Garrod R, Goedendorp MM, Griffith KA, van Harten WH, Hayes SC, Herrero-Roman F, Hiensch AE, Irwin ML, James E, Kenkhuis MF, Kersten MJ, Knoop H, Lucia A, May AM et al. (2024)
Dropout from exercise trials among cancer survivors-An individual patient data meta-analysis from the POLARIS study
Scand J Med Sci Sports, 34 (2), e14575
DOI 10.1111/sms.14575, PubMed 38339809
Westgaard A, Pirnat A, Hjermstad MJ, Aass N, Kaasa S, Dajani OF (2024)
Prognostic Value of Performance Status, Albumin, and CRP in Last-Line Chemotherapy for Pancreatic vs. Other Gastrointestinal Cancers-Simple Tools Matter
Curr Oncol, 31 (9), 5462-5471
DOI 10.3390/curroncol31090404, PubMed 39330032
Willemsen M, Bulgarelli J, Chauhan SK, Lereim RR, Angeli D, Grisendi G, Krebbers G, Davidson I, Kyte JA, Guidoboni M, Luiten RM, Bakker WJ (2024)
Changes in AXL and/or MITF melanoma subpopulations in patients receiving immunotherapy
Immunooncol Technol, 24, 101009
DOI 10.1016/j.iotech.2024.101009, PubMed 39697983
Willmann J, Balermpas P, Rimner A, Appelt AL, Vasquez Osorio EM, Rønde HS, Day M, Embring A, Gabryś D, Guren MG, Hoskin P, Massaccesi M, Mayo C, Murray L, Nieder C, Guckenberger M, Andratschke N (2024)
Ongoing prospective studies on reirradiation: A systematic review of a clinical trials database
Radiother Oncol, 202, 110624
DOI 10.1016/j.radonc.2024.110624, PubMed 39532233
Waage A, Khan A, Labori KJ, Birkeland KI, Scholz H, Jensen TG, Tholfsen T, Line PD, Hagness M (2024)
Implementation of a nationwide program for total pancreatectomy and islet autotransplantation in chronic pancreatitis: A Scandinavian single-center observational study
Scand J Surg, 14574969241298985 (in press)
DOI 10.1177/14574969241298985, PubMed 39558154
Yri OE, Astrup GL, Karlsson AT, van Helvoirt R, Hjermstad MJ, Husby KM, Loge JH, Lund JÅ, Lundeby T, Paulsen Ø, Skovlund E, Taran MI, Winther RR, Aass N, Kaasa S (2024)
Survival and quality of life after first-time diagnosis of brain metastases: a multicenter, prospective, observational study
Lancet Reg Health Eur, 49, 101181
DOI 10.1016/j.lanepe.2024.101181, PubMed 39807153
Yule MS, Thompson J, Leesahatsawat K, Sousa MS, Anker SD, Arends J, Balstad TR, Brown LR, Bye A, Dajani O, Fallon M, Hjermstad MJ, Jakobsen G, McDonald J, McGovern J, Roeland EJ, Sayers J, Skipworth RJE, Ottestad IO, Philips I, Simpson MR, Solheim TS, Vagnildhaug OM, McMillan D, Laird BJA et al. (2024)
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series
J Cachexia Sarcopenia Muscle, 15 (3), 853-867
DOI 10.1002/jcsm.13491, PubMed 38783477
Zhou Y, Ray PS, Zhu J, Stein F, Rettel M, Sekaran T, Sahadevan S, Perez-Perri JI, Roth EK, Myklebost O, Meza-Zepeda LA, von Deimling A, Fu C, Brosig AN, Boye K, Nathrath M, Blattmann C, Lehner B, Hentze MW, Kulozik AE (2024)
Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma
Nat Commun, 15 (1), 2810
DOI 10.1038/s41467-024-47031-y, PubMed 38561347
Østergaard DE, Embring A, Sehested A, Magelssen H, Vogelius IR, Kjærsgaard M, Nysom K, Mathiasen R, Lukacova S, Maraldo MV (2024)
REMIT: Reirradiation of Diffuse Midline Glioma Patients -A Nordic Society of Paediatric Haematology and Oncology Feasibility Study
Clin Oncol (R Coll Radiol), 37, 103682
DOI 10.1016/j.clon.2024.103682, PubMed 39626445

Publications 2023

Abadpour S, Niemi EM, Orrhult LS, Hermanns C, de Vries R, Nogueira LP, Haugen HJ, Josefsen D, Krauss S, Gatenholm P, van Apeldoorn A, Scholz H (2023)
Adipose-Derived Stromal Cells Preserve Pancreatic Islet Function in a Transplantable 3D Bioprinted Scaffold
Adv Healthc Mater, 12 (32), e2300640
DOI 10.1002/adhm.202300640, PubMed 37781993
Acosta Roa AM, Skingen VE, Rekstad BL, Undseth C, Rusten E, Hernes E, Guren MG, Malinen E (2023)
Stability of metabolic tumor volume may enable radiotherapy dose painting in anal cancer
Phys Med, 114, 103151
DOI 10.1016/j.ejmp.2023.103151, PubMed 37813051
Albertsen PC, Bjerner LJ, Pasovic L, Müller S, Fosså S, Carlsson SV, Oldenburg J (2023)
Opportunistic prostate-specific antigen testing in Norwegian men: a public health challenge
BJU Int, 133 (1), 104-111
DOI 10.1111/bju.16211, PubMed 37869764
Alnes SR, Lærum-Onsager E, Bye A, Vistven A, Franzén E, Holst M, Brovold T (2023)
Mobile health technology, exercise adherence and optimal nutrition post rehabilitation among people with Parkinson's Disease (mHEXANUT) - a randomized controlled trial protocol
BMC Neurol, 23 (1), 93
DOI 10.1186/s12883-023-03134-5, PubMed 36864377
Amdal CD, Moan JM, Dale E, Falk RS, Johansen S, Bjordal K (2023)
Impact of hyperfractionated re-irradiation on quality of life in patients with recurrent or second primary head and neck cancer, a prospective single institutional study
Clin Transl Radiat Oncol, 42, 100654
DOI 10.1016/j.ctro.2023.100654, PubMed 37415638
Ascierto PA, Lipson EJ, Dummer R, Larkin J, Long GV, Sanborn RE, Chiarion-Sileni V, Dréno B, Dalle S, Schadendorf D, Callahan MK, Nyakas M, Atkinson V, Gomez-Roca CA, Yamazaki N, Tawbi HA, Sarkis N, Warad D, Dolfi S, Mitra P, Suryawanshi S, Grob JJ (2023)
Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial
J Clin Oncol, 41 (15), 2724-2735
DOI 10.1200/JCO.22.02072, PubMed 36780608
Baech J, Husby S, Trab T, Kragholm K, Brown P, Gørløv JS, Jørgensen JM, Gudbrandsdottir S, Severinsen MT, Grønbaek K, Larsen TS, Wästerlid T, Eloranta S, Smeland KB, Jakobsen LH, El-Galaly TC (2023)
Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study
Br J Haematol, 204 (3), 967-975
DOI 10.1111/bjh.19272, PubMed 38155503
Bartula I, Tran AD, Nowak AK, Ahmed T, Morton RL, Burmeister BH, Dolven-Jacobsen K, Nobes J, Thompson JF, Fogarty GB, Lo SN, Hong AM (2023)
Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial
Clin Transl Radiat Oncol, 41, 100597
DOI 10.1016/j.ctro.2023.100597, PubMed 37441544
Beck C, Casey NP, Persiconi I, Moharrami NN, Sike A, Jin Y, Kyte JA (2023)
Development of a TGFβ-IL-2/15 Switch Receptor for Use in Adoptive Cell Therapy
Biomedicines, 11 (2)
DOI 10.3390/biomedicines11020459, PubMed 36830995
Berndsen M, Renberg S, Hølmebakk T, Hancke E, Puls F, Karlsson F, Stoldt S, Bjerkehagen B, Haglund de Flon F, Muth A, Papakonstantinou A, Boye K, Lindskog S (2023)
Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapy
Br J Surg, 110 (12), 1857-1862
DOI 10.1093/bjs/znad309, PubMed 37758514
Bjerner J, Bratt O, Aas K, Albertsen PC, Fosså SD, Kvåle R, Lilja H, Müller C, Müller S, Stensvold A, Thomas O, Røe OD, Vickers A, Walz J, Carlsson SV, Oldenburg J (2023)
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium
Eur Urol, 86 (1), 20-26
DOI 10.1016/j.eururo.2023.04.028, PubMed 37169639
Bjerre Trent PK, Nordskar NJ, Wangen KR, Engeskaug MI, Opheim MLØ, Aune G, Staff AC, Thorsen L, Falk RS, Eriksson AGZ (2023)
Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional study
Gynecol Oncol, 175, 72-80
DOI 10.1016/j.ygyno.2023.05.070, PubMed 37327542
Blakstad H, Brekke J, Rahman MA, Arnesen VS, Miletic H, Brandal P, Lie SA, Chekenya M, Goplen D (2023)
Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions
PLoS One, 18 (2), e0281166
DOI 10.1371/journal.pone.0281166, PubMed 36730349
Blakstad H, Mendoza Mireles EE, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Vik-Mo EO, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Brandal P (2023)
Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study
Neurooncol Pract, 11 (1), 36-45
DOI 10.1093/nop/npad063, PubMed 38222046
Boye K, Gorunova L, Gunawan B, Hompland I, Sander B, Panagopoulos I, Langer C, Golas M, Heim S, Füzesi L, Hølmebakk T, Micci F (2023)
Genomic Complexity as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal Tumor
JCO Precis Oncol, 7, e2200351
DOI 10.1200/PO.22.00351, PubMed 36724411
Bratland Å, Munoz-Couselo E, Mortier L, Roshdy O, González R, Schachter J, Arance AM, Grange F, Meyer N, Joshi AJ, Billan S, Hughes BGM, Grob JJ, Ramakrishnan K, Ge J, Gumuscu B, Swaby RF, Gutzmer R (2023)
Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629
Dermatol Ther (Heidelb), 13 (12), 3165-3180
DOI 10.1007/s13555-023-01059-y, PubMed 37943491
Bruland ØS, Larsen RH, Baum RP, Juzeniene A (2023)
Editorial: Targeted alpha particle therapy in oncology
Front Med (Lausanne), 10, 1165747
DOI 10.3389/fmed.2023.1165747, PubMed 36960341
Braadland PR, Bergquist A, Kummen M, Bossen L, Engesæter LK, Reims HM, Björk I, Grzyb K, Abildgaard A, Småstuen MC, Folseraas T, Trøseid M, Ulvik A, Ueland PM, Melum E, Line PD, Høivik ML, Grønbæk H, Karlsen TH, Vesterhus M, Hov JR (2023)
Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation
J Hepatol, 79 (4), 955-966
DOI 10.1016/j.jhep.2023.05.038, PubMed 37328069
Bøhn S, Oldervoll LM, Reinertsen KV, Seland M, Fosså A, Kiserud C, Skaali T, Nilsen TS, Blomhoff R, Henriksen HB, Lie HC, Berge T, Fjerstad E, Wisløff T, Slott M, Zajmovic I, Thorsen L (2023)
The feasibility of a multidimensional intervention in lymphoma survivors with chronic fatigue
Support Care Cancer, 32 (1), 22
DOI 10.1007/s00520-023-08204-5, PubMed 38095797
Børø S, Thoresen S, Boge Brant S, Helland Å (2023)
Initial investigation of using Norwegian health data for the purpose of external comparator arms - an example for non-small cell lung cancer
Acta Oncol, 62 (12), 1642-1648
DOI 10.1080/0284186X.2023.2264484, PubMed 37801361
Casey NP, Klee CH, Fåne A, Caulier B, Graczyk-Jarzynka A, Krawczyk M, Fidyt K, Josefsson SE, Köksal H, Dillard P, Patkowska E, Firczuk M, Smeland EB, Winiarska M, Myklebust JH, Inderberg EM, Wälchli S (2023)
Efficient chimeric antigen receptor targeting of a central epitope of CD22
J Biol Chem, 299 (7), 104883
DOI 10.1016/j.jbc.2023.104883, PubMed 37269947
Dahl AA, Bentzen AG, Fosså SD, Hess SL, Kiserud CE (2023)
A study of modifiable factors associated with health-related quality of life in long-term cervical cancer survivors
Acta Obstet Gynecol Scand, 102 (2), 218-225
DOI 10.1111/aogs.14490, PubMed 36683549
Dahl AA, Smedsland SK, Vandraas KF, Bøhn SK, Falk RS, Kiserud CE, Reinertsen KV (2023)
High neuroticism is associated with common late adverse effects in a nationwide sample of long-term breast cancer survivors
Breast Cancer Res Treat, 202 (1), 97-104
DOI 10.1007/s10549-023-07055-2, PubMed 37528264
Dahl AA, Smeland KB, Eikeland S, Fagerli UM, Bersvendsen HS, Fosså A, Kiserud CE (2023)
Work ability and work status changes in long-term Hodgkin lymphoma survivors with focus on late adverse effects
J Cancer Surviv, 18 (6), 1921-1930
DOI 10.1007/s11764-023-01432-y, PubMed 37526861
Dingemans AM, van Walree N, Schramel F, Soud MY, Baltruškevičienė E, Lybaert W, Veldhorst M, van den Berg CA, Kaasa S (2023)
High Protein Oral Nutritional Supplements Enable the Majority of Cancer Patients to Meet Protein Intake Recommendations during Systemic Anti-Cancer Treatment: A Randomised Controlled Parallel-Group Study
Nutrients, 15 (24)
DOI 10.3390/nu15245030, PubMed 38140289
Dueland S, Smedman TM, Syversveen T, Grut H, Hagness M, Line PD (2023)
Long-Term Survival, Prognostic Factors, and Selection of Patients With Colorectal Cancer for Liver Transplant: A Nonrandomized Controlled Trial
JAMA Surg, 158 (9), e232932
DOI 10.1001/jamasurg.2023.2932, PubMed 37494056
Eikeland SA, Smeland KB, Simensen VC, Fagerli UM, Bersvendsen HS, Kiserud CE, Fosså A (2023)
Chronic fatigue in long-term survivors of Hodgkin's lymphoma after contemporary risk-adapted treatment
Acta Oncol, 62 (1), 80-88
DOI 10.1080/0284186X.2023.2168215, PubMed 36715320
Elvebakken H, Hjortland GO, Garresori H, Andresen PA, Janssen EAM, Vintermyr OK, Lothe IMB, Sorbye H (2023)
Impact of KRAS and BRAF mutations on treatment efficacy and survival in high-grade gastroenteropancreatic neuroendocrine neoplasms
J Neuroendocrinol, 35 (4), e13256
DOI 10.1111/jne.13256, PubMed 37017614
Entrop JP, Weibull CE, Smedby KE, Jakobsen LH, Øvlisen AK, Glimelius I, Marklund A, Larsen TS, Holte H, Fosså A, Smeland KB, El-Galaly TC, Eloranta S (2023)
Reproduction patterns among non-Hodgkin lymphoma survivors by subtype in Sweden, Denmark and Norway: A population-based matched cohort study
Br J Haematol, 202 (4), 785-795
DOI 10.1111/bjh.18938, PubMed 37325886
Entrop JP, Weibull CE, Smedby KE, Jakobsen LH, Øvlisen AK, Molin D, Glimelius I, Marklund A, Holte H, Fosså A, Smeland KB, El-Galaly TC, Eloranta S (2023)
Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study
Int J Cancer, 153 (4), 723-731
DOI 10.1002/ijc.34552, PubMed 37119033
Fallon MT, Caraceni A, Laird BJA, Kaasa S (2023)
Reply to the Letter to the Editor "A simple way of doing the complex but utmost important things: cancer pain management" by S. Singhal, M. Verma and D. Kukreja
Ann Oncol, 34 (5), 496-497
DOI 10.1016/j.annonc.2023.02.005, PubMed 37121609
Farnes I, Kleive D, Verbeke CS, Aabakken L, Issa-Epe A, Småstuen MC, Fosby BV, Dueland S, Line PD, Labori KJ (2023)
Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective cohort study (NORPACT-2)
BJS Open, 7 (6)
DOI 10.1093/bjsopen/zrad137, PubMed 38155512
Fauske L, Jebsen NL, Bondevik H, Bruland ØS (2023)
Exploring the Patient Perspective of Bone Sarcoma Survivors Who Have Undergone Particle Radiotherapy Abroad
Anticancer Res, 43 (5), 2031-2039
DOI 10.21873/anticanres.16364, PubMed 37097689
Figlioli G, Billaud A, Wang Q, Bolla MK, Dennis J, Lush M, Kvist A, Adank MA, Ahearn TU, Antonenkova NN, Auvinen P, Behrens S, Bermisheva M, Bogdanova NV, Bojesen SE, Bonanni B, Brüning T, Camp NJ, Campbell A, Castelao JE, Cessna MH, Nbcs Collaborators, Czene K, Devilee P, Dörk T et al. (2023)
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases
Cancers (Basel), 15 (13)
DOI 10.3390/cancers15133313, PubMed 37444426
Fløisand Y, Remberger M, Bigalke I, Josefsen D, Vålerhaugen H, Inderberg EM, Olaussen RW, Gjertsen BT, Goedkoop R, Geiger C, Prinz PU, Schnorfeil FM, Pinkernell K, Schendel DJ, Kvalheim G (2023)
WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy
Leukemia, 37 (9), 1842-1849
DOI 10.1038/s41375-023-01980-3, PubMed 37507426
Flølo TN, Fosså A, Nedkvitne JIP, Waage JER, Rekdal M, Dankel SN, Fernø J, Mellgren G, Nedrebø BG (2023)
Long-term impact of gastropexy on use of acid-reducing medication, second operations for gastroesophageal reflux and subjective reflux symptoms after sleeve gastrectomy
Clin Obes, 13 (5), e12618
DOI 10.1111/cob.12618, PubMed 37583310
Foldvari Z, Knetter C, Yang W, Gjerdingen TJ, Bollineni RC, Tran TT, Lund-Johansen F, Kolstad A, Drousch K, Klopfleisch R, Leisegang M, Olweus J (2023)
A systematic safety pipeline for selection of T-cell receptors to enter clinical use
NPJ Vaccines, 8 (1), 126
DOI 10.1038/s41541-023-00713-y, PubMed 37607971
Fosså SD, Haugnes HS, Dahl AA, Kiserud CE, Fosså A, Skalleberg J, Myklebust TÅ (2023)
Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective
Ann Oncol, 34 (12), 1165-1174
DOI 10.1016/j.annonc.2023.09.3101, PubMed 37739265
Franke FC, Damek A, Steglich J, Kurch L, Hasenclever D, Georgi TW, Wohlgemuth WA, Mauz-Körholz C, Körholz D, Kluge R, Landman-Parker J, Wallace WH, Fosså A, Vordermark D, Karlen J, Fernández-Teijeiro A, Cepelova M, Klekawka T, Attarbaschi A, Ceppi F, Hraskova A, Uyttebroeck A, Beishuizen A, Dieckmann K, Leblanc T et al. (2023)
Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma
Pediatr Blood Cancer, 70 (8), e30421
DOI 10.1002/pbc.30421, PubMed 37243889
Garset-Zamani M, von Buchwald C, Karevold G, Agander TK, Mateu-Regué À, Eide HA, Tvedskov JF (2023)
An HPV-Vaccinated Patient With Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma
JAMA Otolaryngol Head Neck Surg, 149 (1), 92-94
DOI 10.1001/jamaoto.2022.3762, PubMed 36416857
Gelderblom H, Jones RL, Blay JY, George S, von Mehren M, Zalcberg JR, Kang YK, Razak AA, Trent J, Attia S, Le Cesne A, Siontis BL, Goldstein D, Boye K, Sanchez C, Steeghs N, Rutkowski P, Druta M, Serrano C, Somaiah N, Chi P, Harrow B, Becker C, Reichmann W, Sherman ML et al. (2023)
Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study
Eur J Cancer, 192, 113245
DOI 10.1016/j.ejca.2023.113245, PubMed 37598656
Gerdtsson A, Torisson G, Thor A, Grenabo Bergdahl A, Almås B, Håkansson U, Törnblom M, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Haugnes HS, Larsen SM, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A (2023)
Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
BJU Int, 132 (3), 329-336
DOI 10.1111/bju.16040, PubMed 37129962
Gerdtsson AS, Matos Rodrigues J, Eskelund CW, Husby S, Grønbæk K, Räty R, Kolstad A, Geisler C, Porwit A, Jerkeman M, Ek S (2023)
Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established highrisk factors
Haematologica, 108 (4), 1092-1104
DOI 10.3324/haematol.2022.281420, PubMed 36519324
Gjerset GM, Kiserud CE, Wisløff T, McCarthy JB, Thorsen L (2023)
Perceived burden and need for support among caregivers of cancer patients
Acta Oncol, 62 (7), 794-802
DOI 10.1080/0284186X.2023.2240008, PubMed 37540581
Gombos A, Goncalves A, Curigliano G, Bartsch R, Kyte JA, Ignatiadis M, Awada A (2023)
How I treat endocrine-dependent metastatic breast cancer
ESMO Open, 8 (2), 100882
DOI 10.1016/j.esmoop.2023.100882, PubMed 36806375
Groendahl AR, Huynh BN, Tomic O, Søvik Å, Dale E, Malinen E, Skogmo HK, Futsaether CM (2023)
Automatic gross tumor segmentation of canine head and neck cancer using deep learning and cross-species transfer learning
Front Vet Sci, 10, 1143986
DOI 10.3389/fvets.2023.1143986, PubMed 37026102
Grønningsæter SR, Blakkisrud J, Selboe S, Revheim ME, Bruland ØS, Bønsdorff TB, Larsen SG, Stokke C (2023)
Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis
Front Med (Lausanne), 10, 1058914
DOI 10.3389/fmed.2023.1058914, PubMed 36844217
Gudmundstuen AM, Efficace F, Tjønnfjord GE, Skaarud KJ, Cottone F, Hjermstad MJ, Iversen PO (2023)
The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial
Ann Hematol, 102 (4), 927-935
DOI 10.1007/s00277-023-05149-x, PubMed 36864210
Gulbrandsen MS, Nøding AS, Smeland KB, Eikeland SA, Kiserud CE, Hjermstad MJ, Fosså A (2023)
Health-related quality of life, depressive symptoms, and chronic fatigue in long-term survivors of Hodgkin lymphoma
Leuk Lymphoma, 64 (6), 1139-1150
DOI 10.1080/10428194.2023.2198053, PubMed 37144290
Hanekamp BA, Viktil E, Slørdahl KS, Dormagen JB, Kløw NE, Malinen E, Brunborg C, Guren MG, Schulz A (2023)
Magnetic resonance imaging of anal cancer: tumor characteristics and early prediction of treatment outcome
Strahlenther Onkol, 200 (1), 19-27
DOI 10.1007/s00066-023-02114-5, PubMed 37429949
Harrington KJ, Ferris RL, Gillison M, Tahara M, Argiris A, Fayette J, Schenker M, Bratland Å, Walker JWT, Grell P, Even C, Chung CH, Redman R, Coutte A, Salas S, Grant C, de Azevedo S, Soulières D, Hansen AR, Wei L, Khan TA, Miller-Moslin K, Roberts M, Haddad R (2023)
Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714 Randomized Clinical Trial
JAMA Oncol, 9 (6), 779-789
DOI 10.1001/jamaoncol.2023.0147, PubMed 37022706
Haugen MH, von der Lippe Gythfeldt H, Egeland EV, Svartdal Normann L, Pandya AD, Vedin LL, Juell S, Tenstad E, Øy GF, Kristian A, Marangoni E, Sørlie T, Steffensen K, Maelandsmo GM, Engebraaten O (2023)
Liver X receptors induce antiproliferative effects in basal-like breast cancer
Mol Oncol, 17 (10), 2041-2055
DOI 10.1002/1878-0261.13476, PubMed 37341140
Heggebø LC, Borgen IMH, Rylander H, Kiserud C, Nordenmark TH, Hellebust TP, Evensen ME, Gustavsson M, Ramberg C, Sprauten M, Magelssen H, Blakstad H, Moorthy J, Andersson K, Raunert I, Henry T, Moe C, Granlund C, Goplen D, Brekke J, Johannessen TA, Solheim TS, Marienhagen K, Humberset Ø, Bergström P et al. (2023)
Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
BMJ Open, 13 (3), e070071
DOI 10.1136/bmjopen-2022-070071, PubMed 36940951
Helland Å, Myklebust TÅ, Conte S, Frederiksen LE, Aarøe J, Enerly E (2023)
EGFR-mutation testing, treatment patterns and clinical outcomes in patients with stage IB-IIIA non-small cell lung cancer in Norway-a nationwide cohort study
Cancer Treat Res Commun, 38, 100785
DOI 10.1016/j.ctarc.2023.100785, PubMed 38190787
Hiensch AE, Beckhaus J, Witlox L, Monninkhof EM, Schagen SB, van Vulpen JK, Sweegers MG, Newton RU, Aaronson NK, Galvão DA, Steindorf K, Stuiver MM, Mesters I, Knoop H, Goedendorp MM, Bohus M, Thorsen L, Schulz KH, Schmidt ME, Ulrich CM, Sonke GS, van Harten WH, Winters-Stone KM, Velthuis MJ, Taaffe DR et al. (2023)
Moderators of exercise effects on self-reported cognitive functioning in cancer survivors: an individual participant data meta-analysis
J Cancer Surviv, 18 (5), 1492-1503
DOI 10.1007/s11764-023-01392-3, PubMed 37160571
Hindi N, Razak A, Rosenbaum E, Jonczak E, Hamacher R, Rutkowski P, Bhadri VA, Skryd A, Brahmi M, Alshibany A, Jagodzinska-Mucha P, Bauer S, Connolly E, Gelderblom H, Boye K, Henon C, Bae S, Bogefors K, Vincenzi B, Martinez-Trufero J, Lopez-Martin JA, Redondo A, Valverde C, Blay JY, Moura DS et al. (2023)
Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry
ESMO Open, 8 (6), 102045
DOI 10.1016/j.esmoop.2023.102045, PubMed 38016251
Hjelle LV, Sælen M, Aarsæther E, Knutsen T, Andersen S, Bentzen AG, Richardsen E, Wilsgaard T, Fosså SD, Haugnes HS (2023)
The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy
Eur Urol Open Sci, 53, 6-15
DOI 10.1016/j.euros.2023.04.005, PubMed 37441342
Hjermstad MJ, Aass N, Gravli TH, Smeland S, Kaasa S (2023)
[Patient-centred cancer care]
Tidsskr Nor Laegeforen, 143 (1)
DOI 10.4045/tidsskr.22.0668, PubMed 36655956
Hole MJ, Jørgensen KK, Holm K, Braadland PR, Meyer-Myklestad MH, Medhus AW, Reikvam DH, Götz A, Grzyb K, Boberg KM, Karlsen TH, Kummen M, Hov JR (2023)
A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation
Hepatology, 77 (3), 715-728
DOI 10.1002/hep.32773, PubMed 36056902
Hole MJ, Jørgensen KK, Holm K, Braadland PR, Meyer-Myklestad MH, Medhus AW, Reikvam DH, Götz A, Grzyb K, Boberg KM, Karlsen TH, Kummen M, Hov JR (2023)
Reply: The mucosal gut signature in primary sclerosing cholangitis before and after liver transplantation. Is the dysbiosis index really predictive for the recurrence of PSC?
Hepatology, 77 (6), E188-E189
DOI 10.1097/HEP.0000000000000340, PubMed 36815351
Holm MO, Bye A, Falkmer U, Tobberup R, Rasmussen HH, Lauridsen C, Yilmaz MK, Søndergaard J, Poulsen LØ (2023)
The effect of nutritional interventions in acute radiation-induced diarrhoea in patients with primary pelvic cancer: A systematic review
Crit Rev Oncol Hematol, 188, 104038
DOI 10.1016/j.critrevonc.2023.104038, PubMed 37236410
Holme IK, Hollund HA, Vandraas K, Kiserud CE, Reinertsen KV, Loge JH, Lie HC (2023)
Sexual Problems as Late Effects: Awareness and Information Needs Among 1870 Long-term Norwegian Childhood, Adolescent, and Young Adult Cancer Survivors (The NOR-CAYACS Study)
J Adolesc Young Adult Oncol, 13 (1), 203-212
DOI 10.1089/jayao.2023.0031, PubMed 37579257
Huuhtanen J, Kasanen H, Peltola K, Lönnberg T, Glumoff V, Brück O, Dufva O, Peltonen K, Vikkula J, Jokinen E, Ilander M, Lee MH, Mäkelä S, Nyakas M, Li B, Hernberg M, Bono P, Lähdesmäki H, Kreutzman A, Mustjoki S (2023)
Single-cell characterization of anti-LAG-3 and anti-PD-1 combination treatment in patients with melanoma
J Clin Invest, 133 (6)
DOI 10.1172/JCI164809, PubMed 36719749
Huynh BN, Groendahl AR, Tomic O, Liland KH, Knudtsen IS, Hoebers F, van Elmpt W, Malinen E, Dale E, Futsaether CM (2023)
Head and neck cancer treatment outcome prediction: a comparison between machine learning with conventional radiomics features and deep learning radiomics
Front Med (Lausanne), 10, 1217037
DOI 10.3389/fmed.2023.1217037, PubMed 37711738
Huynh TM, Dale E, Falk RS, Hellebust TP, Astrup GL, Malinen E, Edin NFJ, Bjordal K, Herlofson BB, Kiserud CE, Helland Å, Amdal CD (2023)
Radiation-induced long-term dysphagia in survivors of head and neck cancer and association with dose-volume parameters
Radiother Oncol, 190, 110044
DOI 10.1016/j.radonc.2023.110044, PubMed 38061420
Høland M, Berg KCG, Eilertsen IA, Bjerkehagen B, Kolberg M, Boye K, Lingjærde OC, Guren TK, Mandahl N, van den Berg E, Palmerini E, Smeland S, Picci P, Mertens F, Sveen A, Lothe RA (2023)
Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets
EBioMedicine, 97, 104829
DOI 10.1016/j.ebiom.2023.104829, PubMed 37837931
Isaksen KT, Galleberg R, Mastroianni MA, Rinde M, Rusten LS, Barzenje D, Ramslien F, Fluge O, Slaaen M, Meyer P, Liestol K, Smeland EB, Lingjarde OC, Holte H, Brodtkorb M (2023)
The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy
Haematologica, 108 (9), 2454-2466
DOI 10.3324/haematol.2022.282289, PubMed 36861406
Janik AM, Terlecka A, Spałek MJ, Boye K, Szostakowski B, Chmiel P, Szumera-Ciećkiewicz A, Bobak K, Świtaj T, Rutkowski P, Czarnecka AM (2023)
Diagnostics and Treatment of Extrameningeal Solitary Fibrous Tumors
Cancers (Basel), 15 (24)
DOI 10.3390/cancers15245854, PubMed 38136399
Jenul A, Stokmo HL, Schrunner S, Hjortland GO, Revheim ME, Tomic O (2023)
Novel ensemble feature selection techniques applied to high-grade gastroenteropancreatic neuroendocrine neoplasms for the prediction of survival
Comput Methods Programs Biomed, 244, 107934
DOI 10.1016/j.cmpb.2023.107934, PubMed 38016391
Jesse S, Kuhlmann L, Hildebrand LS, Magelssen H, Schmaus M, Timmermann B, Andres S, Fietkau R, Distel LV (2023)
Increased Radiation Sensitivity in Patients with Phelan-McDermid Syndrome
Cells, 12 (5)
DOI 10.3390/cells12050820, PubMed 36899955
Joaquina S, Forcados C, Caulier B, Inderberg EM, Wälchli S (2023)
Determination of CAR T cell metabolism in an optimized protocol
Front Bioeng Biotechnol, 11, 1207576
DOI 10.3389/fbioe.2023.1207576, PubMed 37409169
Joensuu H, Wardelmann E, Eriksson M, Reichardt A, Hall KS, Schütte J, Cameron S, Hohenberger P, Sihto H, Jost PJ, Lindner LH, Bauer S, Nilsson B, Kallio R, Pesonen T, Reichardt P (2023)
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
Clin Cancer Res, 29 (17), 3313-3319
DOI 10.1158/1078-0432.CCR-22-3980, PubMed 37014660
Juzeniene A, Stenberg VY, Bruland ØS, Revheim ME, Larsen RH (2023)
Dual targeting with ²²⁴Ra/²¹²Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach
Front Med (Lausanne), 9, 1051825
DOI 10.3389/fmed.2022.1051825, PubMed 36733936
Kalmbach S, Grau M, Zapukhlyak M, Leich E, Jurinovic V, Hoster E, Staiger AM, Kurz KS, Weigert O, Gaitzsch E, Passerini V, Engelhard M, Herfarth K, Beiske K, Micci F, Möller P, Bernd HW, Feller AC, Klapper W, Stein H, Hansmann ML, Hartmann S, Dreyling M, Holte H, Lenz G et al. (2023)
Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms
Leukemia, 37 (10), 2058-2065
DOI 10.1038/s41375-023-01995-w, PubMed 37563306
Klee CH, Villatoro A, Casey NP, Inderberg EM, Wälchli S (2023)
In vitro re-challenge of CAR T cells
Methods Cell Biol, 183, 335-353
DOI 10.1016/bs.mcb.2023.06.003, PubMed 38548418
Knappskog S, Grob T, Venizelos A, Amstutz U, Hjortland GO, Lothe IM, Kersten C, Hofsli E, Sundlöv A, Elvebakken H, Garresori H, Couvelard A, Svensson J, Sorbye H, Perren A (2023)
Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma
JCO Precis Oncol, 7, e2200336
DOI 10.1200/PO.22.00336, PubMed 36753687
Langberg CW, Horndalsveen H, Helland Å, Haakensen VD (2023)
Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC
Front Oncol, 13, 1217424
DOI 10.3389/fonc.2023.1217424, PubMed 37476372
Larsen SG, Graf W, Mariathasan AB, Sørensen O, Spasojevic M, Goscinski MA, Selboe S, Lundstrøm N, Holtermann A, Revheim ME, Bruland ØS (2023)
First experience with ²²⁴Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study)
Front Med (Lausanne), 10, 1070362
DOI 10.3389/fmed.2023.1070362, PubMed 36936230
Larsen TL, Svalastoga M, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Paulsen PQ, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2023)
Arterial events in cancer patients treated with apixaban for venous thrombosis
Thromb Res, 228, 128-133
DOI 10.1016/j.thromres.2023.05.017, PubMed 37327527
Le Tourneau C, André F, Helland Å, Mileshkin L, Minnaard W, Schiel A, Taskén K, Thomas DM, Veronese ML, Durán-Pacheco G, Leyens L, Rufibach K, Thomas M, Krämer A (2023)
Modified study designs to expand treatment options in personalised oncology: a multistakeholder view
Eur J Cancer, 194, 113278
DOI 10.1016/j.ejca.2023.113278, PubMed 37820553
Leich E, Brodtkorb M, Schmidt T, Altenbuchinger M, Lingjærde OC, Lockmer S, Holte H, Nedeva T, Grieb T, Sander B, Sundström C, Spang R, Kimby E, Rosenwald A (2023)
Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy
Leuk Lymphoma, 64 (12), 1927-1937
DOI 10.1080/10428194.2023.2240462, PubMed 37683053
Leivonen SK, Friman T, Autio M, Vaittinen S, Jensen AW, D'Amore F, Hamilton-Dutoit SJ, Holte H, Beiske K, Kovanen PE, Räty R, Leppä S (2023)
Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas
Haematologica, 108 (11), 3044-3057
DOI 10.3324/haematol.2023.282831, PubMed 37259566
Leske H, Blakstad H, Lund-Iversen M, Skovholt EK, Niehusmann P, Ramm-Pettersen JT, Skogen K, Kongelf G, Sprauten M, Magelssen H, Brandal P (2023)
Astrocytoma (CNS WHO grade 4), IDH-mutant with co-occurrence of BRAF p.V600E mutation, and homozygous loss of CDKN2A
Neuropathology, 43 (5), 385-390
DOI 10.1111/neup.12895, PubMed 36754566
Lilleby W, Seierstad T, Inderberg EM, Hole KH (2023)
Impact of human telomerase reverse transcriptase peptide vaccine combined with androgen deprivation therapy and radiotherapy in de novo metastatic prostate cancer: Long-term clinical monitoring
Int J Cancer, 152 (10), 2166-2173
DOI 10.1002/ijc.34448, PubMed 36715014
Lindberg S, Grozman V, Karlsson K, Onjukka E, Lindbäck E, Jirf KA, Lax I, Wersäll P, Persson GF, Josipovic M, Khalil AA, Møller DS, Hoffmann L, Knap MM, Nyman J, Drugge N, Bergström P, Olofsson J, Rogg LV, Hagen RK, Frøland AS, Ramberg C, Kristiansen C, Jeppesen SS, Nielsen TB et al. (2023)
Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors
Int J Radiat Oncol Biol Phys, 117 (5), 1222-1231
DOI 10.1016/j.ijrobp.2023.06.246, PubMed 37423292
Liu L, Choi J, Musoro JZ, Sauerbrei W, Amdal CD, Alanya A, Barbachano Y, Cappelleri JC, Falk RS, Fiero MH, Regnault A, Reijneveld JC, Sandin R, Thomassen D, Roychoudhury S, Goetghebeur E, le Cessie S, SISAQOL-IMI Work Package 3 (2023)
Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice
Lancet Oncol, 24 (5), e197-e206
DOI 10.1016/S1470-2045(23)00110-9, PubMed 37142381
Lloret I, Hompland I, Lobmaier IV, Sundseth J, Server A (2023)
Ewing sarcoma of the temporal bone with aneurysmal bone cyst-like changes: A rare case report with an unusual radiological presentation
Neuroradiol J, 37 (5), 640-644
DOI 10.1177/19714009231212358, PubMed 37923348
Ludvigsen M, Campbell AJ, Enemark MB, Hybel TE, Karjalainen-Lindsberg ML, Beiske K, Bjerre M, Pedersen LM, Holte H, Leppä S, Jørgensen JM, Honoré B (2023)
Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma
Blood Cancer J, 13 (1), 161
DOI 10.1038/s41408-023-00931-6, PubMed 37884514
Luminari S, Fossa A, Trotman J, Molin D, d'Amore F, Enblad G, Berkahn L, Barrington SF, Radford J, Federico M, Kirkwood AA, Johnson PWM (2023)
Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial
J Clin Oncol, 42 (1), 13-18
DOI 10.1200/JCO.23.01177, PubMed 37883739
Lundereng ED, Nes AAG, Holmen H, Winger A, Thygesen H, Jøranson N, Borge CR, Dajani O, Mariussen KL, Steindal SA (2023)
Health Care Professionals' Experiences and Perspectives on Using Telehealth for Home-based Palliative Care: Scoping Review
J Med Internet Res, 25, e43429
DOI 10.2196/43429, PubMed 36989024
Mauz-Körholz C, Landman-Parker J, Fernández-Teijeiro A, Attarbaschi A, Balwierz W, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Ceppi F, Claviez A, Daw S, Dieckmann K, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T et al. (2023)
Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study
Lancet Oncol, 24 (3), 252-261
DOI 10.1016/S1470-2045(23)00019-0, PubMed 36858722
McDonald J, Sayers J, Anker SD, Arends J, Balstad TR, Baracos V, Brown L, Bye A, Dajani O, Dolan R, Fallon MT, Fraser E, Griel C, Grzyb A, Hjermstad M, Jamal-Hanjani M, Jakobsen G, Kaasa S, McMillan D, Maddocks M, Philips I, Ottestad IO, Reid KF, Sousa MS, Simpson MR et al. (2023)
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
J Cachexia Sarcopenia Muscle, 14 (5), 1932-1948
DOI 10.1002/jcsm.13321, PubMed 37671529
Mediå LM, Sigurdardottir S, Fauske L, Waehre A (2023)
Understanding sexual health concerns among adolescents and young adults with differences of sex development: a qualitative study
Int J Qual Stud Health Well-being, 18 (1), 2204635
DOI 10.1080/17482631.2023.2204635, PubMed 37092307
Mendoza Mireles EE, Skaga E, Server A, Leske H, Brandal P, Helseth E, Rønning PA, Vik-Mo EO (2023)
The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based study
Neurooncol Pract, 10 (6), 555-564
DOI 10.1093/nop/npad037, PubMed 38026582
Mensali N, Köksal H, Joaquina S, Wernhoff P, Casey NP, Romecin P, Panisello C, Rodriguez R, Vimeux L, Juzeniene A, Myhre MR, Fåne A, Ramírez CC, Maggadottir SM, Duru AD, Georgoudaki AM, Grad I, Maturana AD, Gaudernack G, Kvalheim G, Carcaboso AM, de Alava E, Donnadieu E, Bruland ØS, Menendez P et al. (2023)
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma
Nat Commun, 14 (1), 3375
DOI 10.1038/s41467-023-39097-x, PubMed 37291203
Mikalsen SG, Skjøtskift T, Flote VG, Hämäläinen NP, Heydari M, Rydén-Eilertsen K (2023)
Extensive clinical testing of Deep Learning Segmentation models for thorax and breast cancer radiotherapy planning
Acta Oncol, 62 (10), 1184-1193
DOI 10.1080/0284186X.2023.2270152, PubMed 37883678
Miranda R, Raemdonck E, Deliens L, Kaasa S, Zimmermann C, Rodin G, Robijn L, Lundeby T, Houbracken I, Beernaert K (2023)
Do cancer centres and palliative care wards routinely measure patients' quality of life? An international cross-sectional survey study
Support Care Cancer, 31 (8), 499
DOI 10.1007/s00520-023-07964-4, PubMed 37523097
Mo T, Brandal SHB, Geier OM, Engebråten O, Nilsen LB, Kristensen VN, Hole KH, Hompland T, Fleischer T, Seierstad T (2023)
MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients
Cancers (Basel), 15 (18)
DOI 10.3390/cancers15184662, PubMed 37760629
Morken S, Langer SW, Sundlöv A, Vestermark LW, Ladekarl M, Hjortland GO, Svensson JB, Tabaksblat EM, Haslerud TM, Assmus J, Detlefsen S, Couvelard A, Perren A, Sorbye H (2023)
Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms
Br J Cancer, 129 (12), 1930-1939
DOI 10.1038/s41416-023-02462-0, PubMed 37872405
Møller CT, Tafjord G, Blindheim A, Berge V, Fosså S, Andreassen BK (2023)
Initial management and survival of patients with primary metastatic bladder cancer before the immunotherapy era: a population-based study from Norway
Scand J Urol, 58, 101-108
DOI 10.2340/sju.v58.5923, PubMed 37953521
Namløs HM, Khelik K, Nakken S, Vodák D, Hovig E, Myklebost O, Boye K, Meza-Zepeda LA (2023)
Chromosomal instability and a deregulated cell cycle are intrinsic features of high-risk gastrointestinal stromal tumours with a metastatic potential
Mol Oncol, 17 (11), 2432-2450
DOI 10.1002/1878-0261.13514, PubMed 37622176
Nilsen TS, Sæter M, Sarvari SI, Reinertsen KV, Johansen SH, Edvardsen ER, Hallén J, Edvardsen E, Grydeland M, Kiserud CE, Lie HC, Solberg PA, Wisløff T, Sharples AP, Raastad T, Haugaa KH, Thorsen L (2023)
Effects of Aerobic Exercise on Cardiorespiratory Fitness, Cardiovascular Risk Factors, and Patient-Reported Outcomes in Long-Term Breast Cancer Survivors: Protocol for a Randomized Controlled Trial
JMIR Res Protoc, 12, e45244
DOI 10.2196/45244, PubMed 36920460
Nilsen TS, Sæter M, Sarvari SI, Reinertsen KV, Johansen SH, Edvardsen ER, Hallén J, Edvardsen E, Grydeland M, Kiserud CE, Lie HC, Solberg PA, Wisløff T, Sharples AP, Raastad T, Haugaa KH, Thorsen L (2023)
Correction: Effects of Aerobic Exercise on Cardiorespiratory Fitness, Cardiovascular Risk Factors, and Patient-Reported Outcomes in Long-Term Breast Cancer Survivors: Protocol for a Randomized Controlled Trial
JMIR Res Protoc, 12, e54462
DOI 10.2196/54462, PubMed 37963373
Nilssen Y, Solberg S, Brustugun OT, Møller B, Sundset A, Wahl SGF, Helland Å (2023)
Tracheal cancer: a rare and deadly but potentially curable disease that also affects younger people
Eur J Cardiothorac Surg, 64 (1)
DOI 10.1093/ejcts/ezad244, PubMed 37348858
Nilsson K, Klevebro F, Sunde B, Rouvelas I, Lindblad M, Szabo E, Halldestam I, Smedh U, Wallner B, Johansson J, Johnsen G, Aahlin EK, Johannessen HO, Alexandersson von Döbeln G, Hjortland GO, Wang N, Shang Y, Borg D, Quaas A, Bartella I, Bruns C, Schröder W, Nilsson M (2023)
Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial
Ann Oncol, 34 (11), 1015-1024
DOI 10.1016/j.annonc.2023.08.010, PubMed 37657554
Nilsson MP, Undseth C, Albertsson P, Eidem M, Havelund BM, Johannsson J, Johnsson A, Radu C, Serup-Hansen E, Spindler KL, Zakrisson B, Guren MG, Kronborg C (2023)
Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer
Acta Oncol, 62 (8), 897-906
DOI 10.1080/0284186X.2023.2240490, PubMed 37504978
Niyoteka S, Seban RD, Rouhi R, Scarsbrook A, Genestie C, Classe M, Carré A, Sun R, La Greca Saint-Esteven A, Chargari C, McKenna J, McDermott G, Malinen E, Tanadini-Lang S, Guckenberger M, Guren MG, Lemanski C, Deutsch E, Robert C (2023)
A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers
Eur J Nucl Med Mol Imaging, 50 (13), 4010-4023
DOI 10.1007/s00259-023-06320-2, PubMed 37632562
Normann LS, Haugen MH, Hongisto V, Aure MR, Leivonen SK, Kristensen VN, Tahiri A, Engebraaten O, Sahlberg KK, Mælandsmo GM (2023)
High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer
PLoS One, 18 (1), e0280507
DOI 10.1371/journal.pone.0280507, PubMed 36706086
Oh DY, Algazi A, Capdevila J, Longo F, Miller W, Chun Bing JT, Bonilla CE, Chung HC, Guren TK, Lin CC, Motola-Kuba D, Shah M, Hadoux J, Yao L, Jin F, Norwood K, Lebellec L (2023)
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study
Cancer, 129 (8), 1195-1204
DOI 10.1002/cncr.34657, PubMed 36748723
Opheim LØ, Engeskaug I, Bjerre Trent PK, Thorsen L, Staff AC, Nordskar NJ, Utne I, Hagen M, Eriksson AGZ (2023)
Associations between modifiable lifestyle factors and health-related quality of life among endometrial carcinoma survivors - A cross-sectional study
Gynecol Oncol, 179, 52-62
DOI 10.1016/j.ygyno.2023.10.012, PubMed 37924595
Ost P, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Everaerts W, Shelan M, Conde-Moreno A, López Campos F, Papachristofilou A, Guckenberger M, Scorsetti M, Zapatero A, Villafranca Iturre AE, Eito C, Couñago F, Muto P, Van De Voorde L, Mach N, Bultijnck R, Fonteyne V, Moon D, Thon K et al. (2023)
PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial
Eur Urol Oncol, 7 (3), 462-468
DOI 10.1016/j.euo.2023.09.007, PubMed 37821242
Otrebski Nilsson M, Aas K, Myklebust TÅ, Gjelsvik YM, Haug ES, Fosså SD, Johannesen TB (2023)
Do all prostate cancer patients want, and experience shared decision making prior to curative treatment?
Scand J Urol, 58, 133-140
DOI 10.2340/sju.v58.14730, PubMed 38116675
Ottesen JA, Yi D, Tong E, Iv M, Latysheva A, Saxhaug C, Jacobsen KD, Helland Å, Emblem KE, Rubin DL, Bjørnerud A, Zaharchuk G, Grøvik E (2023)
2.5D and 3D segmentation of brain metastases with deep learning on multinational MRI data
Front Neuroinform, 16, 1056068
DOI 10.3389/fninf.2022.1056068, PubMed 36743439
Palmerini E, Reichardt P, Hall KS, Bertulli R, Bielack SS, Comandone A, Egerer G, Hansmeier A, Kevric M, Carretta E, Hansson L, Jebsen N, Eriksson M, Bruland ØS, Donati DM, Ibrahim T, Smeland S, Ferrari S (2023)
Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.)
Cancer, 129 (22), 3564-3573
DOI 10.1002/cncr.34964, PubMed 37530385
Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Ruíz-Borrego M, Moore HCF, Saunders C, Bjelic-Radisic V et al. (2023)
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer
N Engl J Med, 388 (18), 1645-1656
DOI 10.1056/NEJMoa2212856, PubMed 37133584
Pasetto A, Lu YC (2023)
Editorial: Personalized immunotherapy for cancer
Front Oncol, 13, 1171907
DOI 10.3389/fonc.2023.1171907, PubMed 36959783
Pe M, Alanya A, Falk RS, Amdal CD, Bjordal K, Chang J, Cislo P, Coens C, Dirven L, Speck RM, Fitzgerald K, Galinsky J, Giesinger JM, Holzner B, Le Cessie S, O'Connor D, Oliver K, Pawar V, Quinten C, Schlichting M, Ren J, Roychoudhury S, Taphoorn MJB, Velikova G, Wintner LM et al. (2023)
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures
Lancet Oncol, 24 (6), e270-e283
DOI 10.1016/S1470-2045(23)00157-2, PubMed 37269858
Pettersen S, Øy GF, Egeland EV, Juell S, Engebråten O, Mælandsmo GM, Prasmickaite L (2023)
Breast cancer patient-derived explant cultures recapitulate in vivo drug responses
Front Oncol, 13, 1040665
DOI 10.3389/fonc.2023.1040665, PubMed 36910663
Piperno-Neumann S, Carlino MS, Boni V, Loirat D, Speetjens FM, Park JJ, Calvo E, Carvajal RD, Nyakas M, Gonzalez-Maffe J, Zhu X, Shirley MD, Ramkumar T, Fessehatsion A, Burks HE, Yerramilli-Rao P, Kapiteijn E (2023)
A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma
Br J Cancer, 128 (6), 1040-1051
DOI 10.1038/s41416-022-02133-6, PubMed 36624219
Rakaee M, Andersen S, Giannikou K, Paulsen EE, Kilvaer TK, Busund LR, Berg T, Richardsen E, Lombardi AP, Adib E, Pedersen MI, Tafavvoghi M, Wahl SGF, Petersen RH, Bondgaard AL, Yde CW, Baudet C, Licht P, Lund-Iversen M, Grønberg BH, Fjellbirkeland L, Helland Å, Pøhl M, Kwiatkowski DJ, Donnem T (2023)
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial
Ann Oncol, 34 (7), 578-588
DOI 10.1016/j.annonc.2023.04.005, PubMed 37100205
Ramsower CA, Rosenthal A, Robetorye RS, Mwangi R, Maurer M, Villa D, McDonnell T, Feldman A, Cohen JB, Habermann T, Campo E, Clot G, Bühler MM, Kulis M, Martin-Subero JI, Giné E, Cook JR, Hill B, Raess PW, Beiske KH, Reichart A, Hartmann S, Holte H, Scott D, Rimsza L (2023)
Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab
Br J Haematol, 204 (1), 160-170
DOI 10.1111/bjh.19153, PubMed 37881141
Richartz N, Pietka W, Yadav A, Bostad M, Bhagwat S, Naderi S, Naderi EH, Stokke T, Ruud E, Blomhoff HK (2023)
N-acetyl cysteine turns EPAC activators into potent killers of acute lymphoblastic leukemia cells
J Biol Chem, 300 (1), 105509
DOI 10.1016/j.jbc.2023.105509, PubMed 38042493
Riis ML, Augestad L, Flote VG, Tangerud A, Frich L (2023)
Simultaneous cutaneous melanoma and ipsilateral breast cancer with metastasis to the same axilla. A case report with a focus on a multidisciplinary approach
Int J Surg Case Rep, 114, 109119
DOI 10.1016/j.ijscr.2023.109119, PubMed 38061088
Riis RN, Riis MH, Benth JŠ, Augestad KM (2023)
Beyond the transanal total mesorectal excision moratorium: local and distant recurrence among patients operated for low rectal tumours-5-year follow-up from a Norwegian University Hospital
Br J Surg, 110 (11), 1547-1548
DOI 10.1093/bjs/znad275, PubMed 37672389
Robert C, Carlino MS, McNeil C, Ribas A, Grob JJ, Schachter J, Nyakas M, Kee D, Petrella TM, Blaustein A, Lotem M, Arance A, Daud AI, Hamid O, Larkin J, Anderson J, Krepler C, Grebennik D, Long GV (2023)
Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced Melanoma
J Clin Oncol, 41 (24), 3998-4003
DOI 10.1200/JCO.22.01599, PubMed 37348035
Robsahm TE, Tsuruda KM, Hektoen HH, Storås AH, Cook MB, Hurwitz LM, Langseth H (2023)
Applying recommended definition of aggressive prostate cancer: a validation study using high-quality data from the Cancer Registry of Norway
Acta Oncol, 62 (1), 8-14
DOI 10.1080/0284186X.2023.2175331, PubMed 36762472
Rohde M, Eriksen JG, Pareek M, Bratland Å, Mäkitie A, Hammarstedt-Nordenvall L, Wessel I, Lybeck JS, Mäenpää H, Gebre-Medhin M, Godballe C (2023)
Diagnosis of locally recurrent head and neck squamous cell carcinoma in the Nordic HNC centers and feasibility of the Odense-Birmingham definition
Acta Oncol, 62 (9), 1102-1105
DOI 10.1080/0284186X.2023.2245550, PubMed 37602835
Rowsell A, Sodergren SC, Vassiliou V, Darlington AS, Guren MG, Alkhaffaf B, Moorbey C, Dennis K, Terada M (2023)
Correction to: Systematic review of health-related quality of life (HRQoL) issues associated with gastric cancer: capturing cross-cultural differences
Gastric Cancer, 26 (1), 167
DOI 10.1007/s10120-022-01346-1, PubMed 36269499
Rugo HS, Van Poznak CH, Neven P, Danielewicz I, Lee SC, Campone M, Chik JYK, Vega Alonso E, Naume B, Brain E, Siegel JM, Li R, Uema D, Wagner VJ, Coleman RE (2023)
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials
Breast Cancer Res Treat, 204 (2), 249-259
DOI 10.1007/s10549-023-07147-z, PubMed 38123789
Sah VR, Jespersen H, Karlsson J, Nilsson LM, Bergqvist M, Johansson I, Carneiro A, Helgadottir H, Levin M, Ullenhag G, Ståhlberg A, Olofsson Bagge R, Nilsson JA, Ny L (2023)
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy
Cancer Res Commun, 3 (5), 884-895
DOI 10.1158/2767-9764.CRC-22-0490, PubMed 37377898
Salim R, Husby S, Winther Eskelund C, Scott DW, Holte H, Kolstad A, Räty R, Ek S, Jerkeman M, Geisler C, Sommer Kristensen L, Dahl M, Grønbæk K (2023)
Exploring new prognostic biomarkers in Mantle Cell Lymphoma: a comparison of the circSCORE and the MCL35 score
Leuk Lymphoma, 64 (8), 1414-1423
DOI 10.1080/10428194.2023.2216819, PubMed 37259807
Sanchez VA, Shuey MM, Dinh PC, Monahan PO, Fosså SD, Sesso HD, Dolan ME, Einhorn LH, Vaughn DJ, Martin NE, Feldman DR, Kroenke K, Fung C, Frisina RD, Travis LB (2023)
Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy
J Clin Oncol, 41 (12), 2211-2226
DOI 10.1200/JCO.22.01456, PubMed 36626694
Sars C, Sackey H, Frisell J, Dickman PW, Karlsson F, Kindts I, Marta GN, Freitas-Junior R, Tvedskov TF, Kassem L, Ali AS, Ihalainen H, Neron M, Kontos M, Kaidar-Person O, Meattini I, Francken AB, van Duijnhoven F, Moberg IO, Marinko T, Kollar A, Ahmed M, Remoundos D, Banks J, Jagsi R et al. (2023)
Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologists
Breast Cancer Res Treat, 199 (2), 293-304
DOI 10.1007/s10549-023-06896-1, PubMed 36879102
Schipmann-Miletic S, Sivakanesan S, Rath DS, Brandal P, Vik-Mo E, Bjørås M, Solheim O, Ingebrigtsen T, Sund F, Bjerkvig R, Miletic H, Johannessen TA, Sundstrøm T (2023)
[Glioblastoma in adults]
Tidsskr Nor Laegeforen, 143 (2)
DOI 10.4045/tidsskr.22.0314, PubMed 36718891
Schmid MP, Lindegaard JC, Mahantshetty U, Tanderup K, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza A, Hoskin P, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Petric P, Ramazanova D, Ristl R, Kannan S, Hawaldar R, Ecker S, Kirchheiner K, Tan LT et al. (2023)
Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study
J Clin Oncol, 41 (10), 1933-1942
DOI 10.1200/JCO.22.01096, PubMed 36599120
Schneider KM, Kummen M, Trivedi PJ, Hov JR (2023)
Role of microbiome in autoimmune liver diseases
Hepatology, 80 (4), 965-987
DOI 10.1097/HEP.0000000000000506, PubMed 37369002
Shoushtari AN, Olszanski AJ, Nyakas M, Hornyak TJ, Wolchok JD, Levitsky V, Kuryk L, Hansen TB, Jäderberg M (2023)
Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti-PD-1-Resistant Advanced Melanoma
Clin Cancer Res, 29 (1), 100-109
DOI 10.1158/1078-0432.CCR-22-2046, PubMed 36112545
Skjerven HK, Myklebust EM, Korvald C, Stubberud K, Hovda T, Porojnicu AC, Kaaresen R, Hofvind S, Schlicting E, Sahlberg KK (2023)
Long-term follow-up of complex oncoplastic breast-conserving surgery, standard breast conservation and skin-sparing mastectomy in DCIS - a register-based study
Eur J Surg Oncol, 50 (2), 107938
DOI 10.1016/j.ejso.2023.107938, PubMed 38199004
Skoie IM, Skogås JG, Langø T, Myhr KM, Myhre PL, Goll R, Fretland SØ, Helland Å (2023)
New centres to carry out more clinical trials in Norway
Tidsskr Nor Laegeforen, 143 (2)
DOI 10.4045/tidsskr.22.0722, PubMed 36718905
Skaali T, Blomhoff R, Lindemann K, Smeland S, Bruheim K, Seland M, Thorsen L (2023)
Self-reported distress and problems after treatment for gynecological cancer - Correlation between a short screening tool and longer measures of anxiety/depression and health-related quality of life
Acta Obstet Gynecol Scand, 103 (2), 387-395
DOI 10.1111/aogs.14709, PubMed 37991142
Sletten OJ, Aalen JM, Smiseth OA, Khan FH, Fossa A, Kiserud CE, Villegas-Martinez M, Hisdal J, Remme EW, Skulstad H (2023)
Mental Stress Reduces Left Ventricular Strain: Can It Lead to Misinterpretation of Cancer Therapy-Related Cardiac Dysfunction?
J Am Soc Echocardiogr, 37 (5), 564-566
DOI 10.1016/j.echo.2023.11.010, PubMed 37981246
Smedsland SK, Falk RS, Reinertsen KV, Kiserud CE, Brekke M, Bøhn SH, Dahl AA, Vandraas KF (2023)
Burden of late effects in a nationwide sample of long-term breast cancer survivors
Cancer, 130 (1), 140-149
DOI 10.1002/cncr.35019, PubMed 37776533
Smedsland SK, Vandraas KF, Falk RS, Horn J, Reidunsdatter RJ, Kiserud CE, Dahl AA, Brekke M, Reinertsen KV (2023)
Sexual health in long-term breast cancer survivors: a comparison with female population controls from the HUNT study
Breast Cancer Res Treat, 201 (3), 479-488
DOI 10.1007/s10549-023-07021-y, PubMed 37490170
Solbakken AM, Sellevold S, Spasojevic M, Julsrud L, Emblemsvåg HL, Reims HM, Sørensen O, Thorgersen EB, Fauske L, Ågren JSM, Brennhovd B, Ryder T, Larsen SG, Flatmark K (2023)
Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer
Ann Surg Oncol, 30 (12), 7602-7611
DOI 10.1245/s10434-023-13964-9, PubMed 37481493
Solmunde E, Falstie-Jensen AM, Lorenzen EL, Ewertz M, Reinertsen KV, Dekkers OM, Cronin-Fenton DP (2023)
Breast cancer, breast cancer-directed radiation therapy and risk of hypothyroidism: A systematic review and meta-analysis
Breast, 68, 216-224
DOI 10.1016/j.breast.2023.02.008, PubMed 36868138
Spampinato S, Tanderup K, Lindegaard JC, Schmid MP, Sturdza A, Segedin B, Jürgenliemk-Schulz IM, De Leeuw A, Bruheim K, Mahantshetty U, Chargari C, Rai B, Cooper R, van der Steen-Banasik E, Sundset M, Wiebe E, Villafranca E, Van Limbergen E, Pieters BR, Tee Tan L, Lutgens LCHW, Hoskin P, Smet S, Pötter R, Nout R et al. (2023)
Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors
Radiother Oncol, 181, 109501
DOI 10.1016/j.radonc.2023.109501, PubMed 36720348
Spasevska I, Sharma A, Steen CB, Josefsson SE, Blaker YN, Kolstad A, Rustad EH, Meyer S, Isaksen K, Chellappa S, Kushekhar K, Beiske K, Førsund MS, Spetalen S, Holte H, Østenstad B, Brodtkorb M, Kimby E, Olweus J, Taskén K, Newman AM, Lorenz S, Smeland EB, Alizadeh AA, Huse K et al. (2023)
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma
Blood Adv, 7 (23), 7216-7230
DOI 10.1182/bloodadvances.2023010158, PubMed 37695745
Storås AH, Tsuruda K, Fosså SD, Andreassen BK (2023)
Time trends in systemic treatment for patients with metastatic prostate cancer: a national cohort study
Acta Oncol, 62 (12), 1716-1722
DOI 10.1080/0284186X.2023.2257876, PubMed 37725527
Svendsen K, Nes LS, Meland A, Larsson IM, Gjelsvik YM, Børøsund E, Rygg CM, Myklebust TÅ, Reinertsen KV, Kiserud CE, Skjerven H, Antoni MH, Chalder T, Mjaaland I, Carlson LE, Eriksen HR, Ursin G (2023)
Coping After Breast Cancer: Protocol for a Randomized Controlled Trial of Stress Management eHealth Interventions
JMIR Res Protoc, 12, e47195
DOI 10.2196/47195, PubMed 37103493
Switlyk MD, Hopland A, Sivanesan S, Brennhovd B, Ottosson F, Berner K, Axcrona U, Hole KH (2023)
Multi-parametric MRI without artificial erection for preoperative assessment of primary penile carcinoma: A pilot study on the correlation between imaging and histopathological findings
Eur J Radiol Open, 10, 100478
DOI 10.1016/j.ejro.2023.100478, PubMed 36793771
Sælen MG, Hjelle LV, Aarsæther E, Knutsen T, Andersen S, Bentzen AG, Richardsen E, Fosså SD, Haugnes HS (2023)
Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy
Acta Oncol, 62 (6), 657-665
DOI 10.1080/0284186X.2023.2224051, PubMed 37353983
Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, Gama RR, Jacinto A, Hammerlid E, Scricciolo M, Jansen F, Verdonck-de Leeuw IM, Fanetti G, Guntinas-Lichius O, Inhestern J, Dragan T, Fabian A, Boehm A, Wöhner U, Kiyota N, Krüger M, Bonomo P, Pinto M, Nuyts S, Silva JC et al. (2023)
Serious Long-Term Effects of Head and Neck Cancer from the Survivors' Point of View
Healthcare (Basel), 11 (6)
DOI 10.3390/healthcare11060906, PubMed 36981562
Thomsen LCV, Honoré A, Reisæter LAR, Almås B, Børretzen A, Helle SI, Førde K, Kristoffersen EK, Kaada SH, Melve GK, Haslerud TM, Biermann M, Bigalke I, Kvalheim G, Azeem W, Olsen JR, Gabriel B, Knappskog S, Halvorsen OJ, Akslen LA, Bahn D, Pantel K, Riethdorf S, Ragde H, Gjertsen BT et al. (2023)
A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer
Cancer Immunol Immunother, 72 (7), 2357-2373
DOI 10.1007/s00262-023-03421-7, PubMed 36939854
Thorgersen EB, Asvall J, Schjalm C, McAdam KE, Bruland ØS, Larsen SG, Mollnes TE (2023)
Effect of Intraperitoneal ²²⁴Radium-Labelled Microparticles on Compartmentalized Inflammation After Cytoreductive Surgery and Hypertherm Intraperitoneal Chemotherapy
Technol Cancer Res Treat, 22, 15330338231192902
DOI 10.1177/15330338231192902, PubMed 37574949
Thorsen L, Courneya KS, Steene-Johannessen J, Gran JM, Haugnes HS, Negaard HFS, Kiserud CE, Fosså SD (2023)
Association of physical activity with overall mortality among long-term testicular cancer survivors: A longitudinal study
Int J Cancer, 153 (8), 1512-1519
DOI 10.1002/ijc.34625, PubMed 37334652
Tjelta J, Fjæra LF, Ytre-Hauge KS, Boer CG, Stokkevåg CH (2023)
A systematic approach for calibrating a Monte Carlo code to a treatment planning system for obtaining dose, LET, variable proton RBE and out-of-field dose
Phys Med Biol, 68 (22)
DOI 10.1088/1361-6560/ad0281, PubMed 37820690
Trewin-Nybråten CB, Larsen IK, Møller B, Heikkilä R (2023)
Hospital surgical volume and colorectal cancer survival in Norway: A nationwide cohort study
Cancer Epidemiol, 85, 102404
DOI 10.1016/j.canep.2023.102404, PubMed 37343490
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M et al. (2023)
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
Crit Care, 27 (1), 9
DOI 10.1186/s13054-022-04205-8, PubMed 36627655
Turcas A, Kelly SM, Bernier-Chastagner V, Bolle S, Cameron A, Corning C, Clementel E, Dieckmann K, Davila Fajardo R, Gaze MN, Laprie A, Magelssen H, Meroni S, Pignoli E, Safwat A, Scarzello G, Talbot J, Timmermann B, Boterberg T, Mandeville HC (2023)
Management of the vertebrae as an organ at risk in paediatric radiotherapy clinical trials: Initial QUARTET experience
Radiother Oncol, 187, 109810
DOI 10.1016/j.radonc.2023.109810, PubMed 37468069
Upreti RP, Mmbaga E, Haugnes HS, Kiserud CE, Del Risco Kollerud R (2023)
Most common health problems in general practice among adolescents, and young adults' survivors of lymphoma: a register-based cohort study in Norway
Acta Oncol, 62 (12), 1607-1615
DOI 10.1080/0284186X.2023.2273894, PubMed 37897712
Valstad H, Eyjolfsdottir B, Wang Y, Kristensen GB, Skeie-Jensen T, Lindemann K (2023)
Pelvic exenteration for vulvar cancer: Postoperative morbidity and oncologic outcome - A single center retrospective analysis
Eur J Surg Oncol, 49 (9), 106958
DOI 10.1016/j.ejso.2023.06.010, PubMed 37349160
van de Wal D, Fauske L, Bruland ØS, Jones RL, Kasper B, Wilson R, van der Graaf WTA, Husson O (2023)
Psychological and social challenges of patients with locally advanced and metastatic gastrointestinal stromal tumours (GIST) on long-term treatment with tyrosine kinase inhibitors: a qualitative study with patients and medical oncologists
Support Care Cancer, 31 (6), 352
DOI 10.1007/s00520-023-07810-7, PubMed 37233829
van Ewijk R, Cleirec M, Herold N, le Deley MC, van Eijkelenburg N, Boudou-Rouquette P, Risbourg S, Strauss SJ, Palmerini E, Boye K, Kager L, Hecker-Nolting S, Marchais A, Gaspar N, FOSTER Consortium (Fight OsteoSarcoma Through European Research), work package 3 on recurrent/refractory osteosarcoma trials (2023)
A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?
Cancer Treat Rev, 120, 102625
DOI 10.1016/j.ctrv.2023.102625, PubMed 37738712
Vandraas K, Reinertsen KV, Smedsland S, Bøhn S, Kiserud C, Falk RS, Lie HC (2023)
Fear of cancer recurrence eight years after early-stage breast cancer - results from a national survey
Acta Oncol, 62 (6), 635-641
DOI 10.1080/0284186X.2023.2224052, PubMed 37337306
Vandraas KF, Smedsland S, Engan HK, Kiserud C, Naume B, Brekke M, Reinertsen KV (2023)
Late effects after breast cancer treatment
Tidsskr Nor Laegeforen, 143 (11)
DOI 10.4045/tidsskr.23.0017, PubMed 37589367
Venizelos A, Sorbye H, Elvebakken H, Perren A, Lothe IMB, Couvelard A, Hjortland GO, Sundlöv A, Svensson J, Garresori H, Kersten C, Hofsli E, Detlefsen S, Vestermark LW, Ladekarl M, Tabaksblat EM, Knappskog S (2023)
Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
Endocr Relat Cancer, 30 (10)
DOI 10.1530/ERC-23-0057, PubMed 37410378
Vistnes M, Erusappan PM, Sasi A, Nordén ES, Bergo KK, Romaine A, Lunde IG, Zhang L, Olsen MB, Øgaard J, Carlson CR, Wang CH, Riise J, Dahl CP, Fiane AE, Hauge-Iversen IM, Espe E, Melleby AO, Tønnessen T, Aronsen JM, Sjaastad I, Christensen G (2023)
Inhibition of the extracellular enzyme A disintegrin and metalloprotease with thrombospondin motif 4 prevents cardiac fibrosis and dysfunction
Cardiovasc Res, 119 (10), 1915-1927
DOI 10.1093/cvr/cvad078, PubMed 37216909
Vittrup AS, Kirchheiner K, Pötter R, Fokdal LU, Jensen NBK, Spampinato S, Haie-Meder C, Schmid MP, Sturdza AE, Mahantshetty U, Hoskin P, Segedin B, Bruheim K, Rai B, Wiebe E, van der Steen-Banasik E, Cooper R, Van Limbergen E, Sundset M, Pieters BR, Kirisits C, Lindegaard JC, Jürgenliemk-Schulz IM, Nout R, Tanderup K et al. (2023)
Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study
Int J Radiat Oncol Biol Phys, 116 (4), 807-824
DOI 10.1016/j.ijrobp.2023.01.002, PubMed 36641039
Wallander K, Öfverholm I, Boye K, Tsagkozis P, Papakonstantinou A, Lin Y, Haglund de Flon F (2023)
Sarcoma care in the era of precision medicine
J Intern Med, 294 (6), 690-707
DOI 10.1111/joim.13717, PubMed 37643281
Wedde TB, Smaastuen MC, Vatne K, Schulz-Jaavall MB, Fosså SD, Lilleby WL (2023)
External beam radiotherapy of prostate cancer with or without high dose-rate brachytherapy: the Norwegian experience with long-term urinary and bowel adverse effects
Scand J Urol, 58, 68-75
DOI 10.2340/sju.v58.9571, PubMed 37644904
Wehrle CJ, Fujiki M, Schlegel A, Whitsett Linganna M, Pita A, Kim JK, Kwon DCH, Miller C, Hashimoto K, Dueland S, Sasaki K, Sapisochin G, Line PD, Hernandez-Alejandro R, Aucejo F (2023)
Update to 'A Contemporary Systematic Review on Liver Transplantation for Unresectable Liver Metastasis of Colorectal Cancer'
Ann Surg Oncol, 31 (2), 697-700
DOI 10.1245/s10434-023-14611-z, PubMed 37996635
Werlenius K, Kinhult S, Solheim TS, Magelssen H, Löfgren D, Mudaisi M, Hylin S, Bartek J, Strandéus M, Lindskog M, Rashid HB, Carstam L, Gulati S, Solheim O, Bartek J, Salvesen Ø, Jakola AS (2023)
Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial
JAMA Netw Open, 6 (3), e234149
DOI 10.1001/jamanetworkopen.2023.4149, PubMed 37000452
Winge-Main A, Robsahm TE, Nyakas M, Festervoll G, Torkilseng E, Thybo S, Pati S, Carroll R (2023)
Long-term outcomes of stage IIB-IV melanoma patients: nationwide data from Norway
Future Oncol, 19 (3), 205-215
DOI 10.2217/fon-2022-0969, PubMed 36974621
Winther RR, Skovlund E, Andreassen JS, Arvidsson L, Halvardson J, Solheim O, Bartek J, Kaasa S, Hjermstad MJ, Vik-Mo EO (2023)
Preoperative Prognostic Index for Patients with Brain Metastases-A Population-Based Multi-Centre Study
Cancers (Basel), 15 (12)
DOI 10.3390/cancers15123174, PubMed 37370784
Yi D, Grøvik E, Tong E, Iv M, Emblem KE, Nilsen LB, Saxhaug C, Latysheva A, Jacobsen KD, Helland Å, Zaharchuk G, Rubin D (2023)
Erratum: "MRI pulse sequence integration for deep-learning-based brain metastases segmentation"
Med Phys, 50 (8), 5294
DOI 10.1002/mp.16594, PubMed 37573581
Åsberg RE, Nilsen M, Hjermstad MJ, Reinertsen KV, Karlsen J, Giskeødegård GF, Reidunsdatter RJ (2023)
Norwegian general population normative data for the European Organization for Research and Treatment of Cancer questionnaires: the Quality of Life Questionnaire-Core 30, the Sexual Health Questionnaire QLQ-SHQ22 and the sexual domains of the QLQ-BR23/BR45
Eur J Cancer, 190, 112943
DOI 10.1016/j.ejca.2023.112943, PubMed 37515905

Publications 2022

Abrantes R, Duarte HO, Gomes C, Wälchli S, Reis CA (2022)
CAR-Ts: new perspectives in cancer therapy
FEBS Lett, 596 (4), 403-416
DOI 10.1002/1873-3468.14270, PubMed 34978080
Achard V, Jaccard M, Vanhoutte F, Siva S, Heikkilä R, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Berghen C, Shelan M, Conde-Moreno A, López Campos F, Papachristofilou A, Guckenberger M, Meersschout S, Putora PM, Zwahlen D, Couñago F, Scorsetti M, Eito C, Barrado M, Zapatero A, Muto P, Van De Voorde L et al. (2022)
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial
Radiother Oncol, 172, 1-9
DOI 10.1016/j.radonc.2022.04.020, PubMed 35476942
Amdal CD, Falk RS, Singer S, Pe M, Piccinin C, Bottomley A, Appiah LT, Arraras JI, Bayer O, Buanes EA, Darlington AS, Arbanas GD, Hofsø K, Holzner B, Sahlstrand-Johnson P, Kuliś D, Parmar G, Rmeileh NMEA, Schranz M, Sodergren S, Bjordal K (2022)
A multicenter international prospective study of the validity and reliability of a COVID-19-specific health-related quality of life questionnaire
Qual Life Res, 32 (2), 447-459
DOI 10.1007/s11136-022-03272-2, PubMed 36273365
Amdal CD, Taylor K, Kuliś D, Falk RS, Bottomley A, Arraras JI, Barte JH, Darlington AS, Hofsø K, Holzner B, Jørgensen NMH, Mariano MP, Pe M, Piccinin C, Riccetti N, Schranz M, Wheelwright S, Bjordal K (2022)
Health-related quality of life in patients with COVID-19; international development of a patient-reported outcome measure
J Patient Rep Outcomes, 6 (1), 26
DOI 10.1186/s41687-022-00434-1, PubMed 35348945
Ardeshirrouhanifard S, Fossa SD, Huddart R, Monahan PO, Fung C, Song Y, Dolan ME, Feldman DR, Hamilton RJ, Vaughn D, Martin NE, Kollmannsberger C, Dinh P, Einhorn L, Frisina RD, Travis LB (2022)
Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments
Ear Hear, 43 (3), 794-807
DOI 10.1097/AUD.0000000000001172, PubMed 35067571
Bahadoer RR, Bastiaannet E, Peeters KCMJ, van Eycken E, Verbeeck J, Guren MG, Kørner H, Martling A, Johansson R, van de Velde CJH, Dekker JWT (2022)
The survival gap between young and older patients after surgical resection for colorectal cancer remains largely based on early mortality: A EURECCA comparison of four European countries
J Geriatr Oncol, 13 (6), 803-812
DOI 10.1016/j.jgo.2022.04.011, PubMed 35527207
Bajor M, Graczyk-Jarzynka A, Marhelava K, Burdzinska A, Muchowicz A, Goral A, Zhylko A, Soroczynska K, Retecki K, Krawczyk M, Klopotowska M, Pilch Z, Paczek L, Malmberg KJ, Wälchli S, Winiarska M, Zagozdzon R (2022)
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells
J Immunother Cancer, 10 (1)
DOI 10.1136/jitc-2021-002500, PubMed 35078921
Barnes DJ, Dutton P, Bruland Ø, Gelderblom H, Faleti A, Bühnemann C, van Maldegem A, Johnson H, Poulton L, Love S, Tiemeier G, van Beelen E, Herbschleb K, Haddon C, Billingham L, Bradley K, Ferrari S, Palmerini E, Picci P, Dirksen U, Strauss SJ, Hogendoorn PCW, Buddingh E, Blay JY, Cleton-Jansen AM et al. (2022)
Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)
BMC Cancer, 22 (1), 629
DOI 10.1186/s12885-022-09697-9, PubMed 35672690
Berentzen Å, Brevig T, Hermann R, Ryder T, Winge-Main AK (2022)
Melanoma - investigation and primary treatment
Tidsskr Nor Laegeforen, 142 (15)
DOI 10.4045/tidsskr.22.0043, PubMed 36286571
Berentzen Å, Brevig T, Hermann R, Ryder T, Winge-Main AK (2022)
Correction: Melanoma - investigation and primary treatment
Tidsskr Nor Laegeforen, 142 (1)
DOI 10.4045/tidsskr.22.0806, PubMed 36655962
Berg J, Halvorsen AR, Bengtson MB, Lindberg M, Halvorsen B, Aukrust P, Helland Å, Ueland T (2022)
Circulating T Cell Activation and Exhaustion Markers Are Associated With Radiation Pneumonitis and Poor Survival in Non-Small-Cell Lung Cancer
Front Immunol, 13, 875152
DOI 10.3389/fimmu.2022.875152, PubMed 35911763
Berg J, Halvorsen AR, Bengtson MB, Lindberg M, Halvorsen B, Aukrust P, Helland Å, Ueland T (2022)
Corrigendum: Circulating T cell activation and exhaustion markers are associated with radiation pneumonitis and poor survival in non-small-cell lung cancer
Front Immunol, 13, 1051156
DOI 10.3389/fimmu.2022.1051156, PubMed 36263024
Blakstad H, Wohlleben C, Saxhaug C, Brandal P (2022)
SMART syndrome: two cases highlighting a complex and rare complication of brain irradiation
BMJ Case Rep, 15 (9)
DOI 10.1136/bcr-2022-249599, PubMed 36167430
Boye K, Lobmaier I, Kobbeltvedt MR, Thorkildsen J, Taksdal I, Bjerkehagen B, Bruland ØS, Zaikova O, Sundby Hall K, Hompland I (2022)
Real-world evidence on perioperative chemotherapy in localized soft tissue sarcoma of the extremities and trunk wall; a population-based study
Acta Oncol, 61 (7), 793-800
DOI 10.1080/0284186X.2022.2082259, PubMed 35698755
Brunvoll SH, Flote VG, Halset EH, Bertheussen GF, Skjerven H, Lømo J, Thune I, Hjartåker A (2022)
Normal and unusual days for dietary intake during the 12 months after a breast cancer diagnosis in women
Eur J Nutr, 61 (8), 3873-3885
DOI 10.1007/s00394-022-02925-9, PubMed 35750881
Burtness B, Rischin D, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Brana I, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesia R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Ge J, Swaby RF, Gumuscu B, Harrington K (2022)
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score
J Clin Oncol, 40 (21), 2321-2332
DOI 10.1200/JCO.21.02198, PubMed 35333599
Bye A, Bjerkeset E, Stensheim H, Loge JH, Hjermstad MJ, Klepstad P, Habberstad R, Kaasa S, Aass N (2022)
Benefits of Study Participation for Patients with Advanced Cancer Receiving Radiotherapy: A Prospective Observational Study
Palliat Med Rep, 3 (1), 264-271
DOI 10.1089/pmr.2022.0044, PubMed 36876292
Bøhn SH, Vandraas KF, Kiserud CE, Dahl AA, Thorsen L, Ewertz M, Lie HC, Falk R, Reinertsen KV (2022)
Work status changes and associated factors in a nationwide sample of Norwegian long-term breast cancer survivors
J Cancer Surviv, 18 (2), 375-384
DOI 10.1007/s11764-022-01202-2, PubMed 35314959
Børø S, Thoresen S, Helland Å (2022)
Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 - 2020 - A population-based registry study from Norway
Front Oncol, 12, 1017902
DOI 10.3389/fonc.2022.1017902, PubMed 36523970
Callesen LB, Hamfjord J, Boysen AK, Pallisgaard N, Guren TK, Kure EH, Spindler KG (2022)
Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysis
Br J Cancer, 127 (3), 500-513
DOI 10.1038/s41416-022-01816-4, PubMed 35440666
Callesen LB, Takacova T, Hamfjord J, Würschmidt F, Oldhafer KJ, Brüning R, Arnold D, Spindler KG (2022)
Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis
Ther Adv Med Oncol, 14, 17588359221133171
DOI 10.1177/17588359221133171, PubMed 36339929
Carlsson G, Koumarianou A, Guren TK, Haux J, Katsaounis P, Kentepozidis N, Pfeiffer P, Brændengen M, Mavroudis D, Taflin H, Skintemo L, Tell R, Papadimitriou C (2022)
A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer
ESMO Open, 7 (5), 100589
DOI 10.1016/j.esmoop.2022.100589, PubMed 36183444
Dahl M, Husby S, Eskelund CW, Besenbacher S, Fjelstrup S, Côme C, Ek S, Kolstad A, Räty R, Jerkeman M, Geisler CH, Kjems J, Kristensen LS, Grønbæk K (2022)
Correction: Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma: a study of younger patients from the MCL2 and MCL3 clinical trials
Leukemia, 36 (4), 1198
DOI 10.1038/s41375-022-01526-z, PubMed 35181760
Dahl AA, Fosså SD (2022)
High Neuroticism Is Related to More Overall Functional Problems and Lower Function Scores in Men Who Had Surgery for Non-Relapsing Prostate Cancer
Curr Oncol, 29 (8), 5823-5832
DOI 10.3390/curroncol29080459, PubMed 36005197
Dahl AA, Kiserud CE, Fosså SD, Loge JH, Reinertsen KV, Ruud E, Lie HC (2022)
A study of high neuroticism in long-term survivors of childhood, adolescence, and young adult cancers
Sci Rep, 12 (1), 12325
DOI 10.1038/s41598-022-15697-3, PubMed 35853946
Dahle DO, Skauby M, Langberg CW, Brabrand K, Wessel N, Midtvedt K (2022)
Renal Cell Carcinoma and Kidney Transplantation: A Narrative Review
Transplantation, 106 (1), e52-e63
DOI 10.1097/TP.0000000000003762, PubMed 33741842
Dijkstra EA, Hospers GAP, Kranenbarg EM, Fleer J, Roodvoets AGH, Bahadoer RR, Guren MG, Tjalma JJJ, Putter H, Crolla RMPH, Hendriks MP, Capdevila J, Radu C, van de Velde CJH, Nilsson PJ, Glimelius B, van Etten B, Marijnen CAM (2022)
Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial
Radiother Oncol, 171, 69-76
DOI 10.1016/j.radonc.2022.04.013, PubMed 35447283
Dorraji E, Borgen E, Segura-Peña D, Rawat P, Smorodina E, Dunn C, Greiff V, Sekulić N, Russnes H, Kyte JA (2022)
Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 Isoform
Cancers (Basel), 14 (19)
DOI 10.3390/cancers14194859, PubMed 36230782
Dueland S, Smedman TM, Grut H, Syversveen T, Jørgensen LH, Line PD (2022)
PET-Uptake in Liver Metastases as Method to Predict Tumor Biological Behavior in Patients Transplanted for Colorectal Liver Metastases Developing Lung Recurrence
Cancers (Basel), 14 (20)
DOI 10.3390/cancers14205042, PubMed 36291826
Eide IJZ, Stensgaard S, Helland Å, Ekman S, Mellemgaard A, Hansen KH, Cicenas S, Koivunen J, Grønberg BH, Sørensen BS, Brustugun OT (2022)
Osimertinib in non-small cell lung cancer with uncommon EGFR-mutations: a post-hoc subgroup analysis with pooled data from two phase II clinical trials
Transl Lung Cancer Res, 11 (6), 953-963
DOI 10.21037/tlcr-21-995, PubMed 35832438
Eikeland SA, Smeland KB, Brekke M, Kiserud CE, Fosså A (2022)
Late-effect awareness and follow-up of cancer in general practice
Scand J Prim Health Care, 40 (3), 360-369
DOI 10.1080/02813432.2022.2139457, PubMed 36380478
Ellingsen EB, Bounova G, Kerzeli I, Anzar I, Simnica D, Aamdal E, Guren T, Clancy T, Mezheyeuski A, Inderberg EM, Mangsbo SM, Binder M, Hovig E, Gaudernack G (2022)
Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination
J Transl Med, 20 (1), 419
DOI 10.1186/s12967-022-03624-z, PubMed 36089578
Ellingsen EB, Aamdal E, Guren T, Lilleby W, Brunsvig PF, Mangsbo SM, Aamdal S, Hovig E, Mensali N, Gaudernack G, Inderberg EM (2022)
Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials
J Immunother Cancer, 10 (5)
DOI 10.1136/jitc-2021-004345, PubMed 35613827
Eriksen GF, Benth JŠ, Grønberg BH, Rostoft S, Kirkhus L, Kirkevold Ø, Oldervoll LM, Bye A, Hjelstuen A, Slaaen M (2022)
Geriatric impairments are associated with reduced quality of life and physical function in older patients with cancer receiving radiotherapy - A prospective observational study
J Geriatr Oncol, 14 (1), 101379
DOI 10.1016/j.jgo.2022.09.008, PubMed 36180379
Evensen H, Hjermstad MJ, Cvancarova M, Kristensen V, Larssen L, Skattum J, Hauge T, Sandstad O, Medhus AW (2022)
Quality of life in patients with achalasia: Associations with Eckardt score and objective treatment outcomes after peroral endoscopic myotomy
Endosc Int Open, 10 (12), E1570-E1576
DOI 10.1055/a-1968-7682, PubMed 36531682
Evensen ME, Furre T, Malinen E, Løndalen AM, Dale E (2022)
Mucosa-sparing dose painting of head and neck cancer
Acta Oncol, 61 (2), 141-145
DOI 10.1080/0284186X.2021.2022200, PubMed 34991431
Falk P, Severin M, Berglund Å, Guren MG, Hofsli E, Österlund P, Tandberg A, Eberhard J, Sorbye H (2022)
Sex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancer
Cancer Treat Res Commun, 31, 100517
DOI 10.1016/j.ctarc.2022.100517, PubMed 35114500
Fallon M, Dierberger K, Leng M, Hall PS, Allende S, Sabar R, Verastegui E, Gordon D, Grant L, Lee R, McWillams K, Murray GD, Norris L, Reid C, Sande TA, Caraceni A, Kaasa S, Laird BJA (2022)
An international, open-label, randomised trial comparing a two-step approach versus the standard three-step approach of the WHO analgesic ladder in patients with cancer
Ann Oncol, 33 (12), 1296-1303
DOI 10.1016/j.annonc.2022.08.083, PubMed 36055465
Fauske L, Wærstad PH, Hompland I, Bruland ØS (2022)
Hope as a Lifeline: Imatinib Discontinuation in Patients With Oligometastatic Gastrointestinal Stromal Tumours
Anticancer Res, 42 (2), 955-963
DOI 10.21873/anticanres.15555, PubMed 35093895
Forcados C, Joaquina S, Casey NP, Caulier B, Wälchli S (2022)
How CAR T Cells Breathe
Cells, 11 (9)
DOI 10.3390/cells11091454, PubMed 35563759
Fosså SD, Dahl AA, Johannesen TB, Gjelsvik YM, Storås AH, Myklebust TÅ (2022)
Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general population
Clin Transl Radiat Oncol, 37, 78-84
DOI 10.1016/j.ctro.2022.08.003, PubMed 36093341
Fosså SD, Dahl AA, Thorsen L, Hellesnes R, Kiserud CE, Tandstad T, Brydøy M, Haugnes HS, Myklebust TÅ (2022)
Mortality and Second Cancer Incidence After Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors
J Clin Oncol, 40 (23), 2588-2599
DOI 10.1200/JCO.21.02105, PubMed 35380874
Franco P, Segelov E, Johnsson A, Riechelmann R, Guren MG, Das P, Rao S, Arnold D, Spindler KG, Deutsch E, Krengli M, Tombolini V, Sebag-Montefiore D, De Felice F (2022)
A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal Cancer
Cancers (Basel), 14 (7)
DOI 10.3390/cancers14071697, PubMed 35406469
Frich PS, Sigstad E, Berstad AE, Fagerlid KH, Paulsen TH, Bjøro T, Flinder LI (2022)
Long-Term Efficacy of Ethanol Ablation as Treatment of Metastatic Lymph Nodes From Papillary Thyroid Carcinoma
J Clin Endocrinol Metab, 107 (5), e2141-e2147
DOI 10.1210/clinem/dgab907, PubMed 34922379
Georgiesh T, Aggerholm-Pedersen N, Schöffski P, Zhang Y, Napolitano A, Bovée JVMG, Hjelle Å, Tang G, Spalek M, Nannini M, Swanson D, Baad-Hansen T, Sciot R, Hesla AC, Huang P, Dorleijn D, Haugland HK, Lacambra M, Skoczylas J, Pantaleo MA, Haas RL, Meza-Zepeda LA, Haller F, Czarnecka AM, Loong H et al. (2022)
Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour
Br J Cancer, 127 (10), 1793-1798
DOI 10.1038/s41416-022-01959-4, PubMed 36030294
Gianinazzi ME, Kiserud CE, Ruud E, Lie HC (2022)
Who Knows? Information Received, and Knowledge about, Cancer, Treatment and Late Effects in a National Cohort of Long-Term Childhood, Adolescent and Young Adult Cancer Survivors
Cancers (Basel), 14 (6)
DOI 10.3390/cancers14061534, PubMed 35326685
Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, Smit HJM, Peters S, Field JK, Christoph DC, Sibille A, Fietkau R, Haakensen VD, Chouaid C, Markman B, Hiltermann TJN, Taus A, Sawyer W, Allen A, Chander P, Licour M, Solomon B (2022)
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study
J Thorac Oncol, 18 (2), 181-193
DOI 10.1016/j.jtho.2022.10.003, PubMed 36307040
Gjerset GM, Skaali T, Seland M, Thorsen L (2022)
Health-Related Quality of Life, Fatigue, Level of Physical Activity, and Physical Capacity Before and After an Outpatient Rehabilitation Program for Women Within Working Age Treated for Breast Cancer
J Cancer Educ, 38 (3), 948-956
DOI 10.1007/s13187-022-02211-6, PubMed 35974293
Glatzer M, Tanderup K, Rovirosa A, Fokdal L, Ordeanu C, Tagliaferri L, Chargari C, Strnad V, Dimopoulos JA, Šegedin B, Cooper R, Nakken ES, Petric P, van der Steen-Banasik E, Lössl K, Jürgenliemk-Schulz IM, Niehoff P, Hermansson RS, Nout RA, Putora PM, Plasswilm L, Tselis N (2022)
Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists
Cancers (Basel), 14 (4)
DOI 10.3390/cancers14040906, PubMed 35205653
Gongora M, Stranne J, Johansson E, Bottai M, Thellenberg Karlsson C, Brasso K, Hansen S, Jakobsen H, Jäderling F, Lindberg H, Lilleby W, Meidahl Petersen P, Mirtti T, Olsson M, Rannikko A, Røder MA, Henrik Vincent P, Akre O (2022)
Characteristics of Patients in SPCG-15-A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer
Eur Urol Open Sci, 41, 63-73
DOI 10.1016/j.euros.2022.04.013, PubMed 35813256
Gorunova L, Boye K, Panagopoulos I, Berner JM, Bjerkehagen B, Hompland I, Lobmaier I, Hølmebakk T, Hveem TS, Heim S, Micci F (2022)
Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity
Oncotarget, 13, 508-517
DOI 10.18632/oncotarget.28209, PubMed 35284037
Gulati G, Tjessem KH, Horndalsveen H, Halvorsen S, Haakensen VD (2022)
[Checkpoint inhibitor-induced myocarditis]
Tidsskr Nor Laegeforen, 142 (18)
DOI 10.4045/tidsskr.21.0817, PubMed 36511752
Guldvik IJ, Braadland PR, Sivanesan S, Ramberg H, Kristensen G, Tennstedt P, Røder A, Schlomm T, Berge V, Eri LM, Lilleby W, Mills IG, Taskén KA (2022)
Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer
Eur Urol Open Sci, 45, 68-75
DOI 10.1016/j.euros.2022.09.002, PubMed 36353660
Habberstad R, Aass N, Mollnes TE, Damås JK, Brunelli C, Rossi R, Garcia-Alonso E, Kaasa S, Klepstad P (2022)
Inflammatory Markers and Radiotherapy Response in Patients With Painful Bone Metastases
J Pain Symptom Manage, 64 (4), 330-339
DOI 10.1016/j.jpainsymman.2022.06.018, PubMed 35803553
Harrington KJ, Burtness B, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Brana I, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesia R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Lin J, Gumuscu B, Swaby RF, Rischin D (2022)
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study
J Clin Oncol, 41 (4), 790-802
DOI 10.1200/JCO.21.02508, PubMed 36219809
Hauger SL, Borgen IMH, Løvstad M, Lu J, Forslund MV, Kleffelgård I, Andelic N, Røe C (2022)
Community-Based Interventions After Acquired Brain Injury-A Systematic Review of Intervention Types and Their Effectiveness
J Head Trauma Rehabil, 37 (5), E355-E369
DOI 10.1097/HTR.0000000000000765, PubMed 35125426
Helland Å, Andersen KK, Myklebust TÅ, Johannesen TB, Aarøe J, Enerly E (2022)
EGFR-mutation testing and TKI treatment patterns in locally advanced and metastatic NSCLC in Norway - A nationwide retrospective cohort study
Cancer Treat Res Commun, 33, 100636
DOI 10.1016/j.ctarc.2022.100636, PubMed 36155129
Helland Å, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, Bjørge L, Blix E, Bjerkehagen B, Brabrand S, Cameron MG, Dalhaug A, Dietzel D, Dønnem T, Enerly E, Flobak Å, Fluge S, Gilje B, Gjertsen BT, Grønberg BH, Grønås K, Guren T, Hamre H, Haug Å, Heinrich D et al. (2022)
Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
J Transl Med, 20 (1), 225
DOI 10.1186/s12967-022-03432-5, PubMed 35568909
Helland Å, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, Bjørge L, Blix E, Bjerkehagen B, Brabrand S, Cameron MG, Dalhaug A, Dietzel D, Dønnem T, Enerly E, Flobak Å, Fluge S, Gilje B, Gjertsen BT, Grønberg BH, Grønås K, Guren T, Hamre H, Haug Å, Heinrich D et al. (2022)
Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
J Transl Med, 20 (1), 317
DOI 10.1186/s12967-022-03518-0, PubMed 35841045
Helliesen JS, Kristiansen I, Brekke HK, Støkket RS, Bye A (2022)
Nutrition impact symptoms and the risk of malnutrition in people with Parkinson's disease: A cross-sectional study
J Hum Nutr Diet, 36 (1), 40-50
DOI 10.1111/jhn.13070, PubMed 35897145
Horndalsveen H, Alver TN, Dalsgaard AM, Rogg LV, Helbekkmo N, Grønberg BH, Halvorsen TO, Ramberg C, Haakensen VD, Öjlert ÅK, Bjaanaes MM, Helland Å (2022)
Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trial
Mol Oncol, 17 (3), 487-498
DOI 10.1002/1878-0261.13330, PubMed 36330681
Huse K, Bai B, Hilden VI, Bollum LK, Våtsveen TK, Munthe LA, Smeland EB, Irish JM, Wälchli S, Myklebust JH (2022)
Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression
J Immunol, 209 (10), 2042-2053
DOI 10.4049/jimmunol.2200144, PubMed 36426942
Hustad KS, Rundblad A, Ottestad I, Christensen JJ, Holven KB, Ulven SM (2022)
Comprehensive lipid and metabolite profiling in healthy adults with low and high consumption of fatty fish: a cross-sectional study - CORRIGENDUM
Br J Nutr, 128 (2), 367-368
DOI 10.1017/S0007114522001519, PubMed 35579033
Husum YS, Skogen K, Brandal P, Rønning PA, Wigers AR, Evang JA, Jørstad ØK (2022)
Idiopathic Duro-Optic Calcification
J Neuroophthalmol, 44 (1), e204
DOI 10.1097/WNO.0000000000001722, PubMed 36255093
Huynh TTM, Aass HCD, Falk RS, Astrup GL, Helland Å, Bjøro T, Bjordal K, Dale E, Hellebust TP, Herlofson BB, Malinen E, Kiserud CE, Osnes T, Amdal CD (2022)
Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy
J Cancer Surviv, 17 (4), 1082-1093
DOI 10.1007/s11764-022-01273-1, PubMed 36350483
Hynne H, Aqrawi LA, Jensen JL, Thiede B, Palm Ø, Amdal CD, Westgaard KL, Herlofson BB, Utheim TP, Galtung HK (2022)
Proteomic Profiling of Saliva and Tears in Radiated Head and Neck Cancer Patients as Compared to Primary Sjögren's Syndrome Patients
Int J Mol Sci, 23 (7)
DOI 10.3390/ijms23073714, PubMed 35409074
Høye E, Dagenborg VJ, Torgunrud A, Lund-Andersen C, Fretland ÅA, Lorenz S, Edwin B, Hovig E, Fromm B, Inderberg EM, Greiff V, Ree AH, Flatmark K (2022)
T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastases
Gigascience, 12
DOI 10.1093/gigascience/giad032, PubMed 37161965
Ivanova A, Rodríguez-Cano R, Kvalem IL, Harcourt D, Kiserud CE, Amdal CD (2022)
Body image concerns in long-term head and neck cancer survivors: prevalence and role of clinical factors and patient-reported late effects
J Cancer Surviv, 17 (2), 526-534
DOI 10.1007/s11764-022-01311-y, PubMed 36509859
Jaeger U, Tam CS, Borchmann P, McGuirk JP, Johansen M, Waller EK, Jaglowski S, Andreadis C, Foley SR, Westin JR, Fleury I, Ho PJ, Mielke S, Teshima T, Salles G, Schuster SJ, He F, Maziarz RT, Mayer S, Makita S, Kersten MJ, Ghosh M, Wagner-Johnston N, Kato K, Corradini P et al. (2022)
Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma
Blood Adv, 6 (16), 4816-4820
DOI 10.1182/bloodadvances.2021006193, PubMed 35687492
Jakobsen G, Gjeilo KH, Hjermstad MJ, Klepstad P (2022)
An Update on Prevalence, Assessment, and Risk Factors for Sleep Disturbances in Patients with Advanced Cancer-Implications for Health Care Providers and Clinical Research
Cancers (Basel), 14 (16)
DOI 10.3390/cancers14163933, PubMed 36010925
Jakobsen G, Sjue K, Paulsen Ø, Kaasa S, Hjermstad MJ, Klepstad P (2022)
Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer-a double-blind, randomized placebo-controlled clinical multicenter phase IV trial
Support Care Cancer, 31 (1), 60
DOI 10.1007/s00520-022-07537-x, PubMed 36534165
Jespersen H (2022)
Moles and melanoma
Tidsskr Nor Laegeforen, 142 (15)
DOI 10.4045/tidsskr.22.0626, PubMed 36286558
Jin Y, Lorvik KB, Jin Y, Beck C, Sike A, Persiconi I, Kvaløy E, Saatcioglu F, Dunn C, Kyte JA (2022)
Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer
Mol Ther Oncolytics, 26, 189-206
DOI 10.1016/j.omto.2022.06.007, PubMed 35860008
Khadse A, Haakensen VD, Silwal-Pandit L, Hamfjord J, Micke P, Botling J, Brustugun OT, Lingjærde OC, Helland Å, Kure EH (2022)
Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma
Front Oncol, 12, 873532
DOI 10.3389/fonc.2022.873532, PubMed 35574381
Killingberg KT, Halvorsen TO, Fløtten Ø, Brustugun OT, Langer SW, Nyman J, Hornslien K, Madebo T, Schytte T, Risum S, Tsakonas G, Engleson J, Grønberg BH (2022)
Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer
Lung Cancer, 166, 49-57
DOI 10.1016/j.lungcan.2022.02.002, PubMed 35183991
Kiserud CE, Lockmer S, Baerug I, Dahl AA, Kimby E, Østenstad B (2022)
Health-related quality of life and chronic fatigue in long-term survivors of indolent lymphoma - a comparison with normative data
Leuk Lymphoma, 64 (2), 349-355
DOI 10.1080/10428194.2022.2142050, PubMed 36342349
Kishan AU, Marco N, Schulz-Jaavall MB, Steinberg ML, Tran PT, Juarez JE, Dang A, Telesca D, Lilleby WA, Weidhaas JB (2022)
Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation
Radiother Oncol, 167, 226-232
DOI 10.1016/j.radonc.2021.12.040, PubMed 34990726
Kishan AU, Steigler A, Denham JW, Zapatero A, Guerrero A, Joseph D, Maldonado X, Wong JK, Stish BJ, Dess RT, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Pisansky TM et al. (2022)
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts
JAMA Oncol, 8 (3), e216871
DOI 10.1001/jamaoncol.2021.6871, PubMed 35050303
Kopetz S, Grothey A, Van Cutsem E, Yaeger R, Wasan H, Yoshino T, Desai J, Ciardiello F, Loupakis F, Hong YS, Steeghs N, Guren TK, Arkenau HT, Garcia-Alfonso P, Belani A, Zhang X, Tabernero J (2022)
Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRC
ESMO Open, 7 (3), 100477
DOI 10.1016/j.esmoop.2022.100477, PubMed 35653981
Kosgallana S, Jayasekara P, Abeysinghe P, Hjermstad M, Lalloo R (2022)
Translation and validation of Sinhala version of modified EORTC QLQ-OH15 in oral cancer patients who receive radiotherapy with or without chemotherapy in Sri Lanka
BMC Oral Health, 22 (1), 359
DOI 10.1186/s12903-022-02392-y, PubMed 35986341
Kreye G, Lundeby T, Latino N, Galotti M, Kaasa S (2022)
ESMO Designated Centres of Integrated Oncology and Palliative Care (ESMO DCs): education, research and programme development survey
ESMO Open, 7 (6), 100622
DOI 10.1016/j.esmoop.2022.100622, PubMed 36356414
Kristensen A, Grønberg BH, Fløtten Ø, Kaasa S, Solheim TS (2022)
Trajectory of health-related quality of life during the last year of life in patients with advanced non-small-cell lung cancer
Support Care Cancer, 30 (11), 9351-9358
DOI 10.1007/s00520-022-07359-x, PubMed 36109393
Kryeziu K, Bergsland CH, Guren TK, Sveen A, Lothe RA (2022)
Multiplex immunohistochemistry of metastatic colorectal cancer and ex vivo tumor avatars
Biochim Biophys Acta Rev Cancer, 1877 (1), 188682
DOI 10.1016/j.bbcan.2022.188682, PubMed 35065193
Kvammen JA, Stensvold E, Godang K, Bollerslev J, Myklebust TÅ, Brandal P, Henriksen C, Bechensteen AG (2022)
Bone mineral density and nutrition in long-term survivors of childhood brain tumors
Clin Nutr ESPEN, 50, 162-169
DOI 10.1016/j.clnesp.2022.05.025, PubMed 35871919
Kyte JA (2022)
Strategies for Improving the Efficacy of CAR T Cells in Solid Cancers
Cancers (Basel), 14 (3)
DOI 10.3390/cancers14030571, PubMed 35158839
Kørner H, Guren MG, Larsen IK, Haugen DF, Søreide K, Kørner LR, Søreide JA (2022)
Characteristics and fate of patients with rectal cancer not entering a curative-intent treatment pathway: A complete nationwide registry cohort of 3,304 patients
Eur J Surg Oncol, 48 (8), 1831-1839
DOI 10.1016/j.ejso.2022.04.013, PubMed 35527055
Langen Stokmo H, Aly M, Bowitz Lothe IM, Borja AJ, Mehdizadeh Seraj S, Ghorpade R, Miao X, Hjortland GO, Malinen E, Sorbye H, Werner TJ, Alavi A, Revheim ME (2022)
Volumetric parameters from [¹⁸ F]FDG PET/CT predicts survival in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
J Neuroendocrinol, 34 (7), e13170
DOI 10.1111/jne.13170, PubMed 35729738
Larsen BH, Lundeby T, Gulbrandsen P, Førde R, Gerwing J (2022)
Physicians' responses to advanced cancer patients' existential concerns: A video-based analysis
Patient Educ Couns, 105 (10), 3062-3070
DOI 10.1016/j.pec.2022.06.007, PubMed 35738963
Larsen EH, Mellblom AV, Larsen MH, Ruud E, Thorsen L, Petersen NN, Larsen HB, Fridh MK, Lie HC (2022)
Perceived barriers and facilitators to physical activity in childhood cancer survivors and their parents: A large-scale interview study from the International PACCS Study
Pediatr Blood Cancer, 70 (1), e30056
DOI 10.1002/pbc.30056, PubMed 36251019
Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Osvik Velle E, Skuterud Wik H, Ghanima W, Sandset PM, Dahm AEA (2022)
Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up
J Thromb Haemost, 20 (5), 1166-1181
DOI 10.1111/jth.15666, PubMed 35114046
Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2022)
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply
J Thromb Haemost, 20 (8), 1937-1939
DOI 10.1111/jth.15774, PubMed 35859282
Larsen TL, Ghanima W, Sandset PM, Frøen H, Jacobsen EM, Torfoss D, Dahm AEA (2022)
[Factor Xa inhibitors in the prevention and treatment of venous thromboembolism in cancer patients]
Tidsskr Nor Laegeforen, 142 (1)
DOI 10.4045/tidsskr.22.0228, PubMed 36655971
Lee CJ, Modave E, Boeckx B, Kasper B, Aamdal S, Leahy MG, Rutkowski P, Bauer S, Debiec-Rychter M, Sciot R, Lambrechts D, Wozniak A, Schöffski P (2022)
Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial
Int J Mol Sci, 23 (10)
DOI 10.3390/ijms23105689, PubMed 35628499
Lie HC, Anderssen S, Rueegg CS, Raastad T, Grydeland M, Thorsen L, Stensrud T, Edvardsen E, Larsen MH, Torsvik IK, Bovim LP, Götte M, Lähteenmäki PM, Kriemler S, Larsen HB, Fridh MK, Ørstavik K, Brun H, Matthews I, Hornset E, Ruud E (2022)
The Physical Activity and Fitness in Childhood Cancer Survivors (PACCS) Study: Protocol for an International Mixed Methods Study
JMIR Res Protoc, 11 (3), e35838
DOI 10.2196/35838, PubMed 35258456
Lindegaard JC, Petric P, Schmid MP, Nesvacil N, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Tan LT, Nout RA, De Leeuw AAC, Kirchheiner K, Spampinato S, Jürgenliemk-Schulz I, Tanderup K, Kirisits C et al. (2022)
Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I Study
Int J Radiat Oncol Biol Phys, 113 (2), 379-389
DOI 10.1016/j.ijrobp.2022.02.005, PubMed 35157992
Lofterød T, Frydenberg H, Veierød MB, Jenum AK, Reitan JB, Wist EA, Thune I (2022)
The influence of metabolic factors and ethnicity on breast cancer risk, treatment and survival: The Oslo ethnic breast cancer study
Acta Oncol, 61 (5), 649-657
DOI 10.1080/0284186X.2022.2053573, PubMed 35348396
Lunde P, Bye A, Bruusgaard KA, Hellem E, Nilsson BB (2022)
Patients' Experiences of Using a Smartphone App After Cardiac Rehabilitation: Qualitative Study
JMIR Hum Factors, 9 (1), e34294
DOI 10.2196/34294, PubMed 35319476
Lundeby T, Finset A, Kaasa S, Wester TE, Hjermstad MJ, Dajani O, Wist E, Aass N (2022)
A complex communication skills training program for physicians providing advanced cancer care - content development and barriers and solutions for implementation
J Commun Healthc, 16 (1), 46-57
DOI 10.1080/17538068.2022.2039468, PubMed 36919800
Lundeby T, Hjermstad MJ, Aass N, Kaasa S (2022)
Integration of palliative care in oncology-the intersection of cultures and perspectives of oncology and palliative care
Ecancermedicalscience, 16, 1376
DOI 10.3332/ecancer.2022.1376, PubMed 35702405
Lyng H, Skipar K, Hompland T (2022)
Targeted Therapy on the Screen: Do We Hit the Target?
Clin Cancer Res, 28 (24), 5233-5234
DOI 10.1158/1078-0432.CCR-22-2707, PubMed 36240006
Løndalen A, Blakkisrud J, Revheim ME, Dahle J, Kolstad A, Stokke C (2022)
FDG PET/CT and Dosimetric Studies of ¹⁷⁷Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma-Are We Hitting the Target?
Mol Imaging Biol, 24 (5), 807-817
DOI 10.1007/s11307-022-01731-3, PubMed 35486292
Maggadóttir SM, Kvalheim G, Wernhoff P, Sæbøe-Larssen S, Revheim ME, Josefsen D, Wälchli S, Helland Å, Inderberg EM (2022)
A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT)
Front Oncol, 12, 1031232
DOI 10.3389/fonc.2022.1031232, PubMed 36439452
Marabelle A, Cassier PA, Fakih M, Kao S, Nielsen D, Italiano A, Guren TK, van Dongen MGJ, Spencer K, Bariani GM, Ascierto PA, Santoro A, Shah M, Asselah J, Iqbal S, Takahashi S, Piha-Paul SA, Ott PA, Chatterjee A, Jin F, Norwood K, Delord JP (2022)
Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study
Lancet Gastroenterol Hepatol, 7 (5), 446-454
DOI 10.1016/S2468-1253(21)00382-4, PubMed 35114169
Mediå LM, Fauske L, Sigurdardottir S, Feragen KJB, Heggeli C, Wæhre A (2022)
'It was Supposed to be a Secret': a study of disclosure and stigma as experienced by adults with differences of sex development
Health Psychol Behav Med, 10 (1), 579-595
DOI 10.1080/21642850.2022.2102018, PubMed 35898596
Meltzer S, Negård A, Bakke KM, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Flatmark K, Ree AH (2022)
Early radiologic signal of responsiveness to immune checkpoint blockade in microsatellite-stable/mismatch repair-proficient metastatic colorectal cancer
Br J Cancer, 127 (12), 2227-2233
DOI 10.1038/s41416-022-02004-0, PubMed 36229579
Mensali N, Inderberg EM (2022)
Emerging Biomarkers for Immunotherapy in Glioblastoma
Cancers (Basel), 14 (8)
DOI 10.3390/cancers14081940, PubMed 35454848
Meriranta L, Alkodsi A, Pasanen A, Lepistö M, Mapar P, Blaker YN, Jørgensen J, Karjalainen-Lindsberg ML, Fiskvik I, Mikalsen LTG, Autio M, Björkholm M, Jerkeman M, Fluge Ø, Brown P, Jyrkkiö S, Holte H, Pitkänen E, Ellonen P, Leppä S (2022)
Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma
Blood, 139 (12), 1863-1877
DOI 10.1182/blood.2021012852, PubMed 34932792
Merklinger-Gruchala A, Jasienska G, Thune I, Kapiszewska M (2022)
Joint effect of particulate matter and cigarette smoke on women's sex hormones
BMC Womens Health, 22 (1), 3
DOI 10.1186/s12905-021-01586-w, PubMed 34996432
Meyer-Myklestad MH, Medhus AW, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Stiksrud B, Trøseid M, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Reikvam DH (2022)
Human Immunodeficiency Virus-Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction
J Infect Dis, 225 (4), 661-674
DOI 10.1093/infdis/jiaa714, PubMed 33216130
Meyer-Myklestad MH, Medhus AW, Stiksrud B, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Trøseid M, Reikvam DH (2022)
Probiotics to HIV-Infected Immunological Nonresponders: Altered Mucosal Immunity and Microbial Diversity Restricted to Ileum
J Acquir Immune Defic Syndr, 89 (1), 77-86
DOI 10.1097/QAI.0000000000002817, PubMed 34878437
Mo T, Brandal SHB, Köhn-Luque A, Engebraaten O, Kristensen VN, Fleischer T, Hompland T, Seierstad T (2022)
Quantification of Tumor Hypoxia through Unsupervised Modelling of Consumption and Supply Hypoxia MR Imaging in Breast Cancer
Cancers (Basel), 14 (5)
DOI 10.3390/cancers14051326, PubMed 35267636
Monsen KV, Fosså SD, Myklebust TÅ, Smeland S, Dahl AA, Stensvold A (2022)
Long-term satisfaction with curative treatment and follow-up in prostate cancer survivors
Acta Oncol, 61 (3), 357-362
DOI 10.1080/0284186X.2021.2006775, PubMed 35103559
Mucci LA, Vinson J, Gold T, Gerke T, Filipenko J, Green RM, Anderson SG, Badal S, Bjartell A, Chi KN, Davis ID, Enting D, Fay AP, Lazarus J, Mateo J, McDermott R, Odedina FT, Olmos D, Omlin A, Popoola AA, Ragin C, Roberts R, Russnes KM, Waihenya C, Stopsack KH et al. (2022)
IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer
JCO Glob Oncol, 8, e2200154
DOI 10.1200/GO.22.00154, PubMed 36332173
Møller CT, Fosså SD, Tafjord G, Babigumira R, Berge V, Andreassen BK (2022)
Primary versus secondary muscle-invasive bladder cancer: survival after curative treatment
Scand J Urol, 56 (3), 214-220
DOI 10.1080/21681805.2022.2056633, PubMed 35506475
Møller CT, Støer NC, Blindheim A, Berge V, Tafjord G, Fosså SD, Andreassen BK (2022)
Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study
BMC Cancer, 22 (1), 1301
DOI 10.1186/s12885-022-10394-w, PubMed 36510166
Niehusmann P, Stensvold E, Leske H, Pietsch T, Goschzik T, Gielen GH, Due-Tønnessen B, Frič R, Nilssen Y, Brandal P (2022)
Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS-PNET in Oslo 2005-2017
Pediatr Blood Cancer, 69 (9), e29736
DOI 10.1002/pbc.29736, PubMed 35570402
Nielsen HJ, Nedrebø BG, Fosså A, Andersen JR, Assmus J, Dagsland VH, Dankel SN, Gudbrandsen OA, Fernø J, Hjellestad I, Hjermstad MJ, Kolotkin RL, Thorsen HL, Mellgren G, Flølo TN (2022)
Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy
Int J Obes (Lond), 46 (4), 739-749
DOI 10.1038/s41366-021-01028-5, PubMed 34974544
Nilsen TS, Johansen SH, Thorsen L, Fairman CM, Wisløff T, Raastad T (2022)
Does Androgen Deprivation for Prostate Cancer Affect Normal Adaptation to Resistance Exercise?
Int J Environ Res Public Health, 19 (7)
DOI 10.3390/ijerph19073820, PubMed 35409505
Nilssen Y, Brustugun OT, Eriksen MT, Guren MG, Haug ES, Naume B, Schlichting E, Møller B (2022)
Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015-2016
BMC Cancer, 22 (1), 220
DOI 10.1186/s12885-022-09306-9, PubMed 35227226
Nilsson M, Olafsdottir H, Alexandersson von Döbeln G, Villegas F, Gagliardi G, Hellström M, Wang QL, Johansson H, Gebski V, Hedberg J, Klevebro F, Markar S, Smyth E, Lagergren P, Al-Haidari G, Rekstad LC, Aahlin EK, Wallner B, Edholm D, Johansson J, Szabo E, Reynolds JV, Pramesh CS, Mummudi N, Joshi A et al. (2022)
Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial
Front Oncol, 12, 917961
DOI 10.3389/fonc.2022.917961, PubMed 35912196
Nome RV, Småstuen MC, Fosså SD, Kiserud CE, Åsvold BO, Bjøro T (2022)
Re: Thyroid hypofunction in aging testicular cancer survivors by Nome et al
Acta Oncol, 61 (3), 385
DOI 10.1080/0284186X.2021.2023214, PubMed 35037554
Nyakas M, Fleten KG, Haugen MH, Engedal N, Sveen C, Farstad IN, Flørenes VA, Prasmickaite L, Mælandsmo GM, Seip K (2022)
AXL inhibition improves BRAF-targeted treatment in melanoma
Sci Rep, 12 (1), 5076
DOI 10.1038/s41598-022-09078-z, PubMed 35332208
Nyrud MK, Bratland Å, Landrø L, Brevig T, Ryder T, Hermann R, Frich L (2022)
Merkel cell carcinoma
Tidsskr Nor Laegeforen, 142 (9)
DOI 10.4045/tidsskr.21.0693, PubMed 35699540
Olsen SU, Hesseberg K, Aas AM, Pripp AH, Ranhoff AH, Bye A (2022)
Correction to: A comparison of two different refeeding protocols and its effect on hand grip strength and refeeding syndrome: a randomized controlled clinical trial
Eur Geriatr Med, 13 (5), 1231-1232
DOI 10.1007/s41999-022-00653-1, PubMed 35524006
Osong B, Masciocchi C, Damiani A, Bermejo I, Meldolesi E, Chiloiro G, Berbee M, Lee SH, Dekker A, Valentini V, Gerard JP, Rödel C, Bujko K, van de Velde C, Folkesson J, Sainato A, Glynne-Jones R, Ngan S, Brændengen M, Sebag-Montefiore D, van Soest J (2022)
Bayesian network structure for predicting local tumor recurrence in rectal cancer patients treated with neoadjuvant chemoradiation followed by surgery
Phys Imaging Radiat Oncol, 22, 1-7
DOI 10.1016/j.phro.2022.03.002, PubMed 35372704
Patel SA, Ma TM, Wong JK, Stish BJ, Dess RT, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Tran PT, Krauss DJ, Abu-Isa EI, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, DeWeese TL, Tilki D, Ciezki JP et al. (2022)
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis
Int J Radiat Oncol Biol Phys, 115 (3), 645-653
DOI 10.1016/j.ijrobp.2022.09.075, PubMed 36179990
Paur I, Smedshaug GB, Haugum B, Bye A, Eliassen E, Flottorp TL, Juul HJ, Mowe M, Nakken T, Ore S, Sirevåg GK, Sygnestveit K, Thoresen L, Aasen EB, Totland TH, Krogh HW (2022)
The Norwegian Directorate of Health recommends malnutrition screening tool (MST) for all adults
Clin Nutr ESPEN, 52, 28-31
DOI 10.1016/j.clnesp.2022.09.029, PubMed 36513467
Pierson SK, Katz L, Williams R, Mumau M, Gonzalez M, Guzman S, Rubenstein A, Oromendia AB, Beineke P, Fosså A, van Rhee F, Fajgenbaum DC (2022)
CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease
Nat Commun, 13 (1), 7236
DOI 10.1038/s41467-022-34873-7, PubMed 36433996
Preusser M, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepulveda JM, Brandal P, Brazil L, Bonneville-Levard A, Lorgis V, Vauleon E, Bromberg J, Erridge S, Cameron A, Lefranc F, Clement PM, Dumont S, Sanson M, Bronnimann C, Balaná C, Thon N, Lewis J, Mair MJ, Sievers P, Furtner J et al. (2022)
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
Neuro Oncol, 24 (5), 755-767
DOI 10.1093/neuonc/noab243, PubMed 34672349
Pulkka OP, Viisanen L, Tynninen O, Laaksonen M, Reichardt P, Reichardt A, Eriksson M, Hall KS, Wardelmann E, Nilsson B, Sihto H, Joensuu H (2022)
Fibrinogen-like protein 2 in gastrointestinal stromal tumour
J Cell Mol Med, 26 (4), 1083-1094
DOI 10.1111/jcmm.17163, PubMed 35029030
Rao S, Anandappa G, Capdevila J, Dahan L, Evesque L, Kim S, Saunders MP, Gilbert DC, Jensen LH, Samalin E, Spindler KL, Tamberi S, Demols A, Guren MG, Arnold D, Fakih M, Kayyal T, Cornfeld M, Tian C, Catlett M, Smith M, Spano JP (2022)
A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)
ESMO Open, 7 (4), 100529
DOI 10.1016/j.esmoop.2022.100529, PubMed 35816951
Richartz N, Pietka W, Gilljam KM, Skah S, Skålhegg BS, Bhagwat S, Naderi EH, Ruud E, Blomhoff HK (2022)
cAMP-Mediated Autophagy Promotes Cell Survival via ROS-Induced Activation of PARP1: Implications for Treatment of Acute Lymphoblastic Leukemia
Mol Cancer Res, 20 (3), 400-411
DOI 10.1158/1541-7786.MCR-21-0652, PubMed 34880123
Riis M, Csanaky G, Lehne G, Tangerud A (2022)
Anaplastic large cell lymphoma, ALK-negative of the breast diagnosed a short time after removal of breast implant in a patient with breast carcinoma: diagnostic and therapeutic considerations
BMJ Case Rep, 15 (3)
DOI 10.1136/bcr-2021-248232, PubMed 35236698
Riise J, Meyer S, Blaas I, Chopra A, Tran TT, Delic-Sarac M, Hestdalen ML, Brodin E, Rustad EH, Dai KZ, Vaage JT, Nissen-Meyer LSH, Sund F, Wader KF, Bjornevik AT, Meyer PA, Nygaard GO, König M, Smeland S, Lund-Johansen F, Olweus J, Kolstad A (2022)
Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination
Br J Haematol, 197 (6), 697-708
DOI 10.1111/bjh.18149, PubMed 35254660
Rimstad R, Løkkevik E, Juul-Hansen KE, Holtan A (2022)
Patient needs in evacuation of a tertiary oncology center
J Emerg Manag, 20 (3), 267-272
DOI 10.5055/jem.0626, PubMed 35792815
Rischin D, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Braña I, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Ishak WZW, Hong RL, Mendoza RG, Jia L, Chirovsky D, Norquist J, Jin F, Burtness B (2022)
Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048
Oral Oncol, 128, 105815
DOI 10.1016/j.oraloncology.2022.105815, PubMed 35381576
Rowsell A, Sodergren SC, Vassiliou V, Darlington AS, Guren MG, Alkhaffaf B, Moorbey C, Dennis K, Terada M (2022)
Systematic review of health-related quality of life (HRQoL) issues associated with gastric cancer: capturing cross-cultural differences
Gastric Cancer, 25 (4), 665-677
DOI 10.1007/s10120-022-01309-6, PubMed 35689705
Ryg U, Seierstad T, Nilsen LB, Hellebust TP, Djupvik LH, Gustafson H, Hydal J, Kishan AU, Hole KH, Lilleby W (2022)
A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome
Front Oncol, 12, 861127
DOI 10.3389/fonc.2022.861127, PubMed 35463376
Røssevold AH, Andresen NK, Bjerre CA, Gilje B, Jakobsen EH, Raj SX, Falk RS, Russnes HG, Jahr T, Mathiesen RR, Lømo J, Garred Ø, Chauhan SK, Lereim RR, Dunn C, Naume B, Kyte JA (2022)
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial
Nat Med, 28 (12), 2573-2583
DOI 10.1038/s41591-022-02126-1, PubMed 36482103
Schei S, Solheim O, Salvesen Ø, Hjermstad MJ, Bouget D, Sagberg LM (2022)
Pretreatment patient-reported cognitive function in patients with diffuse glioma
Acta Neurochir (Wien), 164 (3), 703-711
DOI 10.1007/s00701-022-05126-9, PubMed 35142918
Schmid MP, Harrabi S, Herfarth K, Bruland ØS, Welzel T, Haberer T, Ellerbrock M, Debus J, Uhl M, Seidensaal K (2022)
Particle Therapy in Adult Patients with Pelvic Ewing Sarcoma-Tumor and Treatment Characteristics and Early Clinical Outcomes
Cancers (Basel), 14 (24)
DOI 10.3390/cancers14246045, PubMed 36551530
Schou-Bredal I, Sørensen EM, Kraglund KH, Jensen VS, Drageset S (2022)
Development of the Breast Cancer Survivors Symptom Checklist for Use in Follow-Up Multidisciplinary Appointments
Patient Relat Outcome Meas, 13, 199-208
DOI 10.2147/PROM.S364625, PubMed 36238534
Segelov E, Guren MG, Sebag-Montefiore D, Rao S, Johnsson A, Franco P, Deutsch E, Arnold D, Spindler KG (2022)
"Global Multidisciplinary Team Meetings": Challenging Cases Virtual Forums from the International Multidisciplinary Anal Cancer Conference (IMACC)
Clin Colorectal Cancer, 21 (3), 175-187
DOI 10.1016/j.clcc.2022.02.006, PubMed 35346604
Seidensaal K, Dostal M, Liermann J, Adeberg S, Weykamp F, Schmid MP, Freudlsperger C, Hoffmann J, Hompland I, Herfarth K, Debus J, Harrabi SB (2022)
Inoperable or incompletely resected craniofacial osteosarcoma treated by particle radiotherapy
Front Oncol, 12, 927399
DOI 10.3389/fonc.2022.927399, PubMed 36212490
Shkodra M, Brunelli C, Zecca E, Infante G, Miceli R, Caputo M, Bracchi P, Lo Dico S, Kaasa S, Caraceni A (2022)
Cancer pain: Results of a prospective study on prognostic indicators of pain intensity including pain syndromes assessment
Palliat Med, 36 (9), 1396-1407
DOI 10.1177/02692163221122354, PubMed 36113091
Silva DN, Chrobok M, Ahlén G, Blomberg P, Sällberg M, Pasetto A (2022)
ATMP development and pre-GMP environment in academia: a safety net for early cell and gene therapy development and manufacturing
Immunooncol Technol, 16, 100099
DOI 10.1016/j.iotech.2022.100099, PubMed 36389443
Skipar K, Hompland T, Lund KV, Løndalen A, Malinen E, Kristensen GB, Lindemann K, Nakken ES, Bruheim K, Lyng H (2022)
Risk of recurrence after chemoradiotherapy identified by multimodal MRI and 18F-FDG-PET/CT in locally advanced cervical cancer
Radiother Oncol, 176, 17-24
DOI 10.1016/j.radonc.2022.09.002, PubMed 36113778
Skjerven HK, Danielsen AS, Schlichting E, Sahlberg KK, Hofvind S (2022)
Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 2018
Breast Care (Basel), 17 (5), 486-494
DOI 10.1159/000524564, PubMed 36684407
Skjerven HK, Myklebust EM, Korvald C, Porojnicu AC, Kaaresen R, Hofvind S, Schlicting E, Sahlberg KK (2022)
Oncological outcomes after simple and skin-sparing mastectomy of ductal carcinoma in situ: A register-based cohort study of 576 Norwegian women
Eur J Surg Oncol, 49 (3), 575-582
DOI 10.1016/j.ejso.2022.11.594, PubMed 36509629
Skåre TS, Midtbust MH, Lund JÅ, Kaasa S, Dreyer A (2022)
Barriers and Facilitators When Implementing Electronic Patient-Reported Outcome Measures at a Municipal Cancer Care Unit: A Qualitative Study
Cancer Nurs, 46 (4), E268-E275
DOI 10.1097/NCC.0000000000001120, PubMed 35439218
Smedman TM, Guren TK, Tveit KM, Thomsen M, Andersen MH, Line PD, Dueland S (2022)
Health-Related Quality of Life in Colorectal Cancer Patients Treated With Liver Transplantation Compared to Chemotherapy
Transpl Int, 35, 10404
DOI 10.3389/ti.2022.10404, PubMed 35707633
Smedsland SK, Vandraas KF, Bøhn SK, Dahl AA, Kiserud CE, Brekke M, Falk RS, Reinertsen KV (2022)
Sexual activity and functioning in long-term breast cancer survivors; exploring associated factors in a nationwide survey
Breast Cancer Res Treat, 193 (1), 139-149
DOI 10.1007/s10549-022-06544-0, PubMed 35226237
Smeland K, Holte H, Fagerli UM, Bersvendsen H, Hjermstad MJ, Loge JH, Murbrach K, Linnsund MD, Fluge O, Stenehjem JS, Lund MB, Kvaloy S, Kiserud CE (2022)
Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life
Haematologica, 107 (11), 2698-2707
DOI 10.3324/haematol.2021.280413, PubMed 35484681
Sodergren SC, Johnson CD, Gilbert A, Darlington AS, Cocks K, Guren MG, Rivin Del Campo E, Brannan C, Christensen P, Chu W, Chung H, Dennis K, Desideri I, Gilbert DC, Glynne-Jones R, Jefford M, Johansson M, Johnsson A, Juul T, Kardamakis D, Lai-Kwon J, McFarlane V, Miguel IMC, Nugent K, Peters F et al. (2022)
International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire
Int J Radiat Oncol Biol Phys, 115 (5), 1155-1164
DOI 10.1016/j.ijrobp.2022.11.002, PubMed 36402360
Solberg S, Nilssen Y, Terje Brustugun O, Magnus Haram P, Helland Å, Møller B, Strand TE, Gyrid Freim Wahl S, Fjellbirkeland L (2022)
Concordance between clinical and pathology TNM-staging in lung cancer
Lung Cancer, 171, 65-69
DOI 10.1016/j.lungcan.2022.07.014, PubMed 35926242
Solheim JM, Dueland S, Line PD, Hagness M (2022)
Transplantation for Nonresectable Colorectal Liver Metastases: Long-Term Follow-Up of the First Prospective Pilot Study
Ann Surg, 278 (2), 239-245
DOI 10.1097/SLA.0000000000005703, PubMed 36082986
Stacchiotti S, Dürr HR, Schaefer IM, Woertler K, Haas R, Trama A, Caraceni A, Bajpai J, Baldi GG, Bernthal N, Blay JY, Boye K, Broto JM, Chen WT, Dei Tos PA, Desai J, Emhofer S, Eriksson M, Gronchi A, Gelderblom H, Hardes J, Hartmann W, Healey J, Italiano A, Jones RL et al. (2022)
Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts
Cancer Treat Rev, 112, 102491
DOI 10.1016/j.ctrv.2022.102491, PubMed 36502615
Stalsberg R, Bertheussen GF, Børset H, Thomsen SN, Husøy A, Flote VG, Thune I, Lundgren S (2022)
Do Breast Cancer Patients Manage to Participate in an Outdoor, Tailored, Physical Activity Program during Adjuvant Breast Cancer Treatment, Independent of Health and Socio-Demographic Characteristics?
J Clin Med, 11 (3)
DOI 10.3390/jcm11030843, PubMed 35160292
Steinberg MF, Olsen JA, Persse D, Souders CM, Wik L (2022)
Efficacy of defibrillator pads placement during ventricular arrhythmias, a before and after analysis
Resuscitation, 174, 16-19
DOI 10.1016/j.resuscitation.2022.03.004, PubMed 35276312
Stenberg VY, Tornes AJK, Nilsen HR, Revheim ME, Bruland ØS, Larsen RH, Juzeniene A (2022)
Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand ²¹²Pb-NG001
Cancers (Basel), 14 (11)
DOI 10.3390/cancers14112784, PubMed 35681766
Stikbakke E, Wilsgaard T, Haugnes HS, Pedersen MI, Knutsen T, Støyten M, Giovannucci E, Eggen AE, Thune I, Richardsen E (2022)
Expression of miR-24-1-5p in Tumor Tissue Influences Prostate Cancer Recurrence: The PROCA-life Study
Cancers (Basel), 14 (5)
DOI 10.3390/cancers14051142, PubMed 35267449
Storm-Larsen C, Hande LN, Kummen M, Thunhaug H, Vestad B, Hansen SH, Hovland A, Trøseid M, Lappegård KT, Hov JR (2022)
Reduced gut microbial diversity in familial hypercholesterolemia with no effect of omega-3 polyunsaturated fatty acids intervention - a pilot trial
Scand J Clin Lab Invest, 82 (5), 363-370
DOI 10.1080/00365513.2022.2102540, PubMed 35913798
Storås AH, Andreassen BK, Fosså SD (2022)
Characterization of long-term survivors of primary metastatic prostate cancer patients in Norway
Acta Oncol, 61 (5), 615-618
DOI 10.1080/0284186X.2022.2051204, PubMed 35300560
Strømsvik N, Olsson P, Gravdehaug B, Lurås H, Schlichting E, Jørgensen K, Wangensteen T, Vamre T, Heramb C, Mæhle L, Grindedal EM (2022)
"It was an important part of my treatment": a qualitative study of Norwegian breast Cancer patients' experiences with mainstreamed genetic testing
Hered Cancer Clin Pract, 20 (1), 6
DOI 10.1186/s13053-022-00212-6, PubMed 35123550
Staaf J, Häkkinen J, Hegardt C, Saal LH, Kimbung S, Hedenfalk I, Lien T, Sørlie T, Naume B, Russnes H, Marcone R, Ayyanan A, Brisken C, Malterling RR, Asking B, Olofsson H, Lindman H, Bendahl PO, Ehinger A, Larsson C, Loman N, Rydén L, Malmberg M, Borg Å, Vallon-Christersson J (2022)
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
NPJ Breast Cancer, 8 (1), 94
DOI 10.1038/s41523-022-00465-3, PubMed 35974007
Svestad JG, Heydari M, Mikalsen SG, Flote VG, Nordby F, Hellebust TP (2022)
Surface-guided positioning eliminates the need for skin markers in radiotherapy of right sided breast cancer: A single center randomized crossover trial
Radiother Oncol, 177, 46-52
DOI 10.1016/j.radonc.2022.10.017, PubMed 36309152
Tanem KE, Stensvold E, Wilberg P, Skaare AB, Brandal P, Herlofson BB (2022)
Oral and dental late effects in long-term survivors of childhood embryonal brain tumors
Support Care Cancer, 30 (12), 10233-10241
DOI 10.1007/s00520-022-07405-8, PubMed 36307656
Tanem KE, Stensvold E, Wilberg P, Skaare AB, Singh PB, Brandal P, Herlofson BB (2022)
Taste and smell function in long-term survivors after childhood medulloblastoma/CNS-PNET
Support Care Cancer, 30 (7), 6155-6162
DOI 10.1007/s00520-022-07048-9, PubMed 35426047
Taskén K, Russnes HEG, Aas E, Bjørge L, Blix ES, CONNECT Public–Private Partnership Consortium, Enerly E, Fagereng GL, Flobak Å, Gilje B, Gjertsen BT, Guren TK, Heix J, Hovig E, Hovland R, InPreD-Norway and National Molecular Tumor Board Consortium, IMPRESS-Norway Consortium, Lønning PE, Meza-Zepeda LA, Mæhle PM, Nilsen HL, Thoresen SØ, Widerberg K, Smeland S, Helland Å (2022)
A national precision cancer medicine implementation initiative for Norway
Nat Med, 28 (5), 885-887
DOI 10.1038/s41591-022-01777-4, PubMed 35513529
Theophanous S, Lønne PI, Choudhury A, Berbee M, Dekker A, Dennis K, Dewdney A, Gambacorta MA, Gilbert A, Guren MG, Holloway L, Jadon R, Kochhar R, Mohamed AA, Muirhead R, Parés O, Raszewski L, Roy R, Scarsbrook A, Sebag-Montefiore D, Spezi E, Spindler KG, van Triest B, Vassiliou V, Malinen E et al. (2022)
Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study
Diagn Progn Res, 6 (1), 14
DOI 10.1186/s41512-022-00128-8, PubMed 35922837
Tonkopi E, Wikan EJ, Hovland TO, Høgset S, Kofod TA, Sefenu SK, Hughes-Ryan E, D Entremont-O Connell D, Gunn C, Holter T, Johansen S (2022)
A survey of local diagnostic reference levels for the head, thorax, abdomen and pelvis computed tomography in Norway and Canada
Acta Radiol Open, 11 (10), 20584601221131477
DOI 10.1177/20584601221131477, PubMed 36225897
Tornes AJK, Stenberg VY, Larsen RH, Bruland ØS, Revheim ME, Juzeniene A (2022)
Targeted alpha therapy with the ²²⁴Ra/²¹²Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma
Front Med (Lausanne), 9, 1058863
DOI 10.3389/fmed.2022.1058863, PubMed 36507500
Totland TH, Krogh HW, Smedshaug GB, Tornes RA, Bye A, Paur I (2022)
Harmonization and standardization of malnutrition screening for all adults - A systematic review initiated by the Norwegian Directorate of Health
Clin Nutr ESPEN, 52, 32-49
DOI 10.1016/j.clnesp.2022.09.028, PubMed 36513471
Umu SU, Langseth H, Zuber V, Helland Å, Lyle R, Rounge TB (2022)
Serum RNAs can predict lung cancer up to 10 years prior to diagnosis
Elife, 11
DOI 10.7554/eLife.71035, PubMed 35147498
Vajavaara H, Leivonen SK, Jørgensen J, Holte H, Leppä S (2022)
Low lymphocyte-to-monocyte ratio predicts poor outcome in high-risk aggressive large B-cell lymphoma
EJHaem, 3 (3), 681-687
DOI 10.1002/jha2.409, PubMed 36051040
van Iersel L, Mulder RL, Denzer C, Cohen LE, Spoudeas HA, Meacham LR, Sugden E, Schouten-van Meeteren AYN, Hoving EW, Packer RJ, Armstrong GT, Mostoufi-Moab S, Stades AM, van Vuurden D, Janssens GO, Thomas-Teinturier C, Murray RD, Di Iorgi N, Neggers SJCMM, Thompson J, Toogood AA, Gleeson H, Follin C, Bardi E, Torno L et al. (2022)
Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors
Endocr Rev, 43 (5), 794-823
DOI 10.1210/endrev/bnab040, PubMed 34962573
Vandraas K, Falk RS, Bøhn SKH, Kiserud C, Lie HC, Smedsland SK, Ewertz M, Dahl S, Brekke M, Reinertsen KV (2022)
Work ability 8 years after breast cancer: exploring the role of social support in a nation-wide survey
Breast Cancer Res Treat, 193 (3), 685-694
DOI 10.1007/s10549-022-06599-z, PubMed 35445949
Vandraas KF, Reinertsen KV, Kiserud CE, Bøhn SK, Lie HC (2022)
Health literacy among long-term survivors of breast cancer; exploring associated factors in a nationwide sample
Support Care Cancer, 30 (9), 7587-7596
DOI 10.1007/s00520-022-07183-3, PubMed 35674792
Weider T, Genoni A, Broccolo F, Paulsen TH, Dahl-Jørgensen K, Toniolo A, Hammerstad SS (2022)
High Prevalence of Common Human Viruses in Thyroid Tissue
Front Endocrinol (Lausanne), 13, 938633
DOI 10.3389/fendo.2022.938633, PubMed 35909527
Westerveld H, Kirchheiner K, Nout RA, Tanderup K, Lindegaard JC, Spampinato S, Sturdza A, Nesvacil N, Bruheim K, Hellebust TP, Pieters BR, Kirisits C, Jürgenliemk-Schulz IM, Pötter R, de Leeuw AAC (2022)
Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study
Radiother Oncol, 168, 8-15
DOI 10.1016/j.radonc.2021.12.034, PubMed 35063582
Winther RR, Hjermstad MJ, Skovlund E, Aass N, Helseth E, Kaasa S, Yri OE, Vik-Mo EO (2022)
Surgery for brain metastases-impact of the extent of resection
Acta Neurochir (Wien), 164 (10), 2773-2780
DOI 10.1007/s00701-021-05104-7, PubMed 35080651
Wolf J, Helland Å, Oh IJ, Migliorino MR, Dziadziuszko R, Wrona A, de Castro J, Mazieres J, Griesinger F, Chlistalla M, Cardona A, Ruf T, Trunzer K, Smoljanovic V, Novello S (2022)
Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancer
ESMO Open, 7 (1), 100333
DOI 10.1016/j.esmoop.2021.100333, PubMed 35042152
Yri OE, Aass N, Kaasa S (2022)
[Whole brain radiotherapy should be restricted]
Tidsskr Nor Laegeforen, 142 (17)
DOI 10.4045/tidsskr.22.0696, PubMed 36416654
Aamdal E, Skovlund E, Jacobsen KD, Straume O, Kersten C, Herlofsen O, Karlsen J, Hussain I, Amundsen A, Dalhaug A, Nyakas M, Hagene KT, Holmsen K, Aamdal S, Kaasa S, Guren TK, Kyte JA (2022)
Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment
ESMO Open, 7 (5), 100588
DOI 10.1016/j.esmoop.2022.100588, PubMed 36116420
Aass N, Kaasa S (2022)
Patient-centred care - is it possible?
Tidsskr Nor Laegeforen, 142 (3)
DOI 10.4045/tidsskr.22.0072, PubMed 35170916

Publications 2021

Abrahamsen CS, Lang-Ree HM, Halvorsen K, Stenbakken CM (2021)
Patients with COPD: Exploring patients' coping ability during an interdisciplinary pulmonary rehabilitation programme: A qualitative focus group study
J Clin Nurs, 30 (9-10), 1479-1488
DOI 10.1111/jocn.15700, PubMed 33555629
Ali M, Giannakopoulou E, Li Y, Lehander M, Virding Culleton S, Yang W, Knetter C, Odabasi MC, Bollineni RC, Yang X, Foldvari Z, Böschen ML, Taraldsrud E, Strønen E, Toebes M, Hillen A, Mazzi S, de Ru AH, Janssen GMC, Kolstad A, Tjønnfjord GE, Lie BA, Griffioen M, Lehmann S, Osnes LT et al. (2021)
T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes
Nat Biotechnol, 40 (4), 488-498
DOI 10.1038/s41587-021-01089-x, PubMed 34873326
Aljabri B, Lilleby W, Switlyk MD, Tafjord G (2021)
Restart of androgen deprivation therapy after goserelin induced pituitary apoplexy in a patient with disseminated prostate cancer a case report and five-years follow-up
Urol Case Rep, 37, 101648
DOI 10.1016/j.eucr.2021.101648, PubMed 33868933
Alonso-Álvarez S, Manni M, Montoto S, Sarkozy C, Morschhauser F, Wondergem MJ, Guarini A, Magnano L, Alcoceba M, Chamuleau M, Galimberti S, Gomes da Silva M, Holte H, Zucca E, Lockmer S, Aurer I, Marcheselli L, Stepanishyna Y, Caballero Barrigón MD, Salles G, Federico M (2021)
Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma
Eur J Cancer, 157, 132-139
DOI 10.1016/j.ejca.2021.08.005, PubMed 34508995
Amdal CD, Pe M, Falk RS, Piccinin C, Bottomley A, Arraras JI, Darlington AS, Hofsø K, Holzner B, Jørgensen NMH, Kulis D, Rimehaug SA, Singer S, Taylor K, Wheelwright S, Bjordal K (2021)
Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review
Qual Life Res, 30 (12), 3367-3381
DOI 10.1007/s11136-021-02908-z, PubMed 34146226
ArdeshirRouhaniFard S, Dinh PC, Monahan PO, Fossa SD, Huddart R, Fung C, Song Y, Feldman DR, Hamilton RJ, Vaughn DJ, Martin NE, Kollmannsberger C, Einhorn L, Kroenke K, Travis LB (2021)
Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study
Cancer Epidemiol Biomarkers Prev, 30 (6), 1129-1138
DOI 10.1158/1055-9965.EPI-20-1762, PubMed 33849970
Areklett EW, Fagereng E, Bruheim K, Andersson S, Lindemann K (2021)
Self-reported cognitive impairment in cervical cancer survivors: A cross-sectional study
Psychooncology, 31 (2), 298-305
DOI 10.1002/pon.5818, PubMed 34516040
Autio M, Leivonen SK, Brück O, Mustjoki S, Mészáros Jørgensen J, Karjalainen-Lindsberg ML, Beiske K, Holte H, Pellinen T, Leppä S (2021)
Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma
Haematologica, 106 (3), 718-729
DOI 10.3324/haematol.2019.243626, PubMed 32079690
Bahadoer RR, Bastiaannet E, Claassen YHM, van der Mark M, van Eycken E, Verbeeck J, Guren MG, Kørner H, Martling A, Johansson R, van de Velde CJH, Dekker JWT (2021)
One-year excess mortality and treatment in surgically treated patients with colorectal cancer: A EURECCA European comparison
Eur J Surg Oncol, 47 (7), 1651-1660
DOI 10.1016/j.ejso.2021.01.011, PubMed 33518367
Balstad TR, Brunelli C, Pettersen CH, Schønberg SA, Skorpen F, Fallon M, Kaasa S, Bye A, Laird BJA, Stene GB, Solheim TS (2021)
Power Comparisons and Clinical Meaning of Outcome Measures in Assessing Treatment Effect in Cancer Cachexia: Secondary Analysis From a Randomized Pilot Multimodal Intervention Trial
Front Nutr, 7, 602775
DOI 10.3389/fnut.2020.602775, PubMed 33585533
Banys-Paluchowski M, Gasparri ML, de Boniface J, Gentilini O, Stickeler E, Hartmann S, Thill M, Rubio IT, Di Micco R, Bonci EA, Niinikoski L, Kontos M, Karadeniz Cakmak G, Hauptmann M, Peintinger F, Pinto D, Matrai Z, Murawa D, Kadayaprath G, Dostalek L, Nina H, Krivorotko P, Classe JM, Schlichting E, Appelgren M et al. (2021)
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study
Cancers (Basel), 13 (7)
DOI 10.3390/cancers13071565, PubMed 33805367
Barkovskaya A, Goodwin CM, Seip K, Hilmarsdottir B, Pettersen S, Stalnecker C, Engebraaten O, Briem E, Der CJ, Moestue SA, Gudjonsson T, Maelandsmo GM, Prasmickaite L (2021)
Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen
Mol Oncol, 15 (8), 2026-2045
DOI 10.1002/1878-0261.12951, PubMed 33759347
Baxter JS, Johnson N, Tomczyk K, Gillespie A, Maguire S, Brough R, Fachal L, Michailidou K, Bolla MK, Wang Q, Dennis J, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Augustinsson A, Becher H, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bogdanova NV, Bojesen SE et al. (2021)
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element
Am J Hum Genet, 108 (7), 1190-1203
DOI 10.1016/j.ajhg.2021.05.013, PubMed 34146516
Berg J, Ramberg C, Haugstvedt JOS, Bengtson MB, Gabrielsen AM, Brustugun OT, Halvorsen AR, Helland Å (2021)
Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers
Front Oncol, 11, 674731
DOI 10.3389/fonc.2021.674731, PubMed 34109123
Beyer J, Collette L, Sauvé N, Daugaard G, Feldman DR, Tandstad T, Tryakin A, Stahl O, Gonzalez-Billalabeitia E, De Giorgi U, Culine S, de Wit R, Hansen AR, Bebek M, Terbuch A, Albany C, Hentrich M, Gietema JA, Negaard H, Huddart RA, Lorch A, Cafferty FH, Heng DYC, Sweeney CJ, Winquist E et al. (2021)
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
J Clin Oncol, 39 (14), 1553-1562
DOI 10.1200/JCO.20.03292, PubMed 33729863
Bishop MR, Dickinson M, Purtill D, Barba P, Santoro A, Hamad N, Kato K, Sureda A, Greil R, Thieblemont C, Morschhauser F, Janz M, Flinn I, Rabitsch W, Kwong YL, Kersten MJ, Minnema MC, Holte H, Chan EHL, Martinez-Lopez J, Müller AMS, Maziarz RT, McGuirk JP, Bachy E, Le Gouill S et al. (2021)
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
N Engl J Med, 386 (7), 629-639
DOI 10.1056/NEJMoa2116596, PubMed 34904798
Bjerring AW, Fosså SD, Haugnes HS, Nome R, Stokke TM, Haugaa KH, Kiserud CE, Edvardsen T, Sarvari SI (2021)
The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up
Eur Heart J Cardiovasc Imaging, 22 (4), 443-450
DOI 10.1093/ehjci/jeaa289, PubMed 33152065
Bjaanæs MM, Nilsen G, Halvorsen AR, Russnes HG, Solberg S, Jørgensen L, Brustugun OT, Lingjærde OC, Helland Å (2021)
Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors
BMC Cancer, 21 (1), 1089
DOI 10.1186/s12885-021-08811-7, PubMed 34625038
Bjaanæs MM, Sande EPS, Loe Ø, Ramberg C, Næss TM, Ottestad A, Rogg LV, Svestad JG, Haakensen VD (2021)
Improved adaptive radiotherapy to adjust for anatomical alterations during curative treatment for locally advanced lung cancer
Phys Imaging Radiat Oncol, 18, 51-54
DOI 10.1016/j.phro.2021.04.003, PubMed 34258408
Blakkisrud J, Løndalen A, Dahle J, Martinsen AC, Kolstad A, Stokke C (2021)
Myelosuppression in patients treated with ¹⁷⁷Lutetium-lilotomab satetraxetan can be predicted with absorbed dose to the red marrow as the only variable
Acta Oncol, 60 (11), 1481-1488
DOI 10.1080/0284186X.2021.1959635, PubMed 34425735
Blindheim AJ, Fosså SD, Babigumira R, Andreassen BK (2021)
The use of reTURB in T1 bladder cancer: a Norwegian population-based study
Scand J Urol, 55 (4), 268-274
DOI 10.1080/21681805.2021.1917652, PubMed 33998957
Bong WK, Gaustadnes LM, Bergland A, Chen W, Bye A (2021)
Community-living older people's interpretation of the Norwegian version of older people's quality of life (OPQOL) questionnaire
Health Soc Care Community, 29 (6), 1695-1705
DOI 10.1111/hsc.13273, PubMed 33440057
Bonsaksen T, Ekeberg Ø, Schou-Bredal I, Skogstad L, Heir T, Grimholt TK (2021)
Use of Alcohol and Addictive Drugs During the COVID-19 Outbreak in Norway: Associations With Mental Health and Pandemic-Related Problems
Front Public Health, 9, 667729
DOI 10.3389/fpubh.2021.667729, PubMed 34195169
Bonsaksen T, Skogstad L, Grimholt TK, Heir T, Ekeberg O, Lerdal A, Schou-Bredal I (2021)
Substance use in the Norwegian general population: prevalence and associations with disease
J. Subst. Use, 26 (2), 144-150
DOI 10.1080/14659891.2020.1784303
Borchgrevink PC, Glette M, Woodhouse A, Butler S, Landmark T, Romundstad P, Dale O, Stiles TC, Bonaa KH, Thorsvik D, Thünte S, Kaasa S (2021)
A Clinical Description of Chronic Pain in a General Population Using ICD-10 and ICD-11 (The HUNT Pain Examination Study)
J Pain, 23 (2), 337-348
DOI 10.1016/j.jpain.2021.08.007, PubMed 34551343
Borgen IMH, Kleffelgård I, Hauger SL, Forslund MV, Søberg HL, Andelic N, Sveen U, Winter L, Løvstad M, Røe C (2021)
Patient-Reported Problem Areas in Chronic Traumatic Brain Injury
J Head Trauma Rehabil, 37 (5), E336-E345
DOI 10.1097/HTR.0000000000000744, PubMed 34743086
Borza T, Harneshaug M, Kirkhus L, Šaltytė Benth J, Selbæk G, Bergh S, Slaaen M (2021)
The course of depressive symptoms and mortality in older patients with cancer
Aging Ment Health, 26 (6), 1153-1160
DOI 10.1080/13607863.2021.1932739, PubMed 34139140
Bousquet PA, Meltzer S, Fuglestad AJ, Lüders T, Esbensen Y, Juul HV, Johansen C, Lyckander LG, Bjørnetrø T, Inderberg EM, Kersten C, Redalen KR, Ree AH (2021)
The mitochondrial DNA constitution shaping T-cell immunity in patients with rectal cancer at high risk of metastatic progression
Clin Transl Oncol, 24 (6), 1157-1167
DOI 10.1007/s12094-021-02756-w, PubMed 34961902
Boye K, Longhi A, Guren T, Lorenz S, Næss S, Pierini M, Taksdal I, Lobmaier I, Cesari M, Paioli A, Løndalen AM, Setola E, Hompland I, Meza-Zepeda LA, Sundby Hall K, Palmerini E (2021)
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
Cancer Immunol Immunother, 70 (9), 2617-2624
DOI 10.1007/s00262-021-02876-w, PubMed 33580363
Brenne AT, Løhre ET, Knudsen AK, Thronæs M, Lund JÅ, Kongshaug N, Neverdal MN, Rystad K, Johansen MH, Braseth TI, Kaasa S (2021)
Implementing a Standardized Care Pathway Integrating Oncology, Palliative Care and Community Care in a Rural Region of Mid-Norway
Oncol Ther, 9 (2), 671-693
DOI 10.1007/s40487-021-00176-y, PubMed 34731447
Brustugun OT (2021)
Cancer and coronavirus risk
Tidsskr Nor Laegeforen, 141 (2)
DOI 10.4045/tidsskr.20.1044, PubMed 33528129
Brustugun OT, Heggelund L (2021)
[COVID-19 vaccination of cancer patients]
Tidsskr Nor Laegeforen, 141 (3)
DOI 10.4045/tidsskr.21.0026, PubMed 33624982
Bruun J, Eide PW, Bergsland CH, Bruck O, Svindland A, Arjama M, Välimäki K, Bjørnslett M, Guren MG, Kallioniemi O, Nesbakken A, Lothe RA, Pellinen T (2021)
E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models
Mol Oncol, 16 (12), 2312-2329
DOI 10.1002/1878-0261.13159, PubMed 34890102
Bugge C, Kaasa S, Sæther EM, Melberg HO, Sonbo Kristiansen I (2021)
What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study
BMJ Open, 11 (9), e050564
DOI 10.1136/bmjopen-2021-050564, PubMed 34580099
Bøhn SK, Thune I, Flote VG, Frydenberg H, Bertheussen GF, Husøy A, Fjeldheim F, Brunvoll SH, Hjartåker A, Mowinckel MC, Sandset PM, Iversen PO (2021)
Effects of a 1-Year Physical Activity Intervention on Markers of Hemostasis among Breast Cancer Survivors: A Randomized Controlled Trial
TH Open, 5 (1), e14-e23
DOI 10.1055/s-0040-1721782, PubMed 33564742
Casali PG, Blay JY, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brodowicz T, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dufresne A, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Frezza AM, Gasperoni S, Gelderblom H, Gouin F et al. (2021)
Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
Ann Oncol, 33 (1), 20-33
DOI 10.1016/j.annonc.2021.09.005, PubMed 34560242
Caulier B, Enserink JM, Wälchli S (2021)
Pharmacologic Control of CAR T Cells
Int J Mol Sci, 22 (9)
DOI 10.3390/ijms22094320, PubMed 33919245
Chen X, Badian RA, Hynne H, Amdal CD, Herlofson BB, Utheim ØA, Westgaard KL, Fineide F, Jensen JL, Utheim TP (2021)
Alterations in meibomian glands in patients treated with intensity-modulated radiotherapy for head and neck cancer
Sci Rep, 11 (1), 22419
DOI 10.1038/s41598-021-01844-9, PubMed 34789830
Choudhury A, Theophanous S, Lønne PI, Samuel R, Guren MG, Berbee M, Brown P, Lilley J, van Soest J, Dekker A, Gilbert A, Malinen E, Wee L, Appelt AL (2021)
Predicting outcomes in anal cancer patients using multi-centre data and distributed learning - A proof-of-concept study
Radiother Oncol, 159, 183-189
DOI 10.1016/j.radonc.2021.03.013, PubMed 33753156
Dahl M, Husby S, Eskelund CW, Besenbacher S, Fjelstrup S, Côme C, Ek S, Kolstad A, Räty R, Jerkeman M, Geisler CH, Kjems J, Kristensen LS, Grønbæk K (2021)
Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma: a study of younger patients from the MCL2 and MCL3 clinical trials
Leukemia, 36 (1), 177-188
DOI 10.1038/s41375-021-01311-4, PubMed 34244612
Dahl AA, Kiserud CE, Fosså SD, Loge JH, Reinertsen KV, Ruud E, Lie HC (2021)
A Controlled Study of Major Depressive Episodes in Long-Term Childhood, Adolescence, and Young Adult Cancer Survivors (The NOR-CAYACS Study)
Cancers (Basel), 13 (22)
DOI 10.3390/cancers13225800, PubMed 34830953
Damhuis RAM, Senan S, Khakwani A, Harden S, Helland Ȧ, Strand TE (2021)
Age-related treatment patterns for stage I NSCLC in three European countries
J Geriatr Oncol, 12 (8), 1214-1219
DOI 10.1016/j.jgo.2021.05.005, PubMed 33994330
Dillard P, Casey N, Pollmann S, Vernhoff P, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2021)
Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors
Oncoimmunology, 10 (1), 1936757
DOI 10.1080/2162402X.2021.1936757, PubMed 34235003
Dueland S, Smedman TM, Røsok B, Grut H, Syversveen T, Jørgensen LH, Line PD (2021)
Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases
Transpl Int, 34 (11), 2205-2213
DOI 10.1111/tri.13995, PubMed 34792825
Eide IJZ, Brustugun OT (2021)
[Lung cancer treated abroad with receptor tyrosine kinase inhibitor]
Tidsskr Nor Laegeforen, 141
DOI 10.4045/tidsskr.21.0147, PubMed 34505490
Eide IJZ, Grut H, Helland Å, Ekman S, Sørensen JB, Hansen KH, Grønberg BH, Cicenas S, Koivunen JP, Mellemgaard A, Brustugun OT (2021)
Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study
Acta Oncol, 60 (12), 1565-1571
DOI 10.1080/0284186X.2021.1973092, PubMed 34486915
Eikeland SA, Smeland KB, Mols F, Fagerli UM, Bersvendsen HS, Kiserud CE, Fosså A (2021)
Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin's lymphoma; symptom burden and quality of life
Acta Oncol, 60 (7), 911-920
DOI 10.1080/0284186X.2021.1917776, PubMed 33905285
Engebraaten O, Yau C, Berg K, Borgen E, Garred Ø, Berstad MEB, Fremstedal ASV, DeMichele A, Veer LV', Esserman L, Weyergang A (2021)
RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer
Nat Commun, 12 (1), 6427
DOI 10.1038/s41467-021-26018-z, PubMed 34741021
Eriksen GF, Šaltytė Benth J, Grønberg BH, Rostoft S, Kirkhus L, Kirkevold Ø, Hjelstuen A, Slaaen M (2021)
Geriatric impairments are prevalent and predictive of survival in older patients with cancer receiving radiotherapy: a prospective observational study
Acta Oncol, 61 (4), 393-402
DOI 10.1080/0284186X.2021.2009561, PubMed 34874228
Eriksson M, Reichardt P, Joensuu H, Krarup-Hansen A, Hagberg O, Hohenberger P, Hagberg H, Hansson L, Foukakis T, Pulkkanen K, Bauer S, Goplen D, Blach Rossen P, Sundby Hall K (2021)
Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST)
ESMO Open, 6 (4), 100217
DOI 10.1016/j.esmoop.2021.100217, PubMed 34271307
Fankhauser CD, Oldenburg J, Albers P, Algaba F, Bokemeyer C, Boormans JL, Fischer S, Fizazi K, Gremmels H, Mayor de Castro J, Janisch F, Muilwijk T, Leão R, Nicol D, Nicolai N, Tandstad T, Pilar Laguna M (2021)
Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021
Eur Urol, 80 (1), 4-6
DOI 10.1016/j.eururo.2021.02.032, PubMed 33722419
Farooqi SJ, Bjaanæs MM, Helland Å, Haakensen VD (2021)
[Immunotherapy for malignant pleural mesothelioma]
Tidsskr Nor Laegeforen, 141
DOI 10.4045/tidsskr.21.0503, PubMed 34505475
Farooqi SJ, Helland A, Haakensen VD, Bjaanaes MM (2021)
Immunotherapy in malignant pleural mesothelioma
Tidsskr. Nor. Laegeforen., 141 (12), 1167-1169
Fauske L, Bruland ØS, Dahl AA, Myklebostad A, Reme SE (2021)
Does the Lightning Process Training Programme Reduce Chronic Fatigue in Adolescent and Young Adult Cancer Survivors? A Mixed-Methods Pilot Study
Cancers (Basel), 13 (16)
DOI 10.3390/cancers13164076, PubMed 34439229
Flatmark K, Torgunrud A, Fleten KG, Davidson B, Juul HV, Mensali N, Lund-Andersen C, Inderberg EM (2021)
Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei
J Immunother Cancer, 9 (10)
DOI 10.1136/jitc-2021-003109, PubMed 34711663
Fowler NH, Dickinson M, Dreyling M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell L, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Pérez-Simón JA, Chen AI, Nastoupil LJ, von Tresckow B, Ferreri AJM, Teshima T, Patten PEM, McGuirk JP, Petzer AL et al. (2021)
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
Nat Med, 28 (2), 325-332
DOI 10.1038/s41591-021-01622-0, PubMed 34921238
Frafjord A, Buer L, Hammarström C, Aamodt H, Woldbæk PR, Brustugun OT, Helland Å, Øynebråten I, Corthay A (2021)
The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed
Front Immunol, 12, 764596
DOI 10.3389/fimmu.2021.764596, PubMed 34868011
Fåne A, Myhre MR, Inderberg EM, Wälchli S (2021)
In vivo experimental mouse model to test CD19CAR T cells generated with different methods
Methods Cell Biol, 167, 149-161
DOI 10.1016/bs.mcb.2021.11.001, PubMed 35152992
Georgiesh T, Namløs HM, Sharma N, Lorenz S, Myklebost O, Bjerkehagen B, Meza-Zepeda LA, Boye K (2021)
Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour
Pathology, 53 (6), 713-719
DOI 10.1016/j.pathol.2020.11.010, PubMed 33745702
Gerdtsson A, Thor A, Grenabo Bergdahl A, Almås B, Håkansson U, Törnblom M, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Sagstuen Haugnes H, Engen Andreassen K, Melsen Larsen S, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A (2021)
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group
Eur Urol Oncol, 5 (2), 235-243
DOI 10.1016/j.euo.2021.02.002, PubMed 33750683
Gillessen S, Sauvé N, Collette L, Daugaard G, de Wit R, Albany C, Tryakin A, Fizazi K, Stahl O, Gietema JA, De Giorgi U, Cafferty FH, Hansen AR, Tandstad T, Huddart RA, Necchi A, Sweeney CJ, Garcia-Del-Muro X, Heng DYC, Lorch A, Chovanec M, Winquist E, Grimison P, Feldman DR, Terbuch A et al. (2021)
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
J Clin Oncol, 39 (14), 1563-1574
DOI 10.1200/JCO.20.03296, PubMed 33822655
Gjersvik P, Heikkila R, Johansen TEB (2021)
Rescue treatment for cancer
Tidsskr. Nor. Laegeforen., 141 (5), 487
Groendahl AR, Moe YM, Kaushal CK, Huynh BN, Rusten E, Tomic O, Hernes E, Hanekamp B, Undseth C, Guren MG, Malinen E, Futsaether CM (2021)
Deep learning-based automatic delineation of anal cancer gross tumour volume: a multimodality comparison of CT, PET and MRI
Acta Oncol, 61 (1), 89-96
DOI 10.1080/0284186X.2021.1994645, PubMed 34783610
Groendahl AR, Skjei Knudtsen I, Huynh BN, Mulstad M, Moe YM, Knuth F, Tomic O, Indahl UG, Torheim T, Dale E, Malinen E, Futsaether CM (2021)
A comparison of methods for fully automatic segmentation of tumors and involved nodes in PET/CT of head and neck cancers
Phys Med Biol, 66 (6), 065012
DOI 10.1088/1361-6560/abe553, PubMed 33666176
Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Blay JY, Bolle S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brennan B, Brodowicz T, Buonadonna A, De Álava E, Del Muro XG, Dufresne A, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A et al. (2021)
Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up^☆
Ann Oncol, 32 (11), 1348-1365
DOI 10.1016/j.annonc.2021.07.006, PubMed 34303806
Grønberg BH, Killingberg KT, Fløtten Ø, Brustugun OT, Hornslien K, Madebo T, Langer SW, Schytte T, Nyman J, Risum S, Tsakonas G, Engleson J, Halvorsen TO (2021)
High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial
Lancet Oncol, 22 (3), 321-331
DOI 10.1016/S1470-2045(20)30742-7, PubMed 33662285
Grøvik E, Yi D, Iv M, Tong E, Nilsen LB, Latysheva A, Saxhaug C, Jacobsen KD, Helland Å, Emblem KE, Rubin DL, Zaharchuk G (2021)
Handling missing MRI sequences in deep learning segmentation of brain metastases: a multicenter study
NPJ Digit Med, 4 (1), 33
DOI 10.1038/s41746-021-00398-4, PubMed 33619361
Guldvik IJ, Ekseth L, Kishan AU, Stensvold A, Inderberg EM, Lilleby W (2021)
Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer
J Pers Med, 11 (7)
DOI 10.3390/jpm11070605, PubMed 34206815
Gullhaug A, Hjermstad MJ, Yri O, Svestad JG, Aass N, Johansen S (2021)
Use of radiotherapy in breast cancer patients with brain metastases: a retrospective 11-year single center study
J Med Imaging Radiat Sci, 52 (2), 214-222
DOI 10.1016/j.jmir.2021.01.002, PubMed 33549504
Guren MG, Sebag-Montefiore D, Franco P, Johnsson A, Segelov E, Deutsch E, Rao S, Spindler KG, Arnold D (2021)
Treatment of Squamous Cell Carcinoma of the Anus, Unresolved Areas and Future Perspectives for Research: Perspectives of Research Needs in Anal Cancer
Clin Colorectal Cancer, 20 (4), 279-287
DOI 10.1016/j.clcc.2021.09.006, PubMed 34645589
Habberstad R, Frøseth TCS, Aass N, Bjerkeset E, Abramova T, Garcia-Alonso E, Caputo M, Rossi R, Boland JW, Brunelli C, Lund JÅ, Kaasa S, Klepstad P (2021)
Clinical Predictors for Analgesic Response to Radiotherapy in Patients with Painful Bone Metastases
J Pain Symptom Manage, 62 (4), 681-690
DOI 10.1016/j.jpainsymman.2021.03.022, PubMed 33794301
Hamfjord J, Guren TK, Glimelius B, Sorbye H, Pfeiffer P, Dajani O, Lingjaerde OC, Tveit KM, Pallisgaard N, Spindler KG, Kure EH (2021)
Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer
Int J Cancer, 149 (6), 1385-1397
DOI 10.1002/ijc.33672, PubMed 33961700
Hamfjord J, Myklebust TÅ, Larsen IK, Kure EH, Glimelius B, Guren TK, Tveit KM, Guren MG (2021)
Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study
Cancer Epidemiol Biomarkers Prev, 31 (2), 342-351
DOI 10.1158/1055-9965.EPI-21-0555, PubMed 34853022
Hartkopf AD, Brucker SY, Taran FA, Harbeck N, von Au A, Naume B, Pierga JY, Hoffmann O, Beckmann MW, Rydén L, Fehm T, Aft R, Solà M, Walter V, Rack B, Schuetz F, Borgen E, Ta MH, Bittner AK, Fasching PA, Fernö M, Krawczyk N, Weilbaecher K, Margelí M, Hahn M et al. (2021)
Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis
Eur J Cancer, 154, 128-137
DOI 10.1016/j.ejca.2021.06.028, PubMed 34265505
Haugen MH, Lingjærde OC, Hedenfalk I, Garred Ø, Borgen E, Loman N, Hatschek T, Børresen-Dale AL, Naume B, Mills GB, Mælandsmo GM, Engebraaten O (2021)
Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers
JCO Precis Oncol, 5
DOI 10.1200/PO.20.00086, PubMed 34036235
Haugnes HS, Negaard HF, Jensvoll H, Wilsgaard T, Tandstad T, Solberg A (2021)
Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000-2014: A Population-based Cohort Study
Eur Urol Open Sci, 32, 19-27
DOI 10.1016/j.euros.2021.07.007, PubMed 34667955
Heck A, Winge-Main AK (2021)
Silent, isolated ACTH deficiency in malignant melanoma patients treated with immune checkpoint inhibitors
BMJ Case Rep, 14 (5)
DOI 10.1136/bcr-2021-241981, PubMed 34045201
Heikkilä R, Myklebust TÅ, Møller B (2021)
Regional variation in cancer survival in Norway
Cancer Epidemiol, 75, 102038
DOI 10.1016/j.canep.2021.102038, PubMed 34571393
Hellesnes R, Myklebust TÅ, Fosså SD, Bremnes RM, Karlsdottir Á, Kvammen Ø, Tandstad T, Wilsgaard T, Negaard HFS, Haugnes HS (2021)
Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort
J Clin Oncol, 39 (32), 3561-3573
DOI 10.1200/JCO.21.00637, PubMed 34388002
Hermansen JU, Wojcik DM, Robinson N, Pahnke J, Haugland HK, Jamtøy AH, Flaegstad T, Halvorsen H, Lund B, Baumbusch LO, Munthe-Kaas MC (2021)
The Norwegian childhood cancer biobank
Cancer Rep (Hoboken), 5 (8), e1555
DOI 10.1002/cnr2.1555, PubMed 34541832
Hernes E, Revheim ME, Hole KH, Tulipan AJ, Strømme H, Lilleby W, Seierstad T (2021)
Prostate-Specific Membrane Antigen PET for Assessment of Primary and Recurrent Prostate Cancer with Histopathology as Reference Standard: A Systematic Review and Meta-Analysis
PET Clin, 16 (2), 147-165
DOI 10.1016/j.cpet.2020.12.001, PubMed 33648661
Hernæs KH, Smeland KB, Fagerli UM, Kiserud CE (2021)
Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation
BMC Cancer, 21 (1), 143
DOI 10.1186/s12885-021-07836-2, PubMed 33557789
Hjermstad MJ, Hamfjord J, Aass N, Dajani O, Lundeby T, Wester T, Kaasa S (2021)
Using Process Indicators to Monitor Documentation of Patient-Centred Variables in an Integrated Oncology and Palliative Care Pathway-Results from a Cluster Randomized Trial
Cancers (Basel), 13 (9)
DOI 10.3390/cancers13092194, PubMed 34063594
Hoel F, Hoel A, Pettersen IK, Rekeland IG, Risa K, Alme K, Sørland K, Fosså A, Lien K, Herder I, Thürmer HL, Gotaas ME, Schäfer C, Berge RK, Sommerfelt K, Marti HP, Dahl O, Mella O, Fluge Ø, Tronstad KJ (2021)
A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome
JCI Insight, 6 (16)
DOI 10.1172/jci.insight.149217, PubMed 34423789
Hompland I, Ferrari S, Bielack S, Palmerini E, Hall KS, Picci P, Hecker-Nolting S, Donati DM, Blattmann C, Bjerkehagen B, Staals E, Kager L, Gambarotti M, Kühne T, Eriksson M, Ferraresi V, Kevric M, Biagini R, Baumhoer D, Brosjø O, Comandone A, Schwarz R, Bertulli R, Kessler T, Hansson L et al. (2021)
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
Eur J Cancer, 151, 150-158
DOI 10.1016/j.ejca.2021.04.017, PubMed 33990016
Hopland OA, Fosså SD, Ottosson F, Brennhovd B, Svindland A, Hole KH, Hernes E, Eri LM, Diep LM, Berge V (2021)
Robotic salvage pelvic lymph node dissection for locoregional recurrence after radical prostatectomy: a single institution experience
Scand J Urol, 55 (4), 287-292
DOI 10.1080/21681805.2021.1946135, PubMed 34196594
Hugenschmidt H, Labori KJ, Borgen E, Brunborg C, Schirmer CB, Seeberg LT, Naume B, Wiedswang G (2021)
Preoperative CTC-Detection by CellSearch^® Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer
Cancers (Basel), 13 (3)
DOI 10.3390/cancers13030485, PubMed 33513877
Husum YS, Skogen K, Brandal P, Rønning PA, Wigers AR, Evang JA, Jørstad ØK (2021)
Bilateral calcification of the optic nerve sheath: A diagnostic dilemma
Am J Ophthalmol Case Rep, 22, 101106
DOI 10.1016/j.ajoc.2021.101106, PubMed 33997471
Høghaug G, Skår R, Tran TN, Diep LM, Bredal IS (2021)
Three-month follow-up effects of a medication management program on nurses' knowledge
Nurse Educ Pract, 51, 102979
DOI 10.1016/j.nepr.2021.102979, PubMed 33588183
Hølmebakk T, Boye K (2021)
ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
Ann Surg Oncol, 28 (11), 6846-6847
DOI 10.1245/s10434-021-09608-5, PubMed 33687615
Hølmebakk T, Boye K (2021)
Correction to: ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
Ann Surg Oncol, 28 (Suppl 3), 873
DOI 10.1245/s10434-021-09939-3, PubMed 33829360
Hølmebakk T, Wiedswang AM, Meza-Zepeda LA, Hompland I, Lobmaier IVK, Berner JM, Stoldt S, Boye K (2021)
Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach
Ann Surg Oncol, 28 (11), 6837-6845
DOI 10.1245/s10434-021-09605-8, PubMed 33651216
Haakensen VD, Nowak AK, Ellingsen EB, Farooqi SJ, Bjaanæs MM, Horndalsveen H, Mcculloch T, Grundberg O, Cedres SM, Helland Å (2021)
NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma
J Transl Med, 19 (1), 232
DOI 10.1186/s12967-021-02905-3, PubMed 34059094
Isaksen KT, Mastroianni MA, Rinde M, Rusten LS, Barzenje DA, Ramslien LF, Slaaen M, Jerm MB, Smeland EB, Rostoft S, Liestøl K, Brodtkorb M, Holte H (2021)
A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL
Blood Adv, 5 (22), 4771-4782
DOI 10.1182/bloodadvances.2021004777, PubMed 34543384
Ito J, Minemura T, Wälchli S, Niimi T, Fujihara Y, Kuroda S, Takimoto K, Maturana AD (2021)
Id2 Represses Aldosterone-Stimulated Cardiac T-Type Calcium Channels Expression
Int J Mol Sci, 22 (7)
DOI 10.3390/ijms22073561, PubMed 33808082
Jakobsen J, Veierød MB, Grimsrud TK, Fosså SD, Hammarström B, Kjærheim K (2021)
Early detection of prostate cancer in firefighters: a register-based study of prognostic factors and survival
Occup Environ Med, 79 (3), 200-206
DOI 10.1136/oemed-2021-107622, PubMed 34510005
Johannesen TB, Smeland S, Aaserud S, Buanes EA, Skog A, Ursin G, Helland Å (2021)
COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway
Front Oncol, 11, 652535
DOI 10.3389/fonc.2021.652535, PubMed 33842366
Johansson ALV, Trewin CB, Fredriksson I, Reinertsen KV, Russnes H, Ursin G (2021)
In modern times, how important are breast cancer stage, grade and receptor subtype for survival: a population-based cohort study
Breast Cancer Res, 23 (1), 17
DOI 10.1186/s13058-021-01393-z, PubMed 33526044
Johnson ML, Zvirbule Z, Laktionov K, Helland A, Cho BC, Gutierrez V, Colinet B, Lena H, Wolf M, Gottfried M, Okamoto I, van der Leest C, Rich P, Hung JY, Appenzeller C, Sun Z, Maag D, Luo Y, Nickner C, Vajikova A, Komarnitsky P, Bar J (2021)
Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study
J Thorac Oncol, 16 (9), 1570-1581
DOI 10.1016/j.jtho.2021.03.012, PubMed 33823285
Juzeniene A, Stenberg VY, Bruland ØS, Larsen RH (2021)
Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer
Cancers (Basel), 13 (4)
DOI 10.3390/cancers13040779, PubMed 33668474
Karlsson AT, Hjermstad MJ, Omdahl T, Aass N, Skovlund E, Hellebust TP, Johansen S, Kaasa S, Yri OE (2021)
Overall survival after initial radiotherapy for brain metastases; a population based study of 2140 patients with non-small cell lung cancer
Acta Oncol, 60 (8), 1054-1060
DOI 10.1080/0284186X.2021.1924399, PubMed 34032536
Kasius JC, Pijnenborg JMA, Lindemann K, Forsse D, van Zwol J, Kristensen GB, Krakstad C, Werner HMJ, Amant F (2021)
Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification
Cancers (Basel), 13 (22)
DOI 10.3390/cancers13225848, PubMed 34831000
Kerboeuf M, Koppang EO, Haaland AH, Lingaas F, Bruland ØS, Teige J, Moe L (2021)
Early immunohistochemical detection of pulmonary micrometastases in dogs with osteosarcoma
Acta Vet Scand, 63 (1), 41
DOI 10.1186/s13028-021-00608-9, PubMed 34732227
Kirchheiner K, Smet S, Jürgenliemk-Schulz IM, Haie-Meder C, Chargari C, Lindegaard JC, Fokdal LU, Spampinato S, Schmid MP, Sturdza A, Mahantshetty U, Segedin B, Bruheim K, Rai B, Cooper R, Van der Steen-Banasik E, Wiebe E, Sundset M, van Limbergen E, Villafranca E, Westerveld H, Tan LT, Pötter R, Tanderup K, Nout RA et al. (2021)
Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study
Int J Radiat Oncol Biol Phys, 112 (2), 400-413
DOI 10.1016/j.ijrobp.2021.08.036, PubMed 34478833
Kishan AU, Karnes RJ, Romero T, Wong JK, Motterle G, Tosoian JJ, Trock BJ, Klein EA, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Levin-Epstein R, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Braccioforte M, Huland H, Tran PT, Martin S et al. (2021)
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features
JAMA Netw Open, 4 (7), e2115312
DOI 10.1001/jamanetworkopen.2021.15312, PubMed 34196715
Knuth F, Adde IA, Huynh BN, Groendahl AR, Winter RM, Negård A, Holmedal SH, Meltzer S, Ree AH, Flatmark K, Dueland S, Hole KH, Seierstad T, Redalen KR, Futsaether CM (2021)
MRI-based automatic segmentation of rectal cancer using 2D U-Net on two independent cohorts
Acta Oncol, 61 (2), 255-263
DOI 10.1080/0284186X.2021.2013530, PubMed 34918621
Korwisi B, Hay G, Attal N, Aziz Q, Bennett MI, Benoliel R, Cohen M, Evers S, Giamberardino MA, Kaasa S, Kosek E, Lavand'homme P, Nicholas M, Perrot S, Schug S, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ, Treede RD, Rief W, Barke A (2021)
Classification algorithm for the International Classification of Diseases-11 chronic pain classification: development and results from a preliminary pilot evaluation
Pain, 162 (7), 2087-2096
DOI 10.1097/j.pain.0000000000002208, PubMed 33492033
Kryeziu K, Moosavi SH, Bergsland CH, Guren MG, Eide PW, Totland MZ, Lassen K, Abildgaard A, Nesbakken A, Sveen A, Lothe RA (2021)
Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases
J Transl Med, 19 (1), 384
DOI 10.1186/s12967-021-03062-3, PubMed 34496878
Krüger K, Silwal-Pandit L, Wik E, Straume O, Stefansson IM, Borgen E, Garred Ø, Naume B, Engebraaten O, Akslen LA (2021)
Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer
Sci Rep, 11 (1), 3388
DOI 10.1038/s41598-021-81914-0, PubMed 33564016
Kurch L, Mauz-Körholz C, Fosså A, Georgi TW, Kluge R, Bartelt JM, Kunze C, Wohlgemuth WA, Pelz T, Vordermark D, Plößl S, Hasenclever D, Sabri O, Landman-Parker J, Wallace WH, Karlen J, Fernández-Teijeiro A, Cepelova M, Klekawka T, Løndalen AM, Steiner D, Krombach G, Attarbaschi A, Hoffmann M, Ceppi F et al. (2021)
Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Importance of multimodality imaging: Results from the EuroNet-PHL-C1 trial
Pediatr Blood Cancer, 68 (4), e28903
DOI 10.1002/pbc.28903, PubMed 33538093
Lanari J, Hagness M, Sartori A, Rosso E, Gringeri E, Dueland S, Cillo U, Line PD (2021)
Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score
Transpl Int, 34 (9), 1722-1732
DOI 10.1111/tri.13981, PubMed 34448271
Lansu J, Bovée JVMG, Braam P, van Boven H, Flucke U, Bonenkamp JJ, Miah AB, Zaidi SH, Thway K, Bruland ØS, Baldini EH, Jebsen NL, Scholten AN, van den Ende PLA, Krol ADG, Ubbels JF, van der Hage JA, van Werkhoven E, Klomp HM, van der Graaf WTA, van Coevorden F, Schrage Y, van Houdt WJ, Haas RL (2021)
Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial
JAMA Oncol, 7 (1), e205865
DOI 10.1001/jamaoncol.2020.5865, PubMed 33180100
Larsen BH, Lundeby T, Gerwing J, Gulbrandsen P, Førde R (2021)
"Eh - What type of cells are these - flourishing in the liver?" Cancer patients' disclosure of existential concerns in routine hospital consultations
Patient Educ Couns, 105 (7), 2019-2026
DOI 10.1016/j.pec.2021.11.010, PubMed 34839995
Larsen SG, Goscinski MA, Dueland S, Steigen SE, Hofsli E, Torgunrud A, Lund-Iversen M, Dagenborg VJ, Flatmark K, Sorbye H (2021)
Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients
Br J Cancer, 126 (5), 726-735
DOI 10.1038/s41416-021-01620-6, PubMed 34887523
Lehtiö J, Arslan T, Siavelis I, Pan Y, Socciarelli F, Berkovska O, Umer HM, Mermelekas G, Pirmoradian M, Jönsson M, Brunnström H, Brustugun OT, Purohit KP, Cunningham R, Foroughi Asl H, Isaksson S, Arbajian E, Aine M, Karlsson A, Kotevska M, Gram Hansen C, Drageset Haakensen V, Helland Å, Tamborero D, Johansson HJ et al. (2021)
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms
Nat Cancer, 2 (11), 1224-1242
DOI 10.1038/s43018-021-00259-9, PubMed 34870237
Li RG, Napoli E, Jorstad IS, Bønsdorff TB, Juzeniene A, Bruland ØS, Larsen RH, Westrøm S (2021)
Calcium Carbonate Microparticles as Carriers of ²²⁴Ra: Impact of Specific Activity in Mice with Intraperitoneal Ovarian Cancer
Curr Radiopharm, 14 (2), 145-153
DOI 10.2174/1874471013666201201102056, PubMed 33261548
Lien TG, Ohnstad HO, Lingjærde OC, Vallon-Christersson J, Aaserud M, Sveli MAT, Borg Å, Osbreac OBO, Garred Ø, Borgen E, Naume B, Russnes H, Sørlie T (2021)
Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer
Cancers (Basel), 13 (23)
DOI 10.3390/cancers13236118, PubMed 34885228
Lilleheie I, Debesay J, Bye A, Bergland A (2021)
The tension between carrying a burden and feeling like a burden: a qualitative study of informal caregivers' and care recipients' experiences after patient discharge from hospital
Int J Qual Stud Health Well-being, 16 (1), 1855751
DOI 10.1080/17482631.2020.1855751, PubMed 33345749
Lindberg K, Grozman V, Karlsson K, Lindberg S, Lax I, Wersäll P, Persson GF, Josipovic M, Khalil AA, Moeller DS, Nyman J, Drugge N, Bergström P, Olofsson J, Rogg LV, Ramberg C, Kristiansen C, Jeppesen SS, Nielsen TB, Lödén B, Rosenbrand HO, Engelholm S, Haraldsson A, Billiet C, Lewensohn R (2021)
The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy
J Thorac Oncol, 16 (7), 1200-1210
DOI 10.1016/j.jtho.2021.03.019, PubMed 33823286
Lindberg Å, Eskelund CW, Albertsson-Lindblad A, Kolstad A, Laurell A, Räty R, Grønbaek K, Geisler CH, Jerkeman M (2021)
Pre-treatment health-related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma: The Nordic Lymphoma Group MCL4 (LENA-BERIT) experience
Hematol Oncol, 40 (1), 22-30
DOI 10.1002/hon.2940, PubMed 34713465
Lindemann K, Smogeli E, Småstuen MC, Bruheim K, Trovik J, Nordberg T, Kristensen GB, Werner HMJ, Nakken E (2021)
Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer
Cancers (Basel), 13 (6)
DOI 10.3390/cancers13061367, PubMed 33803531
Liposits G, Orrevall Y, Kaasa S, Osterlund P, Cederholm T (2021)
Nutrition in Cancer Care: A Brief, Practical Guide With a Focus on Clinical Practice
JCO Oncol. Pract., 17 (7), 442-+
DOI 10.1200/OP.20.00704
Lokhande L, Kuci Emruli V, Eskelund CW, Kolstad A, Hutchings M, Räty R, Niemann CU, Grønbaek K, Jerkeman M, Ek S (2021)
Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma
Cancer Rep (Hoboken), 5 (7), e1524
DOI 10.1002/cnr2.1524, PubMed 34319003
Lundar T, Due-Tønnessen BJ, Frič R, Brandal P, Due-Tønnessen P (2021)
Choroid Plexus Tumors in Children: Long-Term Follow-Up of Consecutive Single-Institutional Series of 59 Patients Treated over a Period of 8 Decades (1939-2020)
World Neurosurg, 158, e810-e819
DOI 10.1016/j.wneu.2021.11.070, PubMed 34823041
Lundar T, Due-Tønnessen BJ, Frič R, Sundseth J, Brandal P, Due-Tønnessen P (2021)
Outcome After Treatment of Spinal Ependymoma in Children and Adolescents: Long-Term Follow-up of a Single Consecutive Institutional Series of 33 Patients Treated Over Eight Decades
World Neurosurg, 150, e228-e235
DOI 10.1016/j.wneu.2021.02.131, PubMed 33684583
Lundar T, Due-Tønnessen BJ, Frič R, Sundseth J, Brandal P, Due-Tønnessen P (2021)
Outcome after treatment of pediatric supratentorial ependymoma: long-term follow-up of a single consecutive institutional series of 26 patients
Br J Neurosurg, 38 (2), 514-522
DOI 10.1080/02688697.2021.1914821, PubMed 34096810
Lundereng ED, Nes AAG, Holmen H, Winger A, Thygesen H, Jøranson N, Borge CR, Chen W, Dajani O, Mariussen KL, Steindal SA (2021)
Health Care Professionals' Experiences and Perspectives on Using Telehealth for Home-Based Palliative Care: Protocol for a Scoping Review
JMIR Res Protoc, 10 (10), e33305
DOI 10.2196/33305, PubMed 34714254
Lærum-Onsager E, Molin M, Olsen CF, Bye A, Debesay J, Hestevik CH, Bjerk M, Pripp AH (2021)
Effect of nutritional and physical exercise intervention on hospital readmission for patients aged 65 or older: a systematic review and meta-analysis of randomized controlled trials
Int J Behav Nutr Phys Act, 18 (1), 62
DOI 10.1186/s12966-021-01123-w, PubMed 33971901
Lærum-Onsager E, Molin M, Olsen CF, Bye A, Debesay J, Hestevik CH, Bjerk M, Pripp AH (2021)
Correction to: Effect of nutritional and physical exercise intervention on hospital readmission for patients aged 65 or older: a systematic review and meta-analysis of randomized controlled trials
Int J Behav Nutr Phys Act, 18 (1), 80
DOI 10.1186/s12966-021-01152-5, PubMed 34172048
Mariathasan AB, Boye K, Dueland S, Flatmark K, Larsen SG (2021)
Metastases in locally advanced rectal cancer undergoing curatively intended treatment
Eur J Surg Oncol, 47 (9), 2377-2383
DOI 10.1016/j.ejso.2021.04.023, PubMed 34049768
Mauz-Körholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Claviez A, Daw S, Dieckmann K, Fernández-Teijeiro A, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kluge R, Kurch L, Leblanc T, Mann G, Montravers F et al. (2021)
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial
Lancet Oncol, 23 (1), 125-137
DOI 10.1016/S1470-2045(21)00470-8, PubMed 34895479
Meltzer S, Torgunrud A, Abrahamsson H, Solbakken AM, Flatmark K, Dueland S, Bakke KM, Bousquet PA, Negård A, Johansen C, Lyckander LG, Larsen FO, Schou JV, Redalen KR, Ree AH (2021)
The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancer
Br J Cancer, 125 (2), 240-246
DOI 10.1038/s41416-021-01377-y, PubMed 33837301
Mensali N, Dillard P, Fayzullin A, Köksal H, Gaudernack G, Kvalheim G, Inderberg EM, Wälchli S (2021)
"Built-in" PD-1 blocker to rescue NK-92 activity from PD-L1-mediated tumor escape mechanisms
FASEB J, 35 (9), e21750
DOI 10.1096/fj.202100025R, PubMed 34424568
Merrien M, Wasik AM, Ljung E, Morsy MHA, de Matos Rodrigues J, Carlsten M, Rassidakis GZ, Christensson B, Kolstad A, Jerkeman M, Ek S, Herold N, Wahlin BE, Sander B (2021)
Clinical and biological impact of SAMHD1 expression in mantle cell lymphoma
Virchows Arch, 480 (3), 655-666
DOI 10.1007/s00428-021-03228-w, PubMed 34738194
Moe YM, Groendahl AR, Tomic O, Dale E, Malinen E, Futsaether CM (2021)
Deep learning-based auto-delineation of gross tumour volumes and involved nodes in PET/CT images of head and neck cancer patients
Eur J Nucl Med Mol Imaging, 48 (9), 2782-2792
DOI 10.1007/s00259-020-05125-x, PubMed 33559711
Moosavi SH, Eide PW, Eilertsen IA, Brunsell TH, Berg KCG, Røsok BI, Brudvik KW, Bjørnbeth BA, Guren MG, Nesbakken A, Lothe RA, Sveen A (2021)
De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity
Genome Med, 13 (1), 143
DOI 10.1186/s13073-021-00956-1, PubMed 34470666
Morra A, Escala-Garcia M, Beesley J, Keeman R, Canisius S, Ahearn TU, Andrulis IL, Anton-Culver H, Arndt V, Auer PL, Augustinsson A, Beane Freeman LE, Becher H, Beckmann MW, Behrens S, Bojesen SE, Bolla MK, Brenner H, Brüning T, Buys SS, Caan B, Campa D, Canzian F, Castelao JE, Chang-Claude J et al. (2021)
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
Breast Cancer Res, 23 (1), 86
DOI 10.1186/s13058-021-01450-7, PubMed 34407845
Mul J, Melchior P, Seravalli E, Saunders D, Bolle S, Cameron AL, Gurtner K, Harrabi S, Lassen-Ramshad Y, Lavan N, Magelssen H, Mandeville H, Boterberg T, Kroon PS, Kotte ANTJ, Hoeben BAW, van Rossum PSN, van Grotel M, Graf N, van den Heuvel-Eibrink MM, Rübe C, Janssens GO (2021)
Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise
Clin Transl Radiat Oncol, 28, 39-47
DOI 10.1016/j.ctro.2021.03.001, PubMed 33796796
Murray C, von Possel N, Lie HC, Breivik J (2021)
The Nine Cancer Frames: A Tool to Facilitate Critical Reading of Cancer-Related Information
J Cancer Educ, 37 (6), 1918-1927
DOI 10.1007/s13187-021-02062-7, PubMed 34279845
Myklebust MP, Thor A, Rosenlund B, Gjengstø P, Karlsdottir Á, Brydøy M, Bercea BS, Olsen C, Johnson I, Berg MI, Langberg CW, Andreassen KE, Kjellman A, Haugnes HS, Dahl O (2021)
Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study
Sci Rep, 11 (1), 15582
DOI 10.1038/s41598-021-94812-2, PubMed 34341387
Nakken S, Lilleby W, Switlyk MD, Knudsen KE, Lilleby O, Zhao S, Kaveh F, Ekstrøm PO, Urbanucci A, Hovig E (2021)
The Quandary of DNA-Based Treatment Assessment in De Novo Metastatic Prostate Cancer in the Era of Precision Oncology
J Pers Med, 11 (5)
DOI 10.3390/jpm11050330, PubMed 33922147
Napoli E, Bønsdorff TB, Jorstad IS, Bruland ØS, Larsen RH, Westrøm S (2021)
Radon-220 diffusion from 224Ra-labeled calcium carbonate microparticles: Some implications for radiotherapeutic use
PLoS One, 16 (3), e0248133
DOI 10.1371/journal.pone.0248133, PubMed 33662039
Nilssen Y, Eriksen MT, Guren MG, Møller B (2021)
Factors associated with emergency-onset diagnosis, time to treatment and type of treatment in colorectal cancer patients in Norway
BMC Cancer, 21 (1), 757
DOI 10.1186/s12885-021-08415-1, PubMed 34187404
Nobre AR, Risson E, Singh DK, Di Martino JS, Cheung JF, Wang J, Johnson J, Russnes HG, Bravo-Cordero JJ, Birbrair A, Naume B, Azhar M, Frenette PS, Aguirre-Ghiso JA (2021)
Bone marrow NG2⁺/Nestin⁺ mesenchymal stem cells drive DTC dormancy via TGFβ2
Nat Cancer, 2 (3), 327-339
DOI 10.1038/s43018-021-00179-8, PubMed 34993493
Nome RV, Småstuen MC, Fosså SD, Kiserud CE, Åsvold BO, Bjøro T (2021)
Thyroid hypofunction in aging testicular cancer survivors
Acta Oncol, 60 (11), 1452-1458
DOI 10.1080/0284186X.2021.1958004, PubMed 34351829
Olsen CF, Bergland A, Bye A, Debesay J, Langaas AG (2021)
Crossing knowledge boundaries: health care providers' perceptions and experiences of what is important to achieve more person-centered patient pathways for older people
BMC Health Serv Res, 21 (1), 310
DOI 10.1186/s12913-021-06312-8, PubMed 33827714
Olsen CF, Bergland A, Debesay J, Bye A, Langaas AG (2021)
Patient Flow or the Patient's Journey? Exploring Health Care Providers' Experiences and Understandings of Implementing a Care Pathway to Improve the Quality of Transitional Care for Older People
Qual Health Res, 31 (9), 1710-1723
DOI 10.1177/10497323211003861, PubMed 34010082
Olsen SU, Hesseberg K, Aas AM, Pripp AH, Ranhoff AH, Bye A (2021)
A comparison of two different refeeding protocols and its effect on hand grip strength and refeeding syndrome: a randomized controlled clinical trial
Eur Geriatr Med, 12 (6), 1201-1212
DOI 10.1007/s41999-021-00520-5, PubMed 34086194
Olsen SU, Hesseberg K, Aas AM, Ranhoff AH, Bye A (2021)
Refeeding syndrome occurs among older adults regardless of refeeding rates: A systematic review
Nutr Res, 91, 1-12
DOI 10.1016/j.nutres.2021.05.004, PubMed 34130206
Olszewski AJ, Jakobsen LH, Collins GP, Cwynarski K, Bachanova V, Blum KA, Boughan KM, Bower M, Dalla Pria A, Danilov A, David KA, Diefenbach C, Ellin F, Epperla N, Farooq U, Feldman TA, Gerrie AS, Jagadeesh D, Kamdar M, Karmali R, Kassam S, Kenkre VP, Khan N, Kim SH, Klein AK et al. (2021)
Burkitt Lymphoma International Prognostic Index
J Clin Oncol, 39 (10), 1129-1138
DOI 10.1200/JCO.20.03288, PubMed 33502927
Osterman E, Ekström J, Sjöblom T, Kørner H, Myklebust TÅ, Guren MG, Glimelius B (2021)
Accurate population-based model for individual prediction of colon cancer recurrence
Acta Oncol, 60 (10), 1241-1249
DOI 10.1080/0284186X.2021.1953138, PubMed 34279175
Pandya AD, Iversen TG, Moestue S, Grinde MT, Mørch Ý, Snipstad S, Åslund AKO, Øy GF, Kildal W, Engebråten O, Sandvig K, Skotland T, Mælandsmo GM (2021)
Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft
Nanomaterials (Basel), 11 (5)
DOI 10.3390/nano11051140, PubMed 33924869
Paria BC, Levin N, Lowery FJ, Pasetto A, Deniger DC, Parkhurst MR, Yossef R, Kim SP, Florentin M, Ngo LT, Ray S, Krishna S, Robbins PF, Rosenberg SA (2021)
Rapid Identification and Evaluation of Neoantigen-reactive T-Cell Receptors From Single Cells
J Immunother, 44 (1), 1-8
DOI 10.1097/CJI.0000000000000342, PubMed 33086340
Park J, Choi JY, Choi J, Chung S, Song N, Park SK, Han W, Noh DY, Ahn SH, Lee JW, Kim MK, Jee SH, Wen W, Bolla MK, Wang Q, Dennis J, Michailidou K, Shah M, Conroy DM, Harrington PA, Mayes R, Czene K, Hall P, Teras LR, Patel AV et al. (2021)
Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?
Cancers (Basel), 13 (10)
DOI 10.3390/cancers13102370, PubMed 34069208
Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Borrego MR, Moore HC, Saunders C, Cardoso F et al. (2021)
Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy
Breast, 59, 327-338
DOI 10.1016/j.breast.2021.07.021, PubMed 34390999
Peneder P, Stütz AM, Surdez D, Krumbholz M, Semper S, Chicard M, Sheffield NC, Pierron G, Lapouble E, Tötzl M, Ergüner B, Barreca D, Rendeiro AF, Agaimy A, Boztug H, Engstler G, Dworzak M, Bernkopf M, Taschner-Mandl S, Ambros IM, Myklebost O, Marec-Bérard P, Burchill SA, Brennan B, Strauss SJ et al. (2021)
Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden
Nat Commun, 12 (1), 3230
DOI 10.1038/s41467-021-23445-w, PubMed 34050156
Peters M, de Leeuw AAC, Nomden CN, Tanderup K, Kirchheiner K, Lindegaard JC, Kirisits C, Haie-Meder C, Sturdza A, Fokdal L, Mahantshetty U, Hoskin P, Segedin B, Bruheim K, Rai B, Huang F, Cooper R, van der Steen-Banasik E, van Limbergen E, Pieters BR, Tan LT, van Rossum PSN, Nesvacil N, Nout R, Schmid MP et al. (2021)
Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysis
Radiother Oncol, 163, 150-158
DOI 10.1016/j.radonc.2021.08.020, PubMed 34480958
Philipson RG, Romero T, Wong JK, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Braccioforte M, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Valle L, Chong N, Pisansky TM, Choo CR et al. (2021)
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer
Eur Urol, 80 (2), 142-146
DOI 10.1016/j.eururo.2021.04.035, PubMed 33985797
Pierson SK, Shenoy S, Oromendia AB, Gorzewski AM, Langan Pai RA, Nabel CS, Ruth JR, Parente SAT, Arenas DJ, Guilfoyle M, Reddy M, Weinblatt M, Shadick N, Bower M, Pria AD, Masaki Y, Katz L, Mezey J, Beineke P, Lee D, Tendler C, Kambayashi T, Fosså A, van Rhee F, Fajgenbaum DC (2021)
Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease
Blood Adv, 5 (17), 3445-3456
DOI 10.1182/bloodadvances.2020004016, PubMed 34438448
Pilleron S, Charvat H, Araghi M, Arnold M, Fidler-Benaoudia MM, Bardot A, Guren MG, Tervonen H, Little A, O'Connell DL, Gavin A, De P, Thomsen LA, Moller B, Jackson C, Bucher O, Walsh PM, Vernon S, Bray F, Soerjomataram I (2021)
Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study. (vol 148, 1575, 2021)
Int. J. Cancer, 149 (6), E9
DOI 10.1002/ijc.33717
Pommergaard HC, Nielsen K, Sorbye H, Federspiel B, Tabaksblat EM, Vestermark LW, Janson ET, Hansen CP, Ladekarl M, Garresori H, Hjortland GO, Sundlöv A, Galleberg R, Knigge P, Kjaer A, Langer SW, Knigge U (2021)
Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms
J Neuroendocrinol, 33 (5), e12967
DOI 10.1111/jne.12967, PubMed 33769624
Popat S, Brustugun OT, Cadranel J, Felip E, Garassino MC, Griesinger F, Helland Å, Hochmair M, Pérol M, Bent-Ennakhil N, Kruhl C, Novello S (2021)
Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer
Lung Cancer, 157, 9-16
DOI 10.1016/j.lungcan.2021.05.017, PubMed 34051652
Popperud TH, Gul KA, Brunborg C, Olaussen RW, Abrahamsen TG, Osnes LT, Kerty E (2021)
Thymectomy in Juvenile Myasthenia Gravis Is Safe Regarding Long Term Immunological Effects
Front Neurol, 12, 596859
DOI 10.3389/fneur.2021.596859, PubMed 33716918
Pötter R, Tanderup K, Schmid MP, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Tan LT, Nout RA, De Leeuw AAC, Ristl R, Petric P, Nesvacil N, Kirchheiner K, Kirisits C et al. (2021)
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
Lancet Oncol, 22 (4), 538-547
DOI 10.1016/S1470-2045(20)30753-1, PubMed 33794207
Ragnum HB, De Bortoli AM, Elsais A, Nilsen KB, Hammarstrom C, Nyakas M (2021)
A man in his sixties with dyspnoea following immunotherapy
Tidsskr. Nor. Laegeforen., 141 (12), 1190-1194
Ragnum HB, De Bortoli AM, Elsais A, Nilsen KB, Hammarström C, Nyakas M (2021)
A man in his sixties with dyspnoea following immunotherapy
Tidsskr Nor Laegeforen, 141 (2021-12)
DOI 10.4045/tidsskr.21.0139, PubMed 34505469
Rao S, Guren MG, Khan K, Brown G, Renehan AG, Steigen SE, Deutsch E, Martinelli E, Arnold D, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org (2021)
Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up^☆
Ann Oncol, 32 (9), 1087-1100
DOI 10.1016/j.annonc.2021.06.015, PubMed 34175386
REACCT Collaborative, Zaborowski AM, Abdile A, Adamina M, Aigner F, d'Allens L, Allmer C, Álvarez A, Anula R, Andric M, Atallah S, Bach S, Bala M, Barussaud M, Bausys A, Bebington B, Beggs A, Bellolio F, Bennett MR, Berdinskikh A, Bevan V, Biondo S, Bislenghi G, Bludau M, Boutall A et al. (2021)
Characteristics of Early-Onset vs Late-Onset Colorectal Cancer: A Review
JAMA Surg, 156 (9), 865-874
DOI 10.1001/jamasurg.2021.2380, PubMed 34190968
Revheim ME, Hole KH, Mo T, Bruland ØS, Reitan E, Julsrud L, Seierstad T (2021)
Multimodal functional imaging for early response assessment in patients with gastrointestinal stromal tumor treated with tyrosine kinase inhibitors
Acta Radiol, 63 (8), 995-1004
DOI 10.1177/02841851211027389, PubMed 34171968
Riis ML (2021)
Management of patients with BRCA mutation from the point of view of a breast surgeon
Ann Med Surg (Lond), 65, 102311
DOI 10.1016/j.amsu.2021.102311, PubMed 33996049
Robbrecht D, Jungels C, Sorensen MM, Spanggaard I, Eskens F, Fretland SØ, Guren TK, Aftimos P, Liberg D, Svedman C, Thorsson L, Steeghs N, Awada A (2021)
First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours
Br J Cancer, 126 (7), 1010-1017
DOI 10.1038/s41416-021-01657-7, PubMed 34903842
Rodrigues JM, Nikkarinen A, Hollander P, Weibull CE, Räty R, Kolstad A, Amini RM, Porwit A, Jerkeman M, Ek S, Glimelius I (2021)
Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors
Br J Haematol, 193 (3), 520-531
DOI 10.1111/bjh.17366, PubMed 33686666
Rye IH, Huse K, Josefsson SE, Kildal W, Danielsen HE, Schlichting E, Garred Ø, Riis ML, Osbreac, Lingjaerde OC, Myklebust JH, Russnes HG (2021)
Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression
Mol Oncol, 16 (1), 88-103
DOI 10.1002/1878-0261.13047, PubMed 34165864
Røen I, Brenne AT, Brunelli C, Stifoss-Hanssen H, Grande G, Solheim TS, Kaasa S, Knudsen AK (2021)
Spiritual quality of life in family carers of patients with advanced cancer-a cross-sectional study
Support Care Cancer, 29 (9), 5329-5339
DOI 10.1007/s00520-021-06080-5, PubMed 33661369
Rønde HS, Kallehauge JF, Kronborg CJS, Nyvang L, Rekstad BL, Hanekamp BA, Appelt AL, Guren MG, Spindler KLS (2021)
Intensity modulated proton therapy planning study for organ at risk sparing in rectal cancer re-irradiation
Acta Oncol, 60 (11), 1436-1439
DOI 10.1080/0284186X.2021.1953139, PubMed 34264785
Schou-Bredal I, Grimholt T, Bonsaksen T, Skogstad L, Heir T, Ekeberg Ø (2021)
Optimists' and pessimists' self-reported mental and global health during the COVID-19 pandemic in Norway
Health Psychol Rep, 9 (2), 160-168
DOI 10.5114/hpr.2021.102394, PubMed 38084286
Schuster SJ, Tam CS, Borchmann P, Worel N, McGuirk JP, Holte H, Waller EK, Jaglowski S, Bishop MR, Damon LE, Foley SR, Westin JR, Fleury I, Ho PJ, Mielke S, Teshima T, Janakiram M, Hsu JM, Izutsu K, Kersten MJ, Ghosh M, Wagner-Johnston N, Kato K, Corradini P, Martinez-Prieto M et al. (2021)
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study
Lancet Oncol, 22 (10), 1403-1415
DOI 10.1016/S1470-2045(21)00375-2, PubMed 34516954
Seierstad T, Hole KH, Tulipan AJ, Strømme H, Lilleby W, Revheim ME, Hernes E (2021)
¹⁸F-Fluciclovine PET for Assessment of Prostate Cancer with Histopathology as Reference Standard: A Systematic Review
PET Clin, 16 (2), 167-176
DOI 10.1016/j.cpet.2020.12.012, PubMed 33648662
Seland M, Skrede K, Lindemann K, Skaali T, Blomhoff R, Bruheim K, Wisløff T, Thorsen L (2021)
Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer
Acta Obstet Gynecol Scand, 101 (3), 313-322
DOI 10.1111/aogs.14310, PubMed 34964982
Shkodra M, Brunelli C, Zecca E, Formaglio F, Bracchi P, Lo Dico S, Caputo M, Kaasa S, Caraceni A (2021)
Neuropathic pain: clinical classification and assessment in patients with pain due to cancer
Pain, 162 (3), 866-874
DOI 10.1097/j.pain.0000000000002076, PubMed 32947548
Singer S, Hammerlid E, Tomaszewska IM, Amdal CD, Bjordal K, Herlofson BB, Santos M, Silva JC, Mehanna H, Fullerton A, Brannan C, Gonzalez LF, Inhestern J, Pinto M, Arraras JI, Yarom N, Bonomo P, Baumann I, Galalae R, Nicolatou-Galitis O, Kiyota N, Raber-Durlacher J, Salem D, Fabian A, Boehm A et al. (2021)
Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale
Qual Life Res, 31 (3), 841-853
DOI 10.1007/s11136-021-02939-6, PubMed 34272632
Skaga E, Skretteberg MA, Johannesen TB, Brandal P, Vik-Mo EO, Helseth E, Langmoen IA (2021)
Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?
Neurooncol Adv, 3 (1), vdab008
DOI 10.1093/noajnl/vdab008, PubMed 33665615
Skalleberg J, Myhrum M, Småstuen MC, Osnes TA, Fosså SD, Bunne M (2021)
Speech perception 30 years after cisplatin-based chemotherapy in adults: limited clinical relevance of long-term ototoxicity?
Acta Oncol, 60 (4), 426-433
DOI 10.1080/0284186X.2021.1887514, PubMed 33617403
Skaarud KJ, Hov JR, Hansen SH, Kummen M, Valeur J, Seljeflot I, Bye A, Paulsen V, Lundin KEA, Trøseid M, Tjønnfjord GE, Iversen PO (2021)
Mortality and microbial diversity after allogeneic hematopoietic stem cell transplantation: secondary analysis of a randomized nutritional intervention trial
Sci Rep, 11 (1), 11593
DOI 10.1038/s41598-021-90976-z, PubMed 34078971
Slørdahl KS, Klotz D, Olsen JÅ, Skovlund E, Undseth C, Abildgaard HL, Brændengen M, Nesbakken A, Larsen SG, Hanekamp BA, Holmboe L, Tvedt R, Sveen A, Lothe RA, Malinen E, Kaasa S, Guren MG (2021)
Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer
Acta Oncol, 60 (7), 921-930
DOI 10.1080/0284186X.2021.1918763, PubMed 33966592
Smet S, Spampinato S, Pötter R, Jürgenliemk-Schulz IM, Nout RA, Chargari C, Mahantshetty U, Sturdza A, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, Van der Steen-Banasik E, Sundset M, Van Limbergen E, Tan LT, Lutgens LCHW, Villafranca E, Pieters BR, Tanderup K, Kirchheiner K (2021)
Risk Factors for Late Persistent Fatigue After Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: An Analysis From the EMBRACE-I Study
Int J Radiat Oncol Biol Phys, 112 (5), 1177-1189
DOI 10.1016/j.ijrobp.2021.11.022, PubMed 34838868
Spampinato S, Fokdal LU, Pötter R, Haie-Meder C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, van der Steen-Banasik E, Van Limbergen E, Sundset M, Westerveld H, Nout RA, Jensen NBK, Kirisits C, Kirchheiner K, Tanderup K, EMBRACE Collaborative Group (2021)
Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis
Radiother Oncol, 158, 312-320
DOI 10.1016/j.radonc.2021.01.019, PubMed 33545254
Spampinato S, Fokdal LU, Pötter R, Haie-Meder C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, van der Steen-Banasik E, Van Limbergen E, Sundset M, Westerveld H, Nout RA, Jensen NBK, Kirisits C, Kirchheiner K, Tanderup K, EMBRACE Collaborative Group (2021)
Response to Yuce Sari et al
Radiother Oncol, 158, 323-324
DOI 10.1016/j.radonc.2021.02.022, PubMed 33647355
Spampinato S, Jensen NBK, Pötter R, Fokdal LU, Chargari C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Hoskin P, Segedin B, Rai B, Bruheim K, Wiebe E, Van der Steen-Banasik E, Cooper R, Van Limbergen E, Sundset M, Pieters BR, Lutgens LCHW, Tan LT, Villafranca E, Smet S, Jastaniyah N et al. (2021)
Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future
Int J Radiat Oncol Biol Phys, 112 (3), 681-693
DOI 10.1016/j.ijrobp.2021.09.055, PubMed 34678431
Spasojevic M, Mariathasan AB, Frich L, Bruland ØS, Larsen SG, Stoldt S (2021)
[Cancer therapy with isolated limb perfusion]
Tidsskr Nor Laegeforen, 141 (2021-12)
DOI 10.4045/tidsskr.21.0194, PubMed 34505491
Spicer J, Marabelle A, Baurain JF, Jebsen NL, Jøssang DE, Awada A, Kristeleit R, Loirat D, Lazaridis G, Jungels C, Brunsvig P, Nicolaisen B, Saunders A, Patel H, Galon J, Hermitte F, Camilio KA, Mauseth B, Sundvold V, Sveinbjørnsson B, Rekdal Ø (2021)
Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors
Clin Cancer Res, 27 (10), 2755-2763
DOI 10.1158/1078-0432.CCR-20-3435, PubMed 33542073
Stacchiotti S, Frezza AM, Blay JY, Baldini EH, Bonvalot S, Bovée JVMG, Callegaro D, Casali PG, Chiang RC, Demetri GD, Demicco EG, Desai J, Eriksson M, Gelderblom H, George S, Gounder MM, Gronchi A, Gupta A, Haas RL, Hayes-Jardon A, Hohenberger P, Jones KB, Jones RL, Kasper B, Kawai A et al. (2021)
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities
Cancer, 127 (16), 2934-2942
DOI 10.1002/cncr.33618, PubMed 33910263
Stacchiotti S, Miah AB, Frezza AM, Messiou C, Morosi C, Caraceni A, Antonescu CR, Bajpai J, Baldini E, Bauer S, Biagini R, Bielack S, Blay JY, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brodowicz T, Callegaro D, De Alava E, Deoras-Sutliff M, Dufresne A, Eriksson M, Errani C, Fedenko A et al. (2021)
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts
ESMO Open, 6 (3), 100170
DOI 10.1016/j.esmoop.2021.100170, PubMed 34090171
Stenberg VY, Larsen RH, Ma LW, Peng Q, Juzenas P, Bruland ØS, Juzeniene A (2021)
Evaluation of the PSMA-Binding Ligand ²¹²Pb-NG001 in Multicellular Tumour Spheroid and Mouse Models of Prostate Cancer
Int J Mol Sci, 22 (9)
DOI 10.3390/ijms22094815, PubMed 34062920
Stikbakke E, Schirmer H, Knutsen T, Støyten M, Wilsgaard T, Giovannucci EL, McTiernan A, Eggen AE, Haugnes HS, Richardsen E, Thune I (2021)
Systolic and diastolic blood pressure, prostate cancer risk, treatment, and survival. The PROCA-life study
Cancer Med, 11 (4), 1005-1015
DOI 10.1002/cam4.4523, PubMed 34939344
Stjernberg M, Schlichting E, Rustoen T, Valeberg BT, Småstuen MC, Raeder JC (2021)
Postdischarge pain, nausea and patient satisfaction after diagnostic and breast-conserving ambulatory surgery for breast cancer: A cross-sectional study
Acta Anaesthesiol Scand, 66 (3), 317-325
DOI 10.1111/aas.14015, PubMed 34888855
Storås AH, Fosså SD, Ursin G, Andreassen BK (2021)
Survival trends for patients with primary metastatic prostate cancer before and after the introduction of new antitumor drugs
Prostate Cancer Prostatic Dis, 26 (1), 53-58
DOI 10.1038/s41391-021-00445-x, PubMed 34493838
Strauss SJ, Frezza AM, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Blay JY, Bolle S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brennan B, Brodowicz T, Buonadonna A, de Álava E, Dei Tos AP, Garcia Del Muro X, Dufresne A, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A et al. (2021)
Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
Ann Oncol, 32 (12), 1520-1536
DOI 10.1016/j.annonc.2021.08.1995, PubMed 34500044
Switlyk MD, Niehusmann P, Sprauten M, Magelssen H, Aarhus M, Rasmussen FØ, Knutstad K, Brandal P (2021)
Neurosarcoidosis resembling multiple meningiomas: A misleading presentation of the disease and diagnostic challenge
Acta Radiol Open, 10 (7), 20584601211036550
DOI 10.1177/20584601211036550, PubMed 34377543
Tabernero J, Grothey A, Van Cutsem E, Yaeger R, Wasan H, Yoshino T, Desai J, Ciardiello F, Loupakis F, Hong YS, Steeghs N, Guren TK, Arkenau HT, Garcia-Alfonso P, Elez E, Gollerkeri A, Maharry K, Christy-Bittel J, Kopetz S (2021)
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study
J Clin Oncol, 39 (4), 273-284
DOI 10.1200/JCO.20.02088, PubMed 33503393
Thorgersen EB, Asvall J, Frøysnes IS, Schjalm C, Larsen SG, Dueland S, Andersson Y, Fodstad Ø, Mollnes TE, Flatmark K (2021)
Increased Local Inflammatory Response to MOC31PE Immunotoxin After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Ann Surg Oncol, 28 (9), 5252-5262
DOI 10.1245/s10434-021-10022-0, PubMed 34019185
Thorsen L, Bøhn SH, Lie HC, Fosså SD, Kiserud CE (2021)
Needs for information about lifestyle and rehabilitation in long-term young adult cancer survivors
Support Care Cancer, 30 (1), 521-533
DOI 10.1007/s00520-021-06418-z, PubMed 34333716
Thorsteinsdottir T, Brustugun OT (2021)
[Cholangiocarcinoma treated with a tumour-agnostic drug]
Tidsskr Nor Laegeforen, 141
DOI 10.4045/tidsskr.21.0064, PubMed 34505477
Torstveit AH, Løyland B, Grov EK, Guren M, Paul SM, Ritchie C, Vistad I, Miaskowski C, Utne I (2021)
Distinctions Between Self-Report and Performance-Based Measures of Physical Function in Older Patients Prior to Chemotherapy
Cancer Nurs, 44 (6), E735-E744
DOI 10.1097/NCC.0000000000000964, PubMed 34183518
Torstveit AH, Miaskowski C, Løyland B, Grov EK, Guren MG, Ritchie CS, Paul SM, Kleven AG, Utne I (2021)
Common and distinct characteristics associated with self-reported functional status in older patients with cancer receiving chemotherapy
Eur J Oncol Nurs, 54, 102033
DOI 10.1016/j.ejon.2021.102033, PubMed 34537538
Toussaint L, Brandal P, Embring A, Engellau J, Evensen ME, Griskeviskius R, Hansen J, Hietala H, Wickart Johansson G, Jørgensen M, Kramer PH, Kristensen I, Lehtio K, Magelssen H, Maraldo MV, Marienhagen K, Martinsson U, Nilsson K, Peters S, Plaude S, Seiersen K, Sendiuliene D, Smulders B, Edvardsen T, Søbstad JM et al. (2021)
Inter-observer variation in target delineation and dose trade-off for radiotherapy of paediatric ependymoma
Acta Oncol, 61 (2), 235-238
DOI 10.1080/0284186X.2021.2022202, PubMed 34970940
Tryggestad AMA, Axcrona K, Axcrona U, Bigalke I, Brennhovd B, Inderberg EM, Hønnåshagen TK, Skoge LJ, Solum G, Saebøe-Larssen S, Josefsen D, Olaussen RW, Aamdal S, Skotheim RI, Myklebust TÅ, Schendel DJ, Lilleby W, Dueland S, Kvalheim G (2021)
Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy
Prostate, 82 (2), 245-253
DOI 10.1002/pros.24267, PubMed 34762317
Vajavaara H, Ekeblad F, Holte H, Jorgensen J, Leivonen SK, Berglund M, Kamper P, Moller HJ, D'Amore F, Molin D, Enblad G, Ludvigsen M, Glimelius I, Leppa S (2021)
Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
Haematologica, 106 (9), 2502-2506
DOI 10.3324/haematol.2020.278182, PubMed 33764002
Vajavaara H, Mortensen JB, Leivonen SK, Hansen IM, Ludvigsen M, Holte H, Jørgensen J, Bjerre M, d'Amore F, Leppä S (2021)
Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma
Cancers (Basel), 13 (3)
DOI 10.3390/cancers13030398, PubMed 33499013
Valsø Å, Rustøen T, Småstuen MC, Puntillo K, Skogstad L, Schou-Bredal I, Sunde K, Tøien K (2021)
Occurrence and characteristics of pain after ICU discharge: A longitudinal study
Nurs Crit Care, 27 (5), 718-727
DOI 10.1111/nicc.12701, PubMed 34382725
van den Berg MH, van Dijk M, Byrne J, Berger C, Dirksen U, Winther JF, Fossa SD, Grabow D, Grandage VL, Haupt R, van den Heuvel-Eibrink MM, Kaiser M, Kepak T, van der Kooi ALF, Kremer LCM, Kruseova J, Lambalk CB, van Leeuwen FE, Leiper A, Modan-Moses D, Spix C, Twisk JWR, Ronckers CM, Kaatsch P, van Dulmen-den Broeder E et al. (2021)
Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE)
Hum Reprod, 36 (6), 1561-1573
DOI 10.1093/humrep/deab035, PubMed 33744927
van der Kooi ALF, van Dijk M, Broer L, van den Berg MH, Laven JSE, van Leeuwen FE, Lambalk CB, Overbeek A, Loonen JJ, van der Pal HJ, Tissing WJ, Versluys B, Bresters D, Beerendonk CCM, Ronckers CR, van der Heiden-van der Loo M, Kaspers GL, de Vries ACH, Robison LL, Hudson MM, Chemaitilly W, Byrne J, Berger C, Clemens E, Dirksen U et al. (2021)
Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function
Hum Reprod, 36 (4), 1120-1133
DOI 10.1093/humrep/deaa342, PubMed 33582778
van der Perk MEM, Broer L, Yasui Y, Robison LL, Hudson MM, Laven JSE, van der Pal HJ, Tissing WJE, Versluys B, Bresters D, Kaspers GJL, de Vries ACH, Lambalk CB, Overbeek A, Loonen JJ, Beerendonk CCM, Byrne J, Berger C, Clemens E, Dirksen U, Winther JF, Fosså SD, Grabow D, Muraca M, Kaiser M et al. (2021)
Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study
Cancers (Basel), 13 (18)
DOI 10.3390/cancers13184598, PubMed 34572825
van Eck I, den Hollander D, Lidington E, Hentschel L, Eichler M, Salah S, Singer S, Pinto M, Fauske L, Fiore M, Nixon I, Constantinidou A, Desar IME, Bonenkamp JJ, van Houdt WJ, Reuvers MJP, Haas RLM, Bruland ØS, Kasper B, van der Graaf WTA, Husson O (2021)
Health-Related Quality of Life Issues Experienced by Thoracic and Breast Sarcoma Patients: A Rare and Understudied Group
J Clin Med, 10 (22)
DOI 10.3390/jcm10225334, PubMed 34830615
Venizelos A, Elvebakken H, Perren A, Nikolaienko O, Deng W, Lothe IMB, Couvelard A, Hjortland GO, Sundlöv A, Svensson J, Garresori H, Kersten C, Hofsli E, Detlefsen S, Krogh M, Sorbye H, Knappskog S (2021)
The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms
Endocr Relat Cancer, 29 (1), 1-14
DOI 10.1530/ERC-21-0152, PubMed 34647903
Vestre K, Persiconi I, Borg Distefano M, Mensali N, Guadagno NA, Bretou M, Wälchli S, Arnold-Schrauf C, Bakke O, Dalod M, Lennon-Dumenil AM, Progida C (2021)
Rab7b regulates dendritic cell migration by linking lysosomes to the actomyosin cytoskeleton
J Cell Sci, 134 (18)
DOI 10.1242/jcs.259221, PubMed 34494097
Våde L, Hompland I, Fauske L (2021)
Exploring Mentorship as a Novel Approach to Improving Quality of Life in Sarcoma Survivors: A Qualitative Pilot Study
Sarcoma, 2021, 2042785
DOI 10.1155/2021/2042785, PubMed 34421328
Weider T, Richardson SJ, Morgan NG, Paulsen TH, Dahl-Jørgensen K, Hammerstad SS (2021)
HLA Class I Upregulation and Antiviral Immune Responses in Graves Disease
J Clin Endocrinol Metab, 106 (4), e1763-e1774
DOI 10.1210/clinem/dgaa958, PubMed 33367784
Westgaard KL, Hynne H, Amdal CD, Young A, Singh PB, Chen X, Rykke M, Hove LH, Aqrawi LA, Utheim TP, Herlofson BB, Jensen JL (2021)
Oral and ocular late effects in head and neck cancer patients treated with radiotherapy
Sci Rep, 11 (1), 4026
DOI 10.1038/s41598-021-83635-w, PubMed 33597629
Winther RR, Vik-Mo EO, Yri OE, Aass N, Kaasa S, Skovlund E, Helseth E, Hjermstad MJ (2021)
Surgery for brain metastases - real-world prognostic factors' association with survival
Acta Oncol, 60 (9), 1161-1168
DOI 10.1080/0284186X.2021.1930150, PubMed 34032547
Wright P, Arnesen MR, Lønne PI, Suilamo S, Silvoniemi A, Dale E, Minn H, Malinen E (2021)
Repeatability of hypoxia dose painting by numbers based on EF5-PET in head and neck cancer
Acta Oncol, 60 (11), 1386-1391
DOI 10.1080/0284186X.2021.1944663, PubMed 34184605
Xiang M, Ma TM, Savjani R, Pollom EL, Karnes RJ, Grogan T, Wong JK, Motterle G, Tosoian JJ, Trock BJ, Klein EA, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Levin-Epstein R, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Huland H et al. (2021)
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
JAMA Netw Open, 4 (12), e2138550
DOI 10.1001/jamanetworkopen.2021.38550, PubMed 34902034
Yap TA, Nakagawa K, Fujimoto N, Kuribayashi K, Guren TK, Calabrò L, Shapira-Frommer R, Gao B, Kao S, Matos I, Planchard D, Chatterjee A, Jin F, Norwood K, Kindler HL (2021)
Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study
Lancet Respir Med, 9 (6), 613-621
DOI 10.1016/S2213-2600(20)30515-4, PubMed 33836153
Yi D, Grøvik E, Tong E, Iv M, Emblem KE, Nilsen LB, Saxhaug C, Latysheva A, Jacobsen KD, Helland Å, Zaharchuk G, Rubin D (2021)
MRI pulse sequence integration for deep-learning-based brain metastases segmentation
Med Phys, 48 (10), 6020-6035
DOI 10.1002/mp.15136, PubMed 34405896
Öjlert ÅK, Nebdal D, Snapkov I, Olsen V, Kidman J, Greiff V, Chee J, Helland Å (2021)
Dynamic changes in the T cell receptor repertoire during treatment with radiotherapy combined with an immune checkpoint inhibitor
Mol Oncol, 15 (11), 2958-2968
DOI 10.1002/1878-0261.13082, PubMed 34402187
Aamdal E, Inderberg EM, Ellingsen EB, Rasch W, Brunsvig PF, Aamdal S, Heintz KM, Vodák D, Nakken S, Hovig E, Nyakas M, Guren TK, Gaudernack G (2021)
Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial
Front Immunol, 12, 663865
DOI 10.3389/fimmu.2021.663865, PubMed 34046035
Aamdal E, Jacobsen KD, Straume O, Kersten C, Herlofsen O, Karlsen J, Hussain I, Amundsen A, Dalhaug A, Nyakas M, Schuster C, Hagene KT, Holmsen K, Russnes HG, Skovlund E, Kaasa S, Aamdal S, Kyte JA, Guren TK (2021)
Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up
Int J Cancer, 150 (1), 100-111
DOI 10.1002/ijc.33768, PubMed 34449877
Aas K, Berge V, Myklebust TÅ, Fosså SD (2021)
Comparative Survival Outcomes of High-risk Prostate Cancer Treated with Radical Prostatectomy or Definitive Radiotherapy Regimens
Eur Urol Open Sci, 26, 55-63
DOI 10.1016/j.euros.2021.01.011, PubMed 34337508

Publications 2020

Abravan A, Eide HA, Helland Å, Malinen E (2020)
Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy
Clin Transl Radiat Oncol, 22, 15-21
DOI 10.1016/j.ctro.2020.02.005, PubMed 32181373
Aksnessæther BY, Myklebust TÅ, Solberg A, Klepp OH, Skovlund E, Hoff SR, Fosså SD, Widmark A, Lund JÅ (2020)
In Reply to Sari et al
Int J Radiat Oncol Biol Phys, 107 (2), 388-389
DOI 10.1016/j.ijrobp.2020.02.027, PubMed 32112877
Al-Haidari G, Skovlund E, Undseth C, Rekstad BL, Larsen SG, Åsli LM, Dueland S, Malinen E, Guren MG (2020)
Re-irradiation for recurrent rectal cancer - a single-center experience
Acta Oncol, 59 (5), 534-540
DOI 10.1080/0284186X.2020.1725111, PubMed 32056476
Aqrawi LA, Chen X, Hynne H, Amdal C, Reppe S, Aass HCD, Rykke M, Hove LH, Young A, Herlofson BB, Westgaard KL, Utheim TP, Galtung HK, Jensen JL (2020)
Cytokines Explored in Saliva and Tears from Radiated Cancer Patients Correlate with Clinical Manifestations, Influencing Important Immunoregulatory Cellular Pathways
Cells, 9 (9)
DOI 10.3390/cells9092050, PubMed 32911805
Araghi M, Arnold M, Rutherford MJ, Guren MG, Cabasag CJ, Bardot A, Ferlay J, Tervonen H, Shack L, Woods RR, Saint-Jacques N, De P, McClure C, Engholm G, Gavin AT, Morgan E, Walsh PM, Jackson C, Porter G, Møller B, Bucher O, Eden M, O'Connell DL, Bray F, Soerjomataram I (2020)
Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project)
Gut, 70 (1), 114-126
DOI 10.1136/gutjnl-2020-320625, PubMed 32482683
Ascierto PA, Del Vecchio M, Mackiewicz A, Robert C, Chiarion-Sileni V, Arance A, Lebbé C, Svane IM, McNeil C, Rutkowski P, Loquai C, Mortier L, Hamid O, Bastholt L, Dreno B, Schadendorf D, Garbe C, Nyakas M, Grob JJ, Thomas L, Liszkay G, Smylie M, Hoeller C, Ferraresi V, Grange F et al. (2020)
Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
J Immunother Cancer, 8 (1)
DOI 10.1136/jitc-2019-000391, PubMed 32503946
Ask EH, Tschan-Plessl A, Gjerdingen TJ, Sætersmoen ML, Hoel HJ, Wiiger MT, Olweus J, Wahlin BE, Lingjærde OC, Horowitz A, Cashen AF, Watkins M, Fehniger TA, Holte H, Kolstad A, Malmberg KJ (2020)
A Systemic Protein Deviation Score Linked to PD-1⁺ CD8⁺ T Cell Expansion That Predicts Overall Survival in Diffuse Large B Cell Lymphoma
Med, 2 (2), 180-195.e5
DOI 10.1016/j.medj.2020.10.006, PubMed 35590201
Astrup GL, Hofsø K, Bjordal K, Rustøen T (2020)
Cancer patients' diagnosis and symptoms and their family caregivers' self-efficacy and social support are associated with different caregiver reactions
Eur J Cancer Care (Engl), 29 (6), e13311
DOI 10.1111/ecc.13311, PubMed 32885524
Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM, Roodvoets AGH, Nagtegaal ID, Beets-Tan RGH, Blomqvist LK, Fokstuen T, Ten Tije AJ, Capdevila J, Hendriks MP, Edhemovic I, Cervantes A, Nilsson PJ, Glimelius B, van de Velde CJH, Hospers GAP, RAPIDO collaborative investigators (2020)
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
Lancet Oncol, 22 (1), 29-42
DOI 10.1016/S1470-2045(20)30555-6, PubMed 33301740
Bai B, Myklebust JH, Wälchli S (2020)
Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology
Methods Mol Biol, 2115, 445-454
DOI 10.1007/978-1-0716-0290-4_25, PubMed 32006416
Beisland E, Hauge EM, Aarstad AKH, Hjermstad MJ, Aarstad HJ, Beisland C (2020)
Personality and educational level determine self-reported health-related quality-of-life and distress in patients with renal tumors awaiting radical surgery
Scand J Urol, 54 (4), 304-312
DOI 10.1080/21681805.2020.1773528, PubMed 32500779
Bell L, Holloway L, Bruheim K, Petrič P, Kirisits C, Tanderup K, Pötter R, Vinod S, Lim K, Pogson E, Metcalfe P, Hellebust TP (2020)
Dose planning variations related to delineation variations in MRI-guided brachytherapy for locally advanced cervical cancer
Brachytherapy, 19 (2), 146-153
DOI 10.1016/j.brachy.2020.01.002, PubMed 32067884
Benard E, Casey NP, Inderberg EM, Wälchli S (2020)
SJI 2020 special issue: A catalogue of Ovarian Cancer targets for CAR therapy
Scand J Immunol, 92 (4), e12917
DOI 10.1111/sji.12917, PubMed 32557659
Bergsland CH, Bruun J, Guren MG, Svindland A, Bjørnslett M, Smeby J, Hektoen M, Kolberg M, Domingo E, Pellinen T, Tomlinson I, Kerr D, Church DN, Nesbakken A, Sveen A, Lothe RA (2020)
Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer
ESMO Open, 5 (6), e001040
DOI 10.1136/esmoopen-2020-001040, PubMed 33219056
Bersvendsen HS, Haugnes HS, Dahl AA, Fagerli UM, Fluge Ø, Holte H, Wilsgaard T, Smeland KB, Kiserud CE (2020)
Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress
Bone Marrow Transplant, 56 (4), 968-970
DOI 10.1038/s41409-020-01098-5, PubMed 33139869
Bhave P, Pallan L, Long GV, Menzies AM, Atkinson V, Cohen JV, Sullivan RJ, Chiarion-Sileni V, Nyakas M, Kahler K, Hauschild A, Plummer R, Trojaniello C, Ascierto PA, Zimmer L, Schadendorf D, Allayous C, Lebbe C, Maurichi A, Santinami M, Roy S, Robert C, Lesimple T, Patel S, Versluis JM et al. (2020)
Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis
Br J Cancer, 124 (3), 574-580
DOI 10.1038/s41416-020-01121-y, PubMed 33087895
Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa RA, Conroy T, Inwald EC, Serpentini S, Pinto M, Weis J, Morag O, Lindviksmoen Astrup G, Tomaszewski KA, Pogoda K, Sinai P, Sprangers M, Aaronson N, Velikova G, Greimel E, Arraras J, Bottomley A, EORTC Quality of Life Group and Breast Cancer Group (2020)
Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288
Ann Oncol, 31 (4), 552
DOI 10.1016/j.annonc.2020.02.001, PubMed 32089397
Bjerkeset E, Röhrl K, Schou-Bredal I (2020)
Symptom cluster of pain, fatigue, and psychological distress in breast cancer survivors: prevalence and characteristics
Breast Cancer Res Treat, 180 (1), 63-71
DOI 10.1007/s10549-020-05522-8, PubMed 31938939
Blindheim A, Fosså S, Babigumira R, Myklebust TÅ, Haug E, Arum CJ, Andreassen BK (2020)
T1 bladder cancer in Norway: treatment and survival
Scand J Urol, 54 (5), 370-375
DOI 10.1080/21681805.2020.1803401, PubMed 32783590
Bonsaksen T, Heir T, Skogstad L, Grimholt TK, Ekeberg O, Lerdal A, Schou-Bredal I (2020)
Daily use of alcohol in the Norwegian general population: Prevalence and associated factors
Drugs Alcohol Today, 20 (2), 109-121
DOI 10.1108/DAT-02-2020-0010
Brandal P, Bergfeldt K, Aggerholm-Pedersen N, Bäckström G, Kerna I, Gubanski M, Björnlinger K, Evensen ME, Kuddu M, Pettersson E, Brydøy M, Hellebust TP, Dale E, Valdman A, Weber L, Høyer M (2020)
A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients
Acta Oncol, 59 (10), 1157-1163
DOI 10.1080/0284186X.2020.1817977, PubMed 32902341
Brenne AT, Knudsen AK, Raj SX, Skjelvan L, Lund JÅ, Thronæs M, Løhre ET, Hågensen LÅ, Brunelli C, Kaasa S (2020)
Fully Integrated Oncology and Palliative Care Services at a Local Hospital in Mid-Norway: Development and Operation of an Innovative Care Delivery Model
Pain Ther, 9 (1), 297-318
DOI 10.1007/s40122-020-00163-7, PubMed 32274655
Breugom AJ, Bastiaannet E, Guren MG, Kørner H, Boelens PG, Dekker FW, Kapiteijn E, Gelderblom H, Larsen IK, Liefers GJ, van de Velde CJH (2020)
Treatment strategies and overall survival for incurable metastatic colorectal cancer - A EURECCA international comparison including 21,196 patients from the Netherlands and Norway
Eur J Surg Oncol, 46 (6), 1167-1173
DOI 10.1016/j.ejso.2020.02.005, PubMed 32151531
Brunelli C, Borreani C, Caraceni A, Roli A, Bellazzi M, Lombi L, Zito E, Pellegrini C, Spada P, Kaasa S, Foschi AM, Apolone G, PATIENT VOICES study group (2020)
PATIENT VOICES, a project for the integration of the systematic assessment of patient reported outcomes and experiences within a comprehensive cancer center: a protocol for a mixed method feasibility study
Health Qual Life Outcomes, 18 (1), 252
DOI 10.1186/s12955-020-01501-1, PubMed 32723341
Brunsvig PF, Guren TK, Nyakas M, Steinfeldt-Reisse CH, Rasch W, Kyte JA, Juul HV, Aamdal S, Gaudernack G, Inderberg EM (2020)
Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer
Front Immunol, 11, 572172
DOI 10.3389/fimmu.2020.572172, PubMed 33324397
Brunvoll SH, Thune I, Bertheussen GF, Fjeldheim F, Flote VG, Frydenberg H, Lundgren S, Skjerven H, Lømo J, Fagerland MW, McTiernan A, Schlichting E, Hjartåker A (2020)
Dietary changes in early-stage breast cancer patients from pre-surgery and over the 12 months post-surgery
Br J Nutr, 125 (2), 172-182
DOI 10.1017/S0007114520002627, PubMed 32811572
Brustugun OT, Sorhaug S, Gronberg BH, Aanerud M, Al-Zubayidy MMZ, Fjellbirkeland L, Helland A, Berg J, Andreassen B, Paulsen EE, Haram PM, Ashraf H, Wahl SGF (2020)
Lung cancer: Improved prognosis presents capacity challenges
Tidsskr. Nor. Laegeforen., 140 (5), 432-434
Bruun J, Kryeziu K, Eide PW, Moosavi SH, Eilertsen IA, Langerud J, Røsok B, Totland MZ, Brunsell TH, Pellinen T, Saarela J, Bergsland CH, Palmer HG, Brudvik KW, Guren T, Dienstmann R, Guren MG, Nesbakken A, Bjørnbeth BA, Sveen A, Lothe RA (2020)
Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity
Clin Cancer Res, 26 (15), 4107-4119
DOI 10.1158/1078-0432.CCR-19-3637, PubMed 32299813
Bye A, Sandmael JA, Stene GB, Thorsen L, Balstad TR, Solheim TS, Pripp AH, Oldervoll LM (2020)
Exercise and Nutrition Interventions in Patients with Head and Neck Cancer during Curative Treatment: A Systematic Review and Meta-Analysis
Nutrients, 12 (11)
DOI 10.3390/nu12113233, PubMed 33105699
Bøhn SH, Lie HC, Reinertsen KV, Fosså SD, Haugnes HS, Kiserud CE, Loge JH, Wisløff T, Thorsen L (2020)
Lifestyle among long-term survivors of cancers in young adulthood
Support Care Cancer, 29 (1), 289-300
DOI 10.1007/s00520-020-05445-6, PubMed 32358776
Clarke M, Mackay A, Ismer B, Pickles JC, Tatevossian RG, Newman S, Bale TA, Stoler I, Izquierdo E, Temelso S, Carvalho DM, Molinari V, Burford A, Howell L, Virasami A, Fairchild AR, Avery A, Chalker J, Kristiansen M, Haupfear K, Dalton JD, Orisme W, Wen J, Hubank M, Kurian KM et al. (2020)
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
Cancer Discov, 10 (7), 942-963
DOI 10.1158/2159-8290.CD-19-1030, PubMed 32238360
Coleman R, Hadji P, Body JJ, Santini D, Chow E, Terpos E, Oudard S, Bruland Ø, Flamen P, Kurth A, Van Poznak C, Aapro M, Jordan K, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org (2020)
Bone health in cancer: ESMO Clinical Practice Guidelines
Ann Oncol, 31 (12), 1650-1663
DOI 10.1016/j.annonc.2020.07.019, PubMed 32801018
Dagenborg VJ, Marshall SE, Yaqub S, Grzyb K, Boye K, Lund-Iversen M, Høye E, Berstad AE, Fretland ÅA, Edwin B, Ree AH, Flatmark K (2020)
Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastases
Cancer Biol Ther, 21 (5), 432-440
DOI 10.1080/15384047.2020.1721252, PubMed 32098573
Dahl O, Myklebust MP, Dale JE, Leon O, Serup-Hansen E, Jakobsen A, Pfeiffer P, Løes IM, Pfeffer F, Spindler KG, Guren MG, Glimelius B, Johnsson A (2020)
Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version
Acta Oncol, 59 (9), 1016-1023
DOI 10.1080/0284186X.2020.1778180, PubMed 32574087
Dahl AA, Bentzen AG, Fosså SD, Hess SL, Steen R, Kiserud CE (2020)
Long-term cervical cancer survivors on disability pension: a subgroup in need of attention from health care providers
J Cancer Surviv, 14 (4), 578-585
DOI 10.1007/s11764-020-00877-9, PubMed 32279150
Dahl AA, Bentzen AG, Fosså SD, Hess SL, Steen R, Vistad I, Kiserud CE (2020)
Sexual Inactivity During the Last 4 Weeks in Long-Term Cervical Cancer Survivors: Prevalence and Associated Factors
J Sex Med, 17 (7), 1359-1369
DOI 10.1016/j.jsxm.2020.03.010, PubMed 32336554
Dahl AA, Brennhovd B, Fosså SD, Axcrona K (2020)
A cross-sectional study of current work ability after radical prostatectomy
BMC Urol, 20 (1), 9
DOI 10.1186/s12894-020-0579-9, PubMed 32005115
Dahl AA, Fosså SD, Brennhovd B, Axcrona K (2020)
The EPIC-26 domain scores after radical prostatectomy are associated with the personality trait of neuroticism
Int Urol Nephrol, 53 (4), 691-698
DOI 10.1007/s11255-020-02688-4, PubMed 33118115
Dahl AA, Grotmol KS, Hjermstad MJ, Kiserud CE, Loge JH (2020)
Norwegian reference data on the Fatigue Questionnaire and the Patient Health Questionnaire-9 and their interrelationship
Ann Gen Psychiatry, 19, 60
DOI 10.1186/s12991-020-00311-5, PubMed 33062033
De Bruycker A, Spiessens A, Dirix P, Koutsouvelis N, Semac I, Liefhooghe N, Gomez-Iturriaga A, Everaerts W, Otte F, Papachristofilou A, Scorsetti M, Shelan M, Siva S, Ameye F, Guckenberger M, Heikkilä R, Putora PM, Zapatero A, Conde-Moreno A, Couñago F, Vanhoutte F, Goetghebeur E, Reynders D, Zilli T, Ost P (2020)
PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial
BMC Cancer, 20 (1), 406
DOI 10.1186/s12885-020-06911-4, PubMed 32398040
Deek M, Lilleby W, Vaage V, Hole KH, DeWeese T, Stensvold A, Tran P, Seierstad T (2020)
Impact of radiation dose on recurrence in high-risk prostate cancer patients
Prostate, 80 (15), 1322-1327
DOI 10.1002/pros.24059, PubMed 33258482
Demetri GD, Antonescu CR, Bjerkehagen B, Bovée JVMG, Boye K, Chacón M, Dei Tos AP, Desai J, Fletcher JA, Gelderblom H, George S, Gronchi A, Haas RL, Hindi N, Hohenberger P, Joensuu H, Jones RL, Judson I, Kang YK, Kawai A, Lazar AJ, Le Cesne A, Maestro R, Maki RG, Martín J et al. (2020)
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
Ann Oncol, 31 (11), 1506-1517
DOI 10.1016/j.annonc.2020.08.2232, PubMed 32891793
Digernes I, Nilsen LB, Grøvik E, Bjørnerud A, Løvland G, Vik-Mo E, Meling TR, Saxhaug C, Helland Å, Jacobsen KD, Geier O, Emblem KE (2020)
Noise dependency in vascular parameters from combined gradient-echo and spin-echo DSC MRI
Phys Med Biol, 65 (22), 225020
DOI 10.1088/1361-6560/abb71a, PubMed 33200748
Dillard P, Köksal H, Maggadottir SM, Winge-Main A, Pollmann S, Menard M, Myhre MR, Mælandsmo GM, Flørenes VA, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2020)
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
Mol Ther, 29 (3), 1199-1213
DOI 10.1016/j.ymthe.2020.11.019, PubMed 33212301
Dillard P, Lie M, Baken E, Lobert VH, Benard E, Köksal H, Inderberg EM, Wälchli S (2020)
Colorectal cysts as a validating tool for CAR therapy
BMC Biotechnol, 20 (1), 30
DOI 10.1186/s12896-020-00623-0, PubMed 32487146
Dueland S, Line PD (2020)
Response to the Comment on"Survival Following Liver Transplantation for Patients With Non-resectable Liver Only Colorectal Metastases": What if those Lesions Are Gone?
Ann Surg, 271 (5), e124
DOI 10.1097/SLA.0000000000003604, PubMed 32301798
Dueland S, Line PD (2020)
Liver segment 2+3 living donation in liver transplantation for colorectal liver metastases
Hepatobiliary Surg Nutr, 9 (3), 382-384
DOI 10.21037/hbsn.2019.11.15, PubMed 32509836
Dummer R, Hauschild A, Santinami M, Atkinson V, Mandalà M, Kirkwood JM, Chiarion Sileni V, Larkin J, Nyakas M, Dutriaux C, Haydon A, Robert C, Mortier L, Schachter J, Lesimple T, Plummer R, Dasgupta K, Gasal E, Tan M, Long GV, Schadendorf D (2020)
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
N Engl J Med, 383 (12), 1139-1148
DOI 10.1056/NEJMoa2005493, PubMed 32877599
Dybvik E, Furnes O, Havelin LI, Fosså SD, Trovik C, Lie SA (2020)
A prospective study on cancer risk after total hip replacements for 41,402 patients linked to the Cancer registry of Norway
BMC Musculoskelet Disord, 21 (1), 599
DOI 10.1186/s12891-020-03605-7, PubMed 32900364
Eide IJZ, Helland Å, Ekman S, Mellemgaard A, Hansen KH, Cicenas S, Koivunen J, Grønberg BH, Brustugun OT (2020)
Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study)
Lung Cancer, 143, 27-35
DOI 10.1016/j.lungcan.2020.03.009, PubMed 32200138
Ekström MP, Palmqvist S, Currow DC, Sjøgren P, Kurita GP, Jakobsen G, Kaasa S, Hjermstad M (2020)
Mild to Moderate Cognitive Impairment Does Not Affect the Ability to Self-Report Important Symptoms in Patients With Cancer: A Prospective Longitudinal Multinational Study (EPCCS)
J Pain Symptom Manage, 60 (2), 346-354.e2
DOI 10.1016/j.jpainsymman.2020.03.007, PubMed 32179133
Elvebakken H, Perren A, Scoazec JY, Tang LH, Federspiel B, Klimstra DS, Vestermark LW, Ali AS, Zlobec I, Myklebust TÅ, Hjortland GO, Langer SW, Gronbaek H, Knigge U, Tiensuu Janson E, Sorbye H (2020)
A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations
Neuroendocrinology, 111 (9), 883-894
DOI 10.1159/000511905, PubMed 33002892
Eskelund CW, Dimopoulos K, Kolstad A, Glimelius I, Räty R, Gjerdrum LMR, Sonnevi K, Josefsson P, Nilsson-Ehle H, Bentzen HHN, Fagerli UM, Kuittinen O, Haaber J, Niemann CU, Pedersen LB, Larsen MT, Geisler CH, Hutchings M, Jerkeman M, Grønbæk K (2020)
Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3
Hemasphere, 5 (1), e510
DOI 10.1097/HS9.0000000000000510, PubMed 33364550
Eskelund CW, Husby S, Favero F, Klausen TW, Rodriguez-Gonzalez FG, Kolstad A, Pedersen LB, Räty RK, Geisler CH, Jerkeman M, Weischenfeldt J, Grønbæk K (2020)
Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL
Blood, 135 (22), 2000-2004
DOI 10.1182/blood.2019003539, PubMed 32181815
Fajgenbaum DC, Wu D, Goodman A, Wong R, Chadburn A, Nasta S, Srkalovic G, Mukherjee S, Leitch H, Jayanthan R, Ferrero S, Sato Y, Schey S, Dispenzieri A, Oksenhendler E, Zinzani PL, Lechowicz MJ, Hoffmann C, Pemmaraju N, Bagg A, Fossa A, Lim MS, van Rhee F, Castleman Disease Collaborative Network Scientific Advisory Board diagnostic criteria international working group and treatment guidelines international working group (2020)
Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease
Am J Hematol, 95 (12), 1553-1561
DOI 10.1002/ajh.25992, PubMed 32894785
Falstie-Jensen AM, Esen BÖ, Kjærsgaard A, Lorenzen EL, Jensen JD, Reinertsen KV, Dekkers OM, Ewertz M, Cronin-Fenton DP (2020)
Incidence of hypothyroidism after treatment for breast cancer-a Danish matched cohort study
Breast Cancer Res, 22 (1), 106
DOI 10.1186/s13058-020-01337-z, PubMed 33050919
Fauske L, Hompland I, Lorem G, Hall KS, Bondevik H (2020)
Striving towards Normality in Daily Life: A Qualitative Study of Patients Living with Metastatic Gastrointestinal Stromal Tumour in Long-Term Clinical Remission
Sarcoma, 2020, 1814394
DOI 10.1155/2020/1814394, PubMed 33082706
Flem-Karlsen K, Nyakas M, Farstad IN, McFadden E, Wernhoff P, Jacobsen KD, Flørenes VA, Mælandsmo GM (2020)
Soluble AXL as a marker of disease progression and survival in melanoma
PLoS One, 15 (1), e0227187
DOI 10.1371/journal.pone.0227187, PubMed 31917795
Fleten KG, Lund-Andersen C, Waagene S, Abrahamsen TW, Mørch Y, Boye K, Torgunrud A, Flatmark K (2020)
Experimental Treatment of Mucinous Peritoneal Metastases Using Patient-Derived Xenograft Models
Transl Oncol, 13 (8), 100793
DOI 10.1016/j.tranon.2020.100793, PubMed 32447231
Fosså A, Smeland KH, Fluge Ø, Tronstad KJ, Loge JH, Midttun Ø, Ueland PM, Kiserud CE (2020)
Metabolic analysis of amino acids and vitamin B6 pathways in lymphoma survivors with cancer related chronic fatigue
PLoS One, 15 (1), e0227384
DOI 10.1371/journal.pone.0227384, PubMed 31923274
Fosså SD, Dahl AA, Myklebust TÅ, Kiserud CE, Nome R, Klepp OH, Brydøy M, Haugnes HS (2020)
Risk of positive selection bias in longitudinal surveys among cancer survivors: Lessons learnt from the national Norwegian Testicular Cancer Survivor Study
Cancer Epidemiol, 67, 101744
DOI 10.1016/j.canep.2020.101744, PubMed 32652337
Fosså SD, Aas K, Müller C, Jerm MB, Tandstad T, Lilleby W, Kvåle R, Gulbrandsen J, Haug E, Myklebust TA (2020)
Definitive radiotherapy for prostate cancer in Norway 2006-2015: Temporal trends, performance and survival
Radiother Oncol, 155, 33-41
DOI 10.1016/j.radonc.2020.10.022, PubMed 33096165
Frafjord A, Skarshaug R, Hammarström C, Stankovic B, Dorg LT, Aamodt H, Woldbaek PR, Helland Å, Brustugun OT, Øynebråten I, Corthay A (2020)
Antibody combinations for optimized staining of macrophages in human lung tumours
Scand J Immunol, 92 (1), e12889
DOI 10.1111/sji.12889, PubMed 32299134
Fredheim OM, Skurtveit S, Loge JH, Sjøgren P, Handal M, Hjellvik V (2020)
Prescription of analgesics to long-term survivors of cancer in early adulthood, adolescence, and childhood in Norway: a national cohort study
Pain, 161 (5), 1083-1091
DOI 10.1097/j.pain.0000000000001800, PubMed 31923046
Frič R, Due-Tønnessen BJ, Lundar T, Egge A, Kronen Krossnes B, Due-Tønnessen P, Stensvold E, Brandal P (2020)
Long-term outcome of posterior fossa medulloblastoma in patients surviving more than 20 years following primary treatment in childhood
Sci Rep, 10 (1), 9371
DOI 10.1038/s41598-020-66328-8, PubMed 32523021
Frydenberg H, Harsem NK, Ofigsbø Å, Skoglund H, Brændengen M, Kaasa S, Guren MG (2020)
Chemotherapy During Pregnancy for Advanced Colon Cancer: A Case Report
Clin Colorectal Cancer, 19 (2), 141-144
DOI 10.1016/j.clcc.2020.02.013, PubMed 32222353
Georgiesh T, Boye K, Bjerkehagen B (2020)
A novel risk score to predict early and late recurrence in solitary fibrous tumour
Histopathology, 77 (1), 123-132
DOI 10.1111/his.14078, PubMed 31991494
Grindedal EM, Jørgensen K, Olsson P, Gravdehaug B, Lurås H, Schlichting E, Vamre T, Wangensteen T, Heramb C, Mæhle L (2020)
Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway
Fam Cancer, 19 (2), 133-142
DOI 10.1007/s10689-020-00160-x, PubMed 32002722
Grov EK, Dahl AA (2020)
Is neuroticism relevant for old cancer survivors? A controlled, population-based study (the Norwegian HUNT-3 survey)
Support Care Cancer, 29 (7), 3623-3632
DOI 10.1007/s00520-020-05870-7, PubMed 33174077
Grut H, Stern NM, Dueland S, Labori KJ, Dormagen JB, Schulz A (2020)
Preoperative 18F-FDG PET/computed tomography predicts survival following resection for colorectal liver metastases
Nucl Med Commun, 41 (9), 916-923
DOI 10.1097/MNM.0000000000001235, PubMed 32796480
Guldvik IJ, Zuber V, Braadland PR, Grytli HH, Ramberg H, Lilleby W, Thiede B, Zucknick M, Saatcioglu F, Gislefoss R, Kvåle R, George A, Grönberg H, Wiklund F, Neal DE, Gnanapragasam VJ, Taskén KA, Mills IG (2020)
Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification
Eur Urol Open Sci, 21, 51-60
DOI 10.1016/j.euros.2020.08.007, PubMed 34337468
Gullestad HP, Haugen G, Fosså SD (2020)
Late arm and shoulder problems after axillary therapeutic lymph node dissection in patients with melanoma
J Plast Surg Hand Surg, 55 (2), 127-131
DOI 10.1080/2000656X.2020.1842746, PubMed 33176535
Hall KS, Bruland ØS, Bjerkehagen B, Lidbrink E, Jebsen N, Hagberg H, Papworth K, Hagberg O, Trovik C, Bauer H, Eriksson M (2020)
Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study
Clin Sarcoma Res, 10 (1), 22
DOI 10.1186/s13569-020-00145-5, PubMed 33292545
Halvorsen AR, Haugen MH, Öjlert ÅK, Lund-Iversen M, Jørgensen L, Solberg S, Mælandsmo GM, Brustugun OT, Helland Å (2020)
Protein Kinase C Isozymes Associated With Relapse Free Survival in Non-Small Cell Lung Cancer Patients
Front Oncol, 10, 590755
DOI 10.3389/fonc.2020.590755, PubMed 33324562
Halvorsen TO, Stokke K, Killingberg KT, Raj SX, Sørhaug S, Brustugun OT, Fløtten Ø, Helbekkmo N, Hornslien K, Madebo T, Fluge S, Grønberg BH (2020)
Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC
Acta Oncol, 59 (9), 1051-1057
DOI 10.1080/0284186X.2020.1778179, PubMed 32543258
Halvorsrud L, Bye A, Brekke LA, Bergland A (2020)
Being a trained volunteer Peer Supporter for carers of people living with dementia in Norway: Reciprocal benefits and challenges
Health Soc Care Community, 28 (6), 2150-2159
DOI 10.1111/hsc.13026, PubMed 32490553
Hamre CFB, Kvammen EMH, Vinge LE, Skeie AT, Hompland I (2020)
Sarcoma of the heart
Tidsskr. Nor. Laegeforen., 140 (6), 582-583
Hannevik TL, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Paulsen PQ, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2020)
Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism
Thromb Res, 196, 238-244
DOI 10.1016/j.thromres.2020.08.042, PubMed 32919178
Harneshaug M, Benth JS, Kirkhus L, Gronberg BH, Bergh S, Rostoft S, Slaaen M (2020)
CT Derived Muscle Measures, Inflammation, and Frailty in a Cohort of Older Cancer Patients
In Vivo, 34 (6), 3565-3572
DOI 10.21873/invivo.12200, PubMed 33144469
Hauge T, Amdal CD, Falk RS, Johannessen HO, Johnson E (2020)
Long-term outcome in patients operated with hybrid esophagectomy for esophageal cancer - a cohort study
Acta Oncol, 59 (7), 859-865
DOI 10.1080/0284186X.2020.1750694, PubMed 32324079
Helland T, Naume B, Hustad S, Bifulco E, Kvaløy JT, Saetersdal AB, Synnestvedt M, Lende TH, Gilje B, Mjaaland I, Weyde K, Blix ES, Wiedswang G, Borgen E, Hertz DL, Janssen EAM, Mellgren G, Søiland H (2020)
Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen
Mol Oncol, 15 (4), 957-967
DOI 10.1002/1878-0261.12865, PubMed 33252186
Hellesnes R, Myklebust TÅ, Bremnes RM, Karlsdottir Á, Kvammen Ø, Negaard HFS, Tandstad T, Wilsgaard T, Fosså SD, Haugnes HS (2020)
Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study
J Clin Oncol, 39 (4), 308-318
DOI 10.1200/JCO.20.02713, PubMed 33356420
Hestevik CH, Molin M, Debesay J, Bergland A, Bye A (2020)
Older patients' and their family caregivers' perceptions of food, meals and nutritional care in the transition between hospital and home care: a qualitative study
BMC Nutr, 6, 11
DOI 10.1186/s40795-020-00335-w, PubMed 32206325
Hjermstad MJ, Aass N, Andersen S, Brunelli C, Dajani O, Garresori H, Hamre H, Haukland EC, Holmberg M, Jordal F, Krogstad H, Lundeby T, Løhre ET, Mjåland S, Nordbø A, Paulsen Ø, Schistad Staff E, Wester T, Kaasa S, Loge JH (2020)
PALLiON - PALLiative care Integrated in ONcology: study protocol for a Norwegian national cluster-randomized control trial with a complex intervention of early integration of palliative care
Trials, 21 (1), 303
DOI 10.1186/s13063-020-4224-4, PubMed 32241299
Hompland I, Fauske L, Lorem GF, Bruland ØS (2020)
Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors
Clin Sarcoma Res, 10, 2
DOI 10.1186/s13569-019-0124-3, PubMed 31969978
Hugenschmidt H, Labori KJ, Brunborg C, Verbeke CS, Seeberg LT, Bendigtsen Schirmer C, Renolen A, Borgen E, Naume B, Wiedswang G (2020)
Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information
BMC Cancer, 20 (1), 1107
DOI 10.1186/s12885-020-07510-z, PubMed 33198661
Hugenschmidt H, Labori KJ, Brunborg C, Verbeke CS, Seeberg LT, Schirmer CB, Renolen A, Borgen EF, Naume B, Wiedswang G (2020)
Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma
Ann Surg, 271 (3), 549-558
DOI 10.1097/SLA.0000000000003035, PubMed 30216219
Haakensen VD, Khadse A, Sandhu V, Halvorsen AR, Solberg SK, Jørgensen LH, Brustugun OT, Kure EH, Helland Å (2020)
Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy
Int J Cancer, 147 (10), 2957-2966
DOI 10.1002/ijc.33121, PubMed 32468587
Inderberg EM, Wälchli S (2020)
Long-term surviving cancer patients as a source of therapeutic TCR
Cancer Immunol Immunother, 69 (5), 859-865
DOI 10.1007/s00262-019-02468-9, PubMed 31915853
Inderberg EM, Wälchli S (2020)
Sympathetic improvement of cancer vaccine efficacy
Hum Vaccin Immunother, 16 (8), 1888-1890
DOI 10.1080/21645515.2019.1703456, PubMed 31977269
Isaksen KT, Beiske K, Smeland EB, Jørgensen J, Brodtkorb M, Myklebust JH, Jerkeman M, Meriranta L, Karjalainen-Lindsberg ML, Leppä S, Scott DW, Holte H, Blaker YN (2020)
The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma
EJHaem, 2 (1), 104-108
DOI 10.1002/jha2.109, PubMed 35846101
Isasi I, Irusta U, Aramendi E, Olsen JA, Wik L (2020)
Detection of Shockable Rhythms Using Convolutional Neural Networks During Chest Compressions Provided by a Load Distributing Band
COMPUT CARDIOL CONF, 45
DOI 10.22489/CinC.2020.045
Jakobsen G, Engstrøm M, Hjermstad MJ, Rosland JH, Aass N, Albert E, Kaasa S, Fayers P, Klepstad P, Paulsen Ø (2020)
The short-term impact of methylprednisolone on patient-reported sleep in patients with advanced cancer in a randomized, placebo-controlled, double-blind trial
Support Care Cancer, 29 (4), 2047-2055
DOI 10.1007/s00520-020-05693-6, PubMed 32856209
Jakobsen LH, Ellin F, Smeland KB, Wästerlid T, Christensen JH, Jørgensen JM, Josefsson PL, Øvlisen AK, Holte H, Blaker YN, Grauslund JH, Bjørn J, Molin D, Lagerlöf I, Smedby KE, Colvin K, Thanarajasingam G, Maurer MJ, Habermann TM, Song KW, Zhu KY, Gerrie AS, Cheah CY, El-Galaly TC (2020)
Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients
Br J Haematol, 189 (4), 661-671
DOI 10.1111/bjh.16425, PubMed 32017050
Janssens GO, Melchior P, Mul J, Saunders D, Bolle S, Cameron AL, Claude L, Gurtner K, van de Ven KP, van Grotel M, Harrabi S, Lassen-Ramshad Y, Lavan N, Magelssen H, Muracciole X, Boterberg T, Mandeville H, Godzinski J, Graf N, van den Heuvel-Eibrink MM, Rübe C (2020)
The SIOP-Renal Tumour Study Group consensus statement on flank target volume delineation for highly conformal radiotherapy
Lancet Child Adolesc Health, 4 (11), 846-852
DOI 10.1016/S2352-4642(20)30183-8, PubMed 33068550
Jeanmougin M, Håvik AB, Cekaite L, Brandal P, Sveen A, Meling TR, Ågesen TH, Scheie D, Heim S, Lothe RA, Lind GE (2020)
Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment
Mol Oncol, 14 (5), 1016-1027
DOI 10.1002/1878-0261.12668, PubMed 32171051
Joensuu H, Eriksson M, Sundby Hall K, Reichardt A, Hermes B, Schütte J, Cameron S, Hohenberger P, Jost PJ, Al-Batran SE, Lindner LH, Bauer S, Wardelmann E, Nilsson B, Kallio R, Jaakkola P, Junnila J, Alvegård T, Reichardt P (2020)
Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-up
JAMA Oncol, 6 (8), 1241-1246
DOI 10.1001/jamaoncol.2020.2091, PubMed 32469385
K Jensen NB, Pötter R, Spampinato S, Fokdal LU, Chargari C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Wiebe E, Cooper R, Van der Steen-Banasik E, Van Limbergen E, Sundset M, Pieters BR, Nout RA, Kirisits C, Kirchheiner K, Tanderup K, EMBRACE Collaborative Group (2020)
Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study
Int J Radiat Oncol Biol Phys, 109 (3), 688-700
DOI 10.1016/j.ijrobp.2020.10.006, PubMed 33068689
Kerns SL, Fung C, Fossa SD, Dinh PC, Monahan P, Sesso HD, Frisina RD, Feldman DR, Hamilton RJ, Vaughn D, Martin N, Huddart R, Kollmannsberger C, Sahasrabudhe D, Ardeshir-Rouhani-Fard S, Einhorn L, Travis LB (2020)
Relationship of Cisplatin-Related Adverse Health Outcomes With Disability and Unemployment Among Testicular Cancer Survivors
JNCI Cancer Spectr, 4 (4), pkaa022
DOI 10.1093/jncics/pkaa022, PubMed 32704617
Kierulf-Vieira KS, Sandberg CJ, Waaler J, Lund K, Skaga E, Saberniak BM, Panagopoulos I, Brandal P, Krauss S, Langmoen IA, Vik-Mo EO (2020)
A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
Cancers (Basel), 12 (6)
DOI 10.3390/cancers12061630, PubMed 32575464
Kimby E, Lockmer S, Holte H, Hagberg H, Wahlin BE, Brown P, Østenstad B (2020)
The simplified follicular lymphoma PRIMA-prognostic index is useful in patients with first-line chemo-free rituximab-based therapy
Br J Haematol, 191 (5), 738-747
DOI 10.1111/bjh.16692, PubMed 32410260
Kluge R, Wittig T, Georgi TW, Kurch L, Sabri O, Wallace WH, Klekawka T, Fernández-Teijeiro A, Ceppi F, Karlén J, Pears J, Cepelová M, Fosså A, Beishuizen A, Hjalgrim LL, Körholz D, Mauz-Körholz C, Hasenclever D (2020)
Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive Disease
J Nucl Med, 62 (3), 338-341
DOI 10.2967/jnumed.120.247924, PubMed 32764122
Knoth J, Pötter R, Jürgenliemk-Schulz IM, Haie-Meder C, Fokdal L, Sturdza A, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Wiebe E, Rai B, Cooper R, van der Steen-Banasik E, van Limbergen E, Pieters BR, Sundset M, Tan LT, Nout RA, Tanderup K, Kirisits C, Nesvacil N, Lindegaard JC, Schmid MP (2020)
Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study
Gynecol Oncol, 159 (1), 136-141
DOI 10.1016/j.ygyno.2020.07.007, PubMed 32798000
Knutsen E, Lellahi SM, Aure MR, Nord S, Fismen S, Larsen KB, Gabriel MT, Hedberg A, Bjørklund SS, Oslo Breast Cancer Research Consortium (OSBREAC), Bofin AM, Mælandsmo GM, Sørlie T, Mortensen ES, Perander M (2020)
The expression of the long NEAT1_2 isoform is associated with human epidermal growth factor receptor 2-positive breast cancers
Sci Rep, 10 (1), 1277
DOI 10.1038/s41598-020-57759-4, PubMed 31992741
Koch M, Hjermstad MJ, Tomaszewski K, Tomaszewska I, Hornslien K, Harle A, Arraras J, Morag O, Pompili C, Ioannidis G, Navarra C, Chie W, Johnson C, Bohrer T, Janssens A, Kulis D, Bottomley A, Schulz C, Zeman F, Koller M (2020)
Gender effects on quality of life and symptom burden in patients with lung cancer: results from a prospective, cross-cultural, multi-center study
J Thorac Dis, 12 (8), 4253-4261
DOI 10.21037/jtd-20-1054, PubMed 32944337
Koller M, Shamieh O, Hjermstad MJ, Hornslien K, Young T, Chalk T, Ioannidis G, Harle A, Johnson CD, Tomaszewski KA, Serpentini S, Pinto M, van der Weijst L, Janssens A, Morag O, Chie WC, Arraras JI, Pompili C, Jungraithmayr W, Hechtner M, Katsochi D, Müller K, Gräfenstein L, Schulz C, Bottomley A et al. (2020)
Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study
Lancet Oncol, 21 (5), 723-732
DOI 10.1016/S1470-2045(20)30093-0, PubMed 32213338
Kolstad A, Illidge T, Bolstad N, Spetalen S, Madsbu U, Stokke C, Blakkisrud J, Løndalen A, O'Rourke N, Beasley M, Jurczak W, Fagerli UM, Kaščák M, Bayne M, Obr A, Dahle J, Rojkjaer L, Pascal V, Holte H (2020)
Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma
Blood Adv, 4 (17), 4091-4101
DOI 10.1182/bloodadvances.2020002583, PubMed 32877524
Kramer I, Hooning MJ, Mavaddat N, Hauptmann M, Keeman R, Steyerberg EW, Giardiello D, Antoniou AC, Pharoah PDP, Canisius S, Abu-Ful Z, Andrulis IL, Anton-Culver H, Aronson KJ, Augustinsson A, Becher H, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bogdanova NV, Bojesen SE, Bolla MK, Bonanni B, Brauch H et al. (2020)
Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk
Am J Hum Genet, 107 (5), 837-848
DOI 10.1016/j.ajhg.2020.09.001, PubMed 33022221
Krause R, Nyakabau A, Gwyther LG, Luyirika E, Kaasa S (2020)
Calling for advocacy, education and public policy actions on pain control for patients with cancer in Africa
ESMO Open, 5 (4)
DOI 10.1136/esmoopen-2020-000757, PubMed 32826300
Krogstad H, Loge JH, Grotmol KS, Kaasa S, Kiserud CE, Salvesen Ø, Hjermstad MJ (2020)
Symptoms in the general Norwegian adult population - prevalence and associated factors
BMC Public Health, 20 (1), 988
DOI 10.1186/s12889-020-09109-2, PubMed 32576168
Kummen M, Thingholm LB, Rühlemann MC, Holm K, Hansen SH, Moitinho-Silva L, Liwinski T, Zenouzi R, Storm-Larsen C, Midttun Ø, McCann A, Ueland PM, Høivik ML, Vesterhus M, Trøseid M, Laudes M, Lieb W, Karlsen TH, Bang C, Schramm C, Franke A, Hov JR (2020)
Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis
Gastroenterology, 160 (5), 1784-1798.e0
DOI 10.1053/j.gastro.2020.12.058, PubMed 33387530
Kværner AS, Harnæs H, Alavi DH, Bärebring L, Henriksen HB, Guren MG, Lauritzen PM, Eggesbø HB, Wiedswang G, Smeland S, Blomhoff R (2020)
Should calculation of chemotherapy dosage for bowel cancer be based on body composition?
Tidsskr Nor Laegeforen, 140 (8)
DOI 10.4045/tidsskr.19.0769, PubMed 32463187
Kyte JA, Andresen NK, Russnes HG, Fretland SØ, Falk RS, Lingjærde OC, Naume B (2020)
ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer
J Transl Med, 18 (1), 269
DOI 10.1186/s12967-020-02421-w, PubMed 32620163
Kyte JA, Røssevold A, Falk RS, Naume B (2020)
ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer
J Transl Med, 18 (1), 252
DOI 10.1186/s12967-020-02424-7, PubMed 32576225
Köksal H, Dillard P, Juzeniene A, Kvalheim G, Smeland EB, Myklebust JH, Inderberg EM, Wälchli S (2020)
Combinatorial CAR design improves target restriction
J Biol Chem, 296, 100116
DOI 10.1074/jbc.RA120.016234, PubMed 33234592
König M, Osnes T, Bruland Ø, Sundby Hall K, Bratland Å, Meling TR (2020)
The Role of Adjuvant Treatment in Craniofacial Malignancy: A Critical Review
Front Oncol, 10, 1402
DOI 10.3389/fonc.2020.01402, PubMed 32850452
Lachota M, Vincenti M, Winiarska M, Boye K, Zagożdżon R, Malmberg KJ (2020)
Prospects for NK Cell Therapy of Sarcoma
Cancers (Basel), 12 (12)
DOI 10.3390/cancers12123719, PubMed 33322371
Lanari J, Dueland S, Line PD (2020)
Liver Transplantation for Colorectal Liver Metastasis
Curr. Transplant. Rep., 7 (4), 311-316
DOI 10.1007/s40472-020-00298-8
Larsson C, Groote I, Vardal J, Kleppestø M, Odland A, Brandal P, Due-Tønnessen P, Holme SS, Hope TR, Meling TR, Fosse E, Emblem KE, Bjørnerud A (2020)
Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy
Magn Reson Imaging, 68, 106-112
DOI 10.1016/j.mri.2020.01.012, PubMed 32004711
Leppä S, Jørgensen J, Tierens A, Meriranta L, Østlie I, de Nully Brown P, Fagerli UM, Larsen TS, Mannisto S, Munksgaard L, Maisenhölder M, Vasala K, Meyer P, Jerkeman M, Björkholm M, Fluge Ø, Jyrkkiö S, Liestøl K, Ralfkiaer E, Spetalen S, Beiske K, Karjalainen-Lindsberg ML, Holte H (2020)
Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis
Blood Adv, 4 (9), 1906-1915
DOI 10.1182/bloodadvances.2020001518, PubMed 32380536
Lichtenegger FS, Schnorfeil FM, Rothe M, Deiser K, Altmann T, Bücklein VL, Köhnke T, Augsberger C, Konstandin NP, Spiekermann K, Moosmann A, Boehm S, Boxberg M, Heemskerk MH, Goerlich D, Wittmann G, Wagner B, Hiddemann W, Schendel DJ, Kvalheim G, Bigalke I, Subklewe M (2020)
Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial
Clin Transl Immunology, 9 (3), e1117
DOI 10.1002/cti2.1117, PubMed 32153780
Lilleheie I, Debesay J, Bye A, Bergland A (2020)
Informal caregivers' views on the quality of healthcare services provided to older patients aged 80 or more in the hospital and 30 days after discharge
BMC Geriatr, 20 (1), 97
DOI 10.1186/s12877-020-1488-1, PubMed 32164569
Lilleheie I, Debesay J, Bye A, Bergland A (2020)
A qualitative study of old patients' experiences of the quality of the health services in hospital and 30 days after hospitalization
BMC Health Serv Res, 20 (1), 446
DOI 10.1186/s12913-020-05303-5, PubMed 32434506
Lindemann K, Martinsson L, Kaasa S, Lindquist D (2020)
Elderly gynaecological cancer patients at risk for poor end of life care: a population-based study from the Swedish Register of Palliative Care
Acta Oncol, 59 (6), 636-643
DOI 10.1080/0284186X.2020.1744717, PubMed 32238040
Lofterød T, Frydenberg H, Flote V, Eggen AE, McTiernan A, Mortensen ES, Akslen LA, Reitan JB, Wilsgaard T, Thune I (2020)
Exploring the effects of lifestyle on breast cancer risk, age at diagnosis, and survival: the EBBA-Life study
Breast Cancer Res Treat, 182 (1), 215-227
DOI 10.1007/s10549-020-05679-2, PubMed 32436147
Lokhande L, Kuci Emruli V, Kolstad A, Hutchings M, Räty R, Jerkeman M, Ek S (2020)
Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk
BMC Cancer, 20 (1), 1202
DOI 10.1186/s12885-020-07678-4, PubMed 33287742
Lorntzsen B, Jacobsen AB, GrØholt KK, Sigstad E, Osnes T (2020)
Survival and Surgical Complications in Anaplastic Thyroid Cancer Patients After Completed Multimodal Treatment
Anticancer Res, 40 (12), 6979-6985
DOI 10.21873/anticanres.14722, PubMed 33288592
Lundar T, Due-Tønnessen BJ, Frič R, Brandal P, Due-Tønnessen P (2020)
Adult outcome after treatment of pediatric posterior fossa ependymoma: long-term follow-up of a single consecutive institutional series of 22 patients with more than 5 years of survival
J Neurosurg Pediatr, 26 (1), 22-26
DOI 10.3171/2020.1.PEDS19700, PubMed 32217795
Lundar T, Due-Tønnessen BJ, Frič R, Brandal P, Stensvold E, Due-Tønnessen P (2020)
Outcomes in adulthood after neurosurgical treatment of brain tumors in the first 3 years of life: long-term follow-up of a single consecutive institutional series of 97 patients
Childs Nerv Syst, 37 (2), 427-433
DOI 10.1007/s00381-020-04859-1, PubMed 32814984
Lunde P, Bye A, Bergland A, Grimsmo J, Jarstad E, Nilsson BB (2020)
Long-term follow-up with a smartphone application improves exercise capacity post cardiac rehabilitation: A randomized controlled trial
Eur J Prev Cardiol, 27 (16), 1782-1792
DOI 10.1177/2047487320905717, PubMed 32106713
Lundeby T, Wester TE, Loge JH, Kaasa S, Aass NK, Grotmol KS, Finset A (2020)
Challenges and Learning Needs for Providers of Advanced Cancer Care: Focus Group Interviews with Physicians and Nurses
Palliat Med Rep, 1 (1), 208-215
DOI 10.1089/pmr.2020.0059, PubMed 34223478
Lundereng ED, Dihle A, Steindal SA (2020)
Nurses' experiences and perspectives on collaborative discharge planning when patients receiving palliative care for cancer are discharged home from hospitals
J Clin Nurs, 29 (17-18), 3382-3391
DOI 10.1111/jocn.15371, PubMed 32533726
Lærum-Onsager E, Brovold T, Bergland A, Pripp AH, Bye A (2020)
Associations between health-related quality of life, body mass index, health status and sociodemographic variables in geriatric patients and non-hospitalized older people: A comparative cross-sectional study
Nutr Health, 26 (2), 141-150
DOI 10.1177/0260106020909047, PubMed 32297563
Løndalen A, Blakkisrud J, Revheim ME, Madsbu UE, Dahle J, Kolstad A, Stokke C (2020)
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of ¹⁷⁷Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma
Eur J Nucl Med Mol Imaging, 48 (6), 1902-1914
DOI 10.1007/s00259-020-05098-x, PubMed 33196921
Ma TM, Lilleby O, Lilleby WA, Kishan AU (2020)
Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
Cancers (Basel), 12 (12)
DOI 10.3390/cancers12123606, PubMed 33276562
Macpherson ME, Hov JR, Ueland T, Dahl TB, Kummen M, Otterdal K, Holm K, Berge RK, Mollnes TE, Trøseid M, Halvorsen B, Aukrust P, Fevang B, Jørgensen SF (2020)
Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency
Front Immunol, 11, 574500
DOI 10.3389/fimmu.2020.574500, PubMed 33042155
Marijnen CAM, Peters FP, Rödel C, Bujko K, Haustermans K, Fokas E, Glynne-Jones R, Valentini V, Spindler KG, Guren MG, Maingon P, Calvo FA, Pares O, Glimelius B, Sebag-Montefiore D (2020)
International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic
Radiother Oncol, 148, 213-215
DOI 10.1016/j.radonc.2020.03.039, PubMed 32342861
Maziarz RT, Waller EK, Jaeger U, Fleury I, McGuirk J, Holte H, Jaglowski S, Schuster SJ, Bishop MR, Westin JR, Mielke S, Teshima T, Bachanova V, Foley SR, Borchmann P, Salles GA, Zhang J, Tiwari R, Pacaud LB, Ma Q, Tam CS (2020)
Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma
Blood Adv, 4 (4), 629-637
DOI 10.1182/bloodadvances.2019001026, PubMed 32074277
Mellblom AV, Kiserud CE, Rueegg CS, Ruud E, Loge JH, Fosså SD, Lie HC (2020)
Self-reported late effects and long-term follow-up care among 1889 long-term Norwegian Childhood, Adolescent, and Young Adult Cancer Survivors (the NOR-CAYACS study)
Support Care Cancer, 29 (6), 2947-2957
DOI 10.1007/s00520-020-05790-6, PubMed 33011832
Meltzer S, Bjørnetrø T, Lyckander LG, Flatmark K, Dueland S, Samiappan R, Johansen C, Kalanxhi E, Ree AH, Redalen KR (2020)
Corrigendum to "Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer" [Transl Oncol 12 (8) (2019) 1038-1044]
Transl Oncol, 13 (1), 122-124
DOI 10.1016/j.tranon.2019.09.005, PubMed 31843135
Mensali N, Myhre MR, Dillard P, Pollmann S, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2020)
Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
Cancer Immunol Immunother, 69 (1), 159-161
DOI 10.1007/s00262-019-02409-6, PubMed 31776597
Milano MT, Dinh PC, Yang H, Zaid MA, Fossa SD, Feldman DR, Monahan PO, Travis LB, Fung C (2020)
Solid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24 900 Survivors
JNCI Cancer Spectr, 4 (3), pkaa017
DOI 10.1093/jncics/pkaa017, PubMed 32455335
Maaland AF, Saidi A, Torgue J, Heyerdahl H, Stallons TAR, Kolstad A, Dahle J (2020)
Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin's lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003
PLoS One, 15 (3), e0230526
DOI 10.1371/journal.pone.0230526, PubMed 32187209
Napoli E, Stenberg VY, Juzeniene A, Hjellum GE, Bruland ØS, Larsen RH (2020)
Calibration of sodium iodide detectors and reentrant ionization chambers for ²¹²Pb activity in different geometries by HPGe activity determined samples
Appl Radiat Isot, 166, 109362
DOI 10.1016/j.apradiso.2020.109362, PubMed 32979756
Nilsen LB, Digernes I, Grøvik E, Saxhaug C, Latysheva A, Geier O, Breivik B, Sætre DO, Jacobsen KD, Helland Å, Emblem KE (2020)
Responses in the diffusivity and vascular function of the irradiated normal brain are seen up until 18 months following SRS of brain metastases
Neurooncol Adv, 2 (1), vdaa028
DOI 10.1093/noajnl/vdaa028, PubMed 32642687
Nilssen Y, Brustugun OT, Eriksen MT, Haug ES, Naume B, Møller B (2020)
Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016
BMC Cancer, 20 (1), 488
DOI 10.1186/s12885-020-06979-y, PubMed 32473650
Nilsson K, Klevebro F, Rouvelas I, Lindblad M, Szabo E, Halldestam I, Smedh U, Wallner B, Johansson J, Johnsen G, Aahlin EK, Johannessen HO, Hjortland GO, Bartella I, Schröder W, Bruns C, Nilsson M (2020)
Surgical Morbidity and Mortality From the Multicenter Randomized Controlled NeoRes II Trial: Standard Versus Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy for Esophageal Cancer
Ann Surg, 272 (5), 684-689
DOI 10.1097/SLA.0000000000004340, PubMed 32833767
Nilsson R, Dahl AA, Bernklev T, Kersten H, Haug ES (2020)
Work status and work ability after radical prostatectomy or active surveillance for prostate cancer
Scand J Urol, 54 (3), 194-200
DOI 10.1080/21681805.2020.1750473, PubMed 32285740
Nome RV, Cvancarova Småstuen M, Bjøro T, Kiserud CE, Fosså SD (2020)
Longitudinal kidney function outcome in aging testicular cancer survivors
Acta Oncol, 59 (4), 467-474
DOI 10.1080/0284186X.2020.1724328, PubMed 32043400
Ny L, Hernberg M, Nyakas M, Koivunen J, Oddershede L, Yoon M, Wang X, Guyot P, Geisler J (2020)
BRAF mutational status as a prognostic marker for survival in malignant melanoma: a systematic review and meta-analysis
Acta Oncol, 59 (7), 833-844
DOI 10.1080/0284186X.2020.1747636, PubMed 32285732
Nygaard A, Halvorsrud L, Bye A, Bergland A (2020)
It takes two to tango: carers' reflections on their participation and the participation of people with dementia in the James Lind Alliance process
BMC Geriatr, 20 (1), 175
DOI 10.1186/s12877-020-01570-3, PubMed 32408893
Olsen CF, Debesay J, Bergland A, Bye A, Langaas AG (2020)
What matters when asking, "what matters to you?" - perceptions and experiences of health care providers on involving older people in transitional care
BMC Health Serv Res, 20 (1), 317
DOI 10.1186/s12913-020-05150-4, PubMed 32299424
Olssøn I, Dahl AA (2020)
Long-term changes in attachment patterns after psychotherapy in outpatients with Axis I and personality disorders vs. Axis I disorders only
Personal Ment Health, 15 (2), 136-146
DOI 10.1002/pmh.1500, PubMed 33300299
Palmer DH, Valle JW, Ma YT, Faluyi O, Neoptolemos JP, Jensen Gjertsen T, Iversen B, Amund Eriksen J, Møller AS, Aksnes AK, Miller R, Dueland S (2020)
TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial
Br J Cancer, 122 (7), 971-977
DOI 10.1038/s41416-020-0752-7, PubMed 32063605
Palmerini E, Leithner A, Windhager R, Gosheger G, Boye K, Laitinen M, Hardes J, Traub F, Jutte P, Willegger M, Casanova J, Setola E, Righi A, Picci P, Donati DM, Ferrari S (2020)
Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS)
Sci Rep, 10 (1), 10853
DOI 10.1038/s41598-020-66579-5, PubMed 32616718
Panagopoulos I, Gorunova L, Johannsdottir IMR, Andersen K, Holth A, Beiske K, Heim S (2020)
Chromosome Translocation t(14;21)(q11;q22) Activates Both OLIG1 and OLIG2 in Pediatric T-cell Lymphoblastic Malignancies and May Signify Adverse Prognosis
Cancer Genomics Proteomics, 17 (1), 41-48
DOI 10.21873/cgp.20166, PubMed 31882550
Pierson SK, Khor JS, Ziglar J, Liu A, Floess K, NaPier E, Gorzewski AM, Tamakloe MA, Powers V, Akhter F, Haljasmaa E, Jayanthan R, Rubenstein A, Repasky M, Elenitoba-Johnson K, Ruth J, Jacobs B, Streetly M, Angenendt L, Patier JL, Ferrero S, Zinzani PL, Terriou L, Casper C, Jaffe E et al. (2020)
ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder
Cell Rep Med, 1 (9), 100158
DOI 10.1016/j.xcrm.2020.100158, PubMed 33377129
Pilleron S, Charvat H, Araghi M, Arnold M, Fidler-Benaoudia MM, Bardot A, Grønlie Guren M, Tervonen H, Little A, O'Connell DL, Gavin A, De P, Aagard Thomsen L, Møller B, Jackson C, Bucher O, Walsh PM, Vernon S, Bray F, Soerjomataram I (2020)
Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study
Int J Cancer, 148 (7), 1575-1585
DOI 10.1002/ijc.33326, PubMed 33006395
Pladsen AV, Nilsen G, Rueda OM, Aure MR, Borgan Ø, Liestøl K, Vitelli V, Frigessi A, Langerød A, Mathelier A, OSBREAC, Engebråten O, Kristensen V, Wedge DC, Van Loo P, Caldas C, Børresen-Dale AL, Russnes HG, Lingjærde OC (2020)
DNA copy number motifs are strong and independent predictors of survival in breast cancer
Commun Biol, 3 (1), 153
DOI 10.1038/s42003-020-0884-6, PubMed 32242091
Puzanov I, Ribas A, Robert C, Schachter J, Nyakas M, Daud A, Arance A, Carlino MS, O'Day SJ, Long GV, Margolin KA, Dummer R, Schadendorf D, Lutzky J, Ascierto PA, Tarhini A, Lin J, Mogg R, Homet Moreno B, Ibrahim N, Hamid O (2020)
Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition With Pembrolizumab Outcomes in Advanced Melanoma: Pooled Analysis of 3 Clinical Trials
JAMA Oncol, 6 (8), 1256-1264
DOI 10.1001/jamaoncol.2020.2288, PubMed 32672795
Radaelli S, Fossati P, Stacchiotti S, Akiyama T, Asencio JM, Bandiera S, Boglione A, Boland P, Bolle S, Bruland Ø, Brunello A, Bruzzi P, Campanacci D, Cananzi F, Capanna R, Casadei R, Cordoba A, Court C, Dei Tos AP, DeLaney TF, De Paoli A, De Pas TM, Desai A, Di Brina L, Donati DM et al. (2020)
The sacral chordoma margin
Eur J Surg Oncol, 46 (8), 1415-1422
DOI 10.1016/j.ejso.2020.04.028, PubMed 32402509
Rahman MA, Brekke J, Arnesen V, Hannisdal MH, Navarro AG, Waha A, Herfindal L, Rygh CB, Bratland E, Brandal P, Haasz J, Oltedal L, Miletic H, Lundervold A, Lie SA, Goplen D, Chekenya M (2020)
Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study
Immun Inflamm Dis, 8 (3), 342-359
DOI 10.1002/iid3.315, PubMed 32578964